Glycoprotein receptor mediated regulation of platelet morphology by Calaminus, Simon
Glycoprotein receptor mediated regulation of
platelet morphology
by
Simon Calaminus
UNIVERS IT¥OF
BIR INGHAM
A thesis submitted to the
University of Birmingham
for the degree of
Doctor of Philosophy
Department of Physiology
University of Birmingbam
Medical school
August 2007
 
 
 
 
 
 
 
 
 
University of Birmingham Research Archive 
 
e-theses repository 
 
 
This unpublished thesis/dissertation is copyright of the author and/or third 
parties. The intellectual property rights of the author or third parties in respect 
of this work are as defined by The Copyright Designs and Patents Act 1988 or 
as modified by any successor legislation.   
 
Any use made of information contained in this thesis/dissertation must be in 
accordance with that legislation and must be properly acknowledged.  Further 
distribution or reproduction in any format is prohibited without the permission 
of the copyright holder.  
 
 
 
THESIS
CONTAINS
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ABSTRACT
Spreading platelets sequentially form filopodia, lamellipodia, and stress fibres. This
thesis demonstrates the formation of each actin structure in spread platelets, and in
addition the formation of a novel actin structure, which I have termed an actin nodule.
Actin nodules require Src kinase activation, and actin polymerisation, but are
negatively correlated to ROCK and myosin-Il activation.
This thesis has investigated the role of WAVE-l, Rho kinase (ROCK) and
myosin-Il in spreading and aggregate stability in vitro and in vivo. ROCK or myosin-
II inhibition, prevents stress fibre formation leading to appearance of splits and holes
(termed fenestrations) in spread platelets on collagen. In addition, ROCK or myosin-
II inhibition compromises aggregate stability on collagen at arterial rates of flow.
Lamellipodia formation is inhibited in WAVE-l·l- platelets spread on CRP, whilst
shape change and aggregation downstream of GPVI is severely disrupted. However,
GPCR agonists induce full lamellipodia formation on fibrinogen in WA VE-I-I-.
Aggregate formation on collagen under arterial rates of flow is unaffected further
indicating WAVE-2 can compensate for WAVE-I. Thus, WAVE-I maybe
differentially regulated downstream of GPCR and glycoprotein signalling.
The actin regulatory proteins, Spin-90, P-Pix and Nck are tyrosine
phosphorylated by multiple platelet agonists, but do not form a complex upon platelet
adhesion. However, strikingly P-Pix is more heavily phosphorylated downstream of
the collagen receptor integrin, a2P) in comparison to GPVI. I speculate P-Pix may
play an important role in connecting PLCyl to Rae activation.
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Chapter 1: General Introduction
1.0 GENERAL INTRODUCTION
Platelets playa critical role in the prevention of excessive blood loss at sites of vessel
injury. This is a highly important role as too little activation can cause a bleeding
diathesis. However, too much platelet activation leads to formation of occlusive
thrombi which can cause disorders such as myocardial infarction and stroke. Platelets
are therefore a major target for anti-thrombotic drugs.
The platelet is also involved in several other physiological and pathological
processes including inflammation (Bazzoni et al, 1991), removal of bacteria (Tang et
al, 2002) and cancer metastasis (Jurasz et al, 2004). The multiple roles of the platelet
may be due in part to its derivation from the same haematopoetic stem cell as the
neutrophil and eosinophil (Fig. I. 1) and its evolutionary origin as a haemocyte.
1.1 Platelet production and structure
The platelet is a small (0.5-3Ilm) discoid subcellular fragment. which is present at
between 1.5-4.2x 108/ml in whole blood. Platelets exist in the vasculature for between
7-10 days before removal from the blood by the spleen. Platelets are produced in the
bone marrow from precursor cells, known as megakaryocytes. Megakaryocytes are
multi-nucleated cells, which generate branch-like structures known as proplatelets that
give rise to platelets within the vasculature (Becker et ai, 1976). Proplatelets are
elongated structures formed from the megakaryocyte cell body through rearrangement
of both the microtubular and actin cytoskeletons. They are believed to protrude
through the endothelial cells in the vascular niche of the bone marrow, from where
proplatelets bud off into the vasculature. It is estimated that 3,000-4,000 platelets are
generated from a single megakaryocyte and lOll platelets are replenished in humans
every day. The half-life of a platelet is 5 days for human and 2 days for mouse.
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Chapter I: General Introduction
The platelet receives all its constituents, including granules and membranes
from the megakaryocyte. The platelet does not possess a nucleus and, therefore, has a
very low level ofmRNA and under resting conditions no significant protein synthesis,
although there is evidence of synthesis of a limited number of proteins upon platelet
activation (Fink et aI, 2003, Lindemann et aI, 200 I). It remains unclear whether the
presence of mRNA or protein synthesis plays a physiological role within platelet
function or whether they have been carried over from the megakaryocyte.
The discoid shape of circulating platelets is maintained by the actin
cytoskeleton and the rings of tubulin that surround the platelet periphery. The small
size and structure of the platelet causes it to travel along the edge of blood vessels in
the presence of red blood cells, thereby placing it in the prime position to attach to the
extracellular matrix (ECM) upon damage to the endothelial layer. Platelets contain
three types of granules, a-granules, dense granules and lysosomes. The larger, more
abundant a-granules (40-80 per platelet) contain many proteins that support various
stages of thrombus formation and vascular repair, including P-selectin and integrin
allbP), which become incorporated into the platelet surface membrane upon
stimulation, and the matrix proteins, fibrinogen, von Willebrand factor (VWF) and
fibronectin. The smaller, less numerous dense granules (-7 per platelet) carry small,
soluble activating agents, such as adenine diphosphate (ADP), serotonin and calcium
(Ca2+). The release of ADP plays a critical feedback role in platelet activation.
Activated platelets express the procoagulant phospholipid, phosphatidylscrine
(PS), on their outer membrane. PS provides a surface which supports the coagulation
cascade. The coagulation cascade generates thrombin from prothrombin, which plays
a critical role in further supporting platelet activation and in converting plasma
fibrinogen into fibrin.
4
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1.1.2 The endothelial cell and extracellular matrix
The vasculature is lined with endothelial cells, which form a basement membrane that
is a specialised forrn of the ECM. The endothelial cells continually monitor the
vasculature and help prevent unwanted platelet activation through production of the
inhibitors, prostacyclin and nitric oxide (NO). Disruption of their production can lead
to platelet activation and is implicated in plaque formation (Shimokawa et ai, 2007).
Endothelial cells also produce heparin, a thrombin inhibitor, and provide a surface to
support the fibrinolytic system.
The endothelial layer is usually nonthrombogcnic, thereby preventing platelet
attachment to the vessel wall. Damage to the endothelial layer leads to exposure of
the basement membrane and exposure to collagen type IV and laminin which provide
a surface for platelet adhesion and activation. Furthermore, deeper lesions lead to
exposure to an increased number of matrix proteins, including collagens types I and
III which also induce powerful platelet activation. The endothelial cells also produce
VWF which plays a critical role in supporting platelet attachment and activation in the
high shear rates found within arteries and arterioles (review, Ruggeri et al, 2007).
1.1.3 Thrombus formation
Thrombus formation is initiated via damage to the endothelial layer, leading to
exposure of the ECM. Platelet activation then occurs via a defined sequence of events
(Fig.1.2).
I) Tethering: Exposure to the ECM in a high shear environment leads to platelet
tethering via binding of VWF, which has become immobilised on exposed
collagen fibres, to the GPlb-IX-V complex. This interaction is transient due to
5
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Chapter 1: General Introduction
a very high on-off rate of association/dissociation between VWF and GPlb-
IX-V. The transient association causes platelets to roll along the exposed
surface until further interactions lead to stable adhesion.
2) Integrin activation: The interaction between VWF and GPlb-IX- V brings the
platelet into close contact with collagen fibres, which induce activation
through the low affinity, immunoglobulin receptor, GPVI. This leads to an
increase in the affinity of surface integrins for their receptors, a process known
as integrin activation, including allb~), a receptor for VWF and fibrinogen, and
a~~I' a receptor for collagen.
3) Stable adhesion: Integrin activation leads to stable adhesion through either
the interaction of collagen with integrin a2P, or VWF with allbP3. The stable
adhesion is the result of the high affinity interaction between the two ligands
and their receptors and the relatively slow rates of dissociation.
4) Spreading: A massive reorganisation of the platelet actin cytoskeleton leads
to filopodia and lamell ipodia formation, a response described as platelet
spreading. This dramatically increases the platelet surface area, and further
strengthens adhesion within the high shear environment.
5) Secretion and release: a- and dense granule secretion further support
thrombus formation. Dense granules contain the secondary mediator ADP
which synergises with signals from other receptors to support thrombus
formation. a-granules contain adhesive proteins such as fibrinogen, VWF and
fibronectin. The fusion of a-granules with the membrane also leads to up-
regulation of integrin allbP, Alongside these events, platelets release the
feedback agonist thromboxane A2 (TxA2). which is formed de 110\·0 from
7
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arachidonic acid liberated by activation of cytosolic phospholipase A2
(cPLA2).
6) Aggregate formation: Platelet aggregation IS mediated by binding of
circulating fibrinogen and VWF to activated integrin allb~3 Platelet tethering
to VWF and the subsequent activation of tethered platelets by ADP and TxA2
plays a critical role in aggregation.
7) Procoagulant activity: Platelet activation leads to exposure of the membrane
phospholipid, PS, which supports the coagulation cascade. Activation of the
coagulation cascade drives thrombin generation, reinforcing platelet
activation.
8) Clot retraction: Thrombin cleaves fibrinogen to form fibrin, which serves to
further strengthen the thrombus through an active process known as clot
retraction. Clot retraction is mediated by the action of fibrin and the actin
cytoskeleton via integrin allb~3.
Thrombus formation is thus mediated by the combination of activation of both
platelets and the coagulation cascade.
1.1.4 Dependence of thrombus formation on shear
The process of thrombus formation is dependent on shear. The events described
above govern thrombus formation at medium to high shear rates found within the
arteriolar system. However, at the low shear rates found with the venous system.
fibrinogen is the most important protein driving thrombus formation. It competes
with VWF for binding to allbP3. and probably due to its higher molar ratio in plasma,
dominates binding to the integrin under these conditions. As the shear rate increases.
8
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thrombus formation becomes increasingly dependent on VWF because of its critical
role in the initial capture (or tether) of platelets.
Fibronectin is also implicated in thrombus formation as mice deficient in VWF
and fibrinogen form thrombi upon damage to the endothelium (Ni et al, 2000).
Fibronectin has been proposed as the protein driving this thrombus formation.
Fibronectin-deficient mice (Ni et al, 2003) have deficient thrombus growth, initiation,
and stability, implicating fibronectin as playing a role in each stage of thrombus
formation. However, the role of fibronectin in supporting thrombus formation is not
well defined.
9
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1.2 PLATELET RECEPTORS
The platelet membrane contains many different types of receptors thereby enabling
the platelet to respond to a large range of agonists. These receptors can be placed into
two broad classes, G protein-coupled receptors (GPCRs) and tyrosine kinase
receptors.
1.2.1 GPCR receptors
GPCRs are 7 transmembrane proteins that induce activation through a G protein,
which is composed of a, p, and y subunits. The G protein subtype takes its name
from the a-subunit. Upon activation, GOP dissociates from the a-subunit and is
replaced by GTP. This causes a conformational change that liberates the py complex.
The a subunit is a GTPase and hydrolyses GTP to GOP, thereby switching off the G
protein signal. Examples of platelet GPCRs include the two ADP receptors. P2Y1 and
P2Y12, the thrombin receptors, Protease activated receptor (PAR)1 and PAR4. and the
thromboxane receptor, TP (Murugappans et al, 2004, Coughlin. 2005). The P2Yl2
ADP receptor is coupled to Gil family of G proteins. while the other four receptors are
coupled to the G, and G1J families. G, signals via PLCP leading to an increase in
intracellular ci+ and protein kinase C (PKC) activation. GI2U signals via the
RhoA/Rho kinase (ROCK) pathway leading to shape change. stress fibre formation
and aggregation (Moers et al, 2004).
G protein signalling plays an important role within platelet activation. For
example, platelets lacking Gaq or Gau show a marked reduction in responsiveness to
agonists such as thrombin and TxA2• In addition these platelets will adhere normally
to collagen. but cannot form thrombi. This implicates G protein signalling as playing
10
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a fundamental role within platelet activation and thrombus formation (Moers et al.
2004 ).
1.2.2 Tyrosine kinase receptors
A distinct number of platelet glycoprotein receptors signal via tyrosine kinase
receptors, including GPlb-IX- Y, GPYI and integrins. These receptors signal through
sequential activation of Src and Syk tyrosine kinases, leading to PLCy2 activation,
although each signalling pathway is distinct. All of these signalling cascades rely on
adaptor proteins which serve as scaffolds integrating proteins into signalling
complexes. These interactions are mediated through a number of protein and lipid
binding domains including Src homology 2 (SH2), Src homology 3 (SH3) and
pleckstrin homology (PH) domains. SH2 and SH3 protein binding domains interact
with phosphotyrosine, and proline rich regions respectively (review Pawson et al.
2001, review Vidal et al, 2001). PH domains interact with lipid phosphoinositides in
the membrane.
11
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1.3 PLATELET AGONISTS AND THEIR RECEPTORS
The major platelet ligands and their receptors that support thrombus formation are
discussed below.
1.3.1 Fibrinogen and integrin (l.lIbP3
Fibrinogen, comprises of two sets of a, P and y chains linked by both interchain and
intrachain disulphide bonds (Doolittle et al, 1979). A sequence of II amino acids on
the y chain of fibrinogen is essential for integrin allb~J binding rather than the
arginine-glycine-aspartate (RGD) sequence present on the a chains. Due to its
structure, fibrinogen can mediate crosslinking of platelets through integrin allb~3.
allb~3 is the major integrin present on the platelet surface with over 80,000
copies on the plasma membrane and a further 40,000 copies on a-granules. It
represents approximately 3% of the total protein within the cell (Niya et al. 1987,
Phillips et aI, 1988). allh~J is a heterodimer of two non-covalently bound subunits,
allb and p3. In addition to binding fibrinogen, it also serves as a receptor for VWF,
fibronectin, vitronectin and CD40 Iigand. Patients with defects in expression or
function of either subunit of the integrin have a major bleeding problem, known as
Glanzmanrr's thrombasthenia (George et al. 1990).
allbP3 is present on platelets in a low-affinity (or inactive) state, but can be
induced to bind its ligands in response to 'inside-out signals' during platelet
activation. This in tum leads to ligand binding and the generation of 'outside-in'
signals (Fig.!.3) which serve to reinforce platelet activation. Clustering of allhP1
leads to activation of the tyrosine kinases, Src and Syk. Src is constitutively
associated with the [3 tail through its SH3 domain (Arias-Salgado et al, 2003), and is
critical both for recruitment and activation of Syk (Obergfell et al, 20(2). Src
12
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1P3 + DAG
Tyrosine kinase Other protein
Phospholipase Adaptor proteins
Site of tyrosine phosphorylation
Figure 1.3: Syk dependent intracellular signalling induced by UllbJ33
integrin activation after ligand binding. Ligand binding initiates the
autophosphorylation of Src leading to the recruitment of Syk. Src mediated
Syk phosphorylation leads to the recruitment of SLP-76, Vav1/3 and
PLCy2. PLCy2 is then activated leading to the formation of diacylglycerol
(OAG) and inositol phosphate (IP3).
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activation downstream of allbPJ is mediated through autophosphorylation at position
418 (Arias-Salgado et al, 2003). This leads to Syk recruitment to the p3 tail through
an interaction between its N-terminal SH2 domain and the last 28 amino acids of the
p3 tail. However, this interaction does not require phosphorylation of the p3 tail, a
key difference to Syk recruitment in GPVI signalling (Woodside et al, 2001). Syk
activation leads to recruitment of Vav 113 and SLP- 76, and subsequent
phospholipaseCy2 (PLCy2) activation. This is independent of the adapter Linker for
Activation ofT cells (LAT) as the signalling cascade takes place outside of lipid rafts,
in contrast to signalling by the collagen receptor, GPVI (Wonerow et ai, 2002).
PLCy2 recruitment to the membrane is proposed to be mediated through the actin
cytoskeleton, as cytochalasin 0 can cause a decrease in PLCy2 phosphorylation. In
addition, maximum PLCy2 activity is driven by PI 3-kinase, whose product,
phosphatidylinositol 3,4,5-trisphosphate (PI 3,4,5-P3) is thought to interact with the
PH domains on PLCy2 and Tee family kinases, which mediate PLCy2
phosphorylation.
Outside-in signalling also involves tyrosine phosphorylation of two conserved
tyrosines on the p3 tail. The first tyrosine residue is present within a NPXY motif and
upon phosphorylation associates with binding adaptor proteins such as DOK2. The
second residue is present in a NXXY motif, and associates with adapter proteins such
as She. Interestingly, the two tyrosine residues have been mutated to phenylalanine to
make the diYF mouse (Law et al. 1999). This mouse has a significant increase in
recurrent bleeding and impairment in clot retraction. This is associated with a defect
in myosin binding to the p3 integrin tail (Jenkins et al, 1998). Both tyrosines are
required for myosin binding. Tyrosine phosphorylation of the p3 tail also leads to
formation of a complex between Receptor for activated C-kinase (RACK 1) and
14
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protein kinase C 13 (PKC13), and an association with focal adhesion kinase (FAK)
(Buensuceso et ai, 2005).
1.3.2 VWF and GPlb-IX-V
VWF is a multimeric protein that is assembled into disulphide-linked multimers that
consist of between 2-500 subunits and can have a molecular weight of several million.
The major receptors for VWF are GPIb-IX- V and integrin UllbP3. There are
approximately 25,000 copies of the GPIb-IX- V complex per platelet. This complex is
a product of four genes: GPIbu, GPIbp, GPXI, and GPV, each of which is
characterised by a series of leucine-rich repeats. The binding of VWF to GPIb-IX-V
complex takes place at intermediate to high rates of shear. However, this interaction
can also be induced through use of the snake C-type lectin modulator, botrocetin, and
the bacterial glycopeptide, ristocetin. The use of these reagents enables dissection of
the VWF signalling cascades, as botrocetin induces signalling via GPIb-IX- V, and
ristocetin via both GPIb-IX- V and UllbP3(McCarty et al, 2006).
GPIb-IX- V is associated with the initial transient platelet adhesion that takes
place under high shear conditions. In addition, there is evidence that GPJb-IX- V
generates intracellular signals which are generally considered to be weak (Nesbitt et
ai, 2002, Jackson et ai, 1994, and Asazuma et ai, 1997), but under certain conditions
can be strong (Canobbio et ai, 2001, and Torti et al, 1999). The GPlb signalling
cascade is similar to those used by GPVI and integrin Ullb133,but with several
important differences. GPIb-IX- V signals via the non-tyrosine receptor kinases Fyn,
Lyn, and Syk, and the adapters She and SLP- 76 leading to PLCy2 activation
(Asazuma et aI, 1997, Falati et al, 1999, Jackson et al. 1994, Marshall et al, 2002,
Torti et ai, 1999, and Wu et al, 2001). GPIb also physically associates with FcRy-
15
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chain and FcyRIlA (Cannobbio et aI, 2001), although neither association is essential
for signalling as demonstrated in mice deficient in the FcRy-chain, while FcyRIIA is
absent from the mouse genome.
The absence of GPIb-IX- V leads to Bernard Soulier syndrome, which is
characterised by thrombocytopenia, enlarged platelets and a marked bleeding
syndrome (Lopez et ai, 1998, Tomer et al. 1994).
1.3.3 Collagen
Collagen is the most platelet reactive protein within the ECM. It supports platelet
adhesion through direct and indirect (via VWF) mechanisms, and activates platelets
leading to aggregation and formation of a pro-coagulant surface. Collagen-platelet
interactions are most important at medium to high rates of shear (Nieswandt et aI,
2003).
There are over 20 different forms of collagen within the human body, with 9
forms present within the vessel wall (Nieswandt et ai, 2003). Fibrillar collagen type I
and III are the major forms of collagen within the ECM. Collagens are made up of
multiple repeats of glycine-X- Y, and are rich in prolines and hydroxyprolines. The
sequence GPO (single amino acid code; 0 = hydroxyproline) is estimated to represent
10% of collagens types I and III. The collagen receptor GPVI binds selectively to this
sequence to mediate platelet activation.
Collagen causes platelet activation through the immunoglobulin-like receptor
GPVI and the integrin a2PI. Collagen is proposed to activate platelets via the "two
site-two step" model (Fig.lAi). Here, the platelet initially interacts with collagen via
GPVI, which generates intracellular signals that lead to activation of integrin ad31•
Binding to integrin a2PI has the net effect of reinforcing the binding to GPVI and
16
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thereby increasing the net strength of signalling. In addition, integrin U2Pl generates
weak intracellular signals of unknown physiological relevance. At high shear, both
GPYI and U2Pl are required to propagate formation of a stable aggregate, with the
former mediating integrin activation and the latter contributing both to the net strength
of GPVI signalling and stable adhesion (Auger et ai, 2005). Interestingly, there is also
evidence that platelets can bind directly to the non-activated form of integrin U2Pl
independent of GPYI (Fig.l.4ii). Once stable adhesion has occurred, secretion of the
secondary mediators, ADP and TxA2 drives aggregate formation. It is unknown
whether there are additional collagen receptors that support activation, though several
others have been proposed (Moog et aI, 2001, Chiang et ai, 1997 & 2002).
1.3.3.1 GPVI
GPYI signals via its binding partner, the FcRy-chain (Tsuji et ai, 1997; Gibbins et ai,
1997). GPYT can be activated by the snake venom toxin, convulxin, and by the
synthetic collagen, collagen repeated peptide (CRP), which signals through a repeat
GPO motif. Clustering of GPYI initiates tyrosine kinase signalling (Fig.l.5) that is
regulated by phosphorylation of the two conserved tyrosines in the immunoreceptor
tyrosine activation motif (ITAM) that is present in the FcRy-chain. This motif,
YXXLlIX6-8 YXXL/I, is phosphorylated by the Src family kinases, Fyn and Lyn
(Ezumi et aI, 1998, Quek et ai, 2000), which are held in association with the proline
rich region of GPVI through their SH3 domains (Suzuki-Inoue et aI, 2002).
Interestingly, mice deficient in both Fyn and Lyn can still cause residual GPVI
signalling, indicating that one or more additional Src family kinases are able to
mediate activation as this response is abolished in the presence of Src kinase
inhibitors (Quek et ai, 2000).
18
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Collagen
FcRy-Chain
1
IP3 + DAG
~ ~
PKC Ca2+
\t ~
Platelet
activation
LAT Signalosome
Tyrosine kinase Other protein
Phospholipase Adaptor proteins
Site of tyrosine phosphorylation
Figure 1.5: The GPVI signalling cascade. Collagen interaction with
GPVI causes ITAM phosphorylation, by Fyn and Lyn. Syk is recruited,
through interaction of the ITAMs and its tandem SH2 domains. Syk causes
LAT phosphorylation, and the formation of the LAT signalosome, of SLP-
76, Gads,Vav1/3, Btk, and PLCy2. PLCy2 is then activated leading to the
formation of DAG and IP3.
19
Chapter I: General Introduction
Syk recruitment to the FcRy-chain ITAM via its two SH2 domains leads to its
phosphorylation either downstream of Fyn and Lyn or through autophosphorylation.
Syk is fundamentally required for GPVI signalling, as shown using Syk" mice (Poole
et al, 1997). Syk generates formation of a signalosome which is central to GPVI
signalling. At the core of the signalosome is the transmembrane adaptor protein,
LAT, and two cytosolic adaptors SLP-76, and Gads. LAT undergoes phosphorylation
on several conserved tyrosines allowing it to bind multiple proteins (Gibbins et al,
1998). SLP-76 is fundamental to the GPVI cascade with an almost complete abolition
of GPVI signalling in SLP-76- - mice (Judd et al, 2002). However, there is a residual
response in mice deficient in LAT, while there is no alteration in platelet activation in
the absence of Gads, thereby demonstrating the presence of additional adaptor
proteins (Judd et al, 2002). The formation of the signalosome brings in several
additional proteins including the adaptor proteins, Vavl and 3, and the tyrosine
kinases, Btk/Tec, which also playa critical role in PLCy2 regulation (Pearce et ai,
2002, 2004; Quek et al, 2000; Atkinson et ai, 2003). PI 3-kinase also contributes to
PLCy2 activation by GPVI as demonstrated using the structurally distinct inhibitors,
wortmann in and Ly294002 (Pasquet et al, 1999). Rae has also been reported to
activate PLCy2 and PI 3-kinase. Mouse and human platelets express both forms of
PLCy, 1 and 2, but the latter has the predominant role in mediating activation, as
shown using PLCy2-1- platelets (Wang et ai, 2000). In addition, in human platelets,
PLCy I does not undergo phosphorylation following GPVI activation.
As discussed above, GPVI plays an important role in platelet adhesion to
collagen at high shear. However, although platelet adhesion to collagen, and
thrombus formation is defective within GPVI deficient mice, there is only a minor
bleeding phenotype associated with GPVI deficient mice and humans (review
20
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Nieswandt et aI, 2003), thereby demonstrating redundancy within the regulation of
platelet activation.
1.3.3.2 Integrin a.2~)
azPI mediates weak platelet activation as demonstrated by platelet spreading on an
a2PI-selective peptide, containing the sequence GFOGER, despite the peptide being
unable to induce aggregation (Inoue et aI, 2003, Suzuki-Inoue et ai, 2001).
Interestingly, integrin a2~1 signals via a similar pathway to that used by integrin
allb~3, namely via Src kinase regulation of PLCy2. It is possible that this signalling
pathway helps to minimise the bleeding in mice deficient in GPYI (Nieswandt et ai,
2001 ).
1.3.4 ADP and ATP, and the P2Y), P2Y12 and P2X) receptors
ADP signals via the two GPCRs, P2Y1, and P2Y1z• P2Y1 is expressed on multiple
tissues, including blood vessels, platelets and heart. In platelets, it is coupled to G,
and G 13. P2Y 1 activation leads to shape change and weak, reversible aggregation
(Leon et ai, 1999). Mice deficient in P2Y 1have impaired thrombus formation and an
increase in bleeding time (Fabre et aI, 1999), although the overall significance of the
ADP receptor remains unclear since, as yet, no patients have been identified with a
defect in the nucleotide receptor.
P2Y 12 is coupled to the GaiZ, which inhibits adenyl cyclase and therefore
potentiates platelet activation. In addition, P2Y 12mediates GPy regulation of PI 3-
kinase P and y isoforms, which synergises with signals from Cal+ -mobilising
receptors to induce full platelet activation. In response to ADP, P2Y1z·· platelets
undergo transient aggregation through activation of P2Y 1(Foster et aI, 200 I). P2Y 12··
21
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mice and P2YI2-1- human patients have a marked increase In bleeding tendency
thereby illustrating the critical role of this receptor in mediating activation (Foster et
ai, 2001, Hollopeter et ai, 2001). P2Y 12 is the target for one of the two major classes
of orally-available anti platelet agents, clopidigrel (Bennet et ai, 2001).
P2X1 is a ligand-gated ion channel which serves as a receptor for ATP.
Activation of P2X 1 leads to transient shape change but not aggregation (Takano et al,
1999, Rolf et ai, 2001). Activation of P2X1 potentiates granule release and
aggregation to low-dose collagen, TXA2 and thrombin receptors (Oury et al 2001,
2002). P2X 1-1- mice exhibit normal bleeding times, but show less tendency to form
thrombi in both the ferric chloride and laser-induced model of vascular injury
(Hechler et aI, 2003). The overall significance of P2X1, however, remains unclear as
no patients with a bona fide mutation in the ATP receptor are reported.
1.3.5 Thromboxane Az and the TP receptor
TXA2 is a lipid synthesised from arachidonic acid by the action of prostaglandin G/H
synthase, and thromboxane synthase. It is a potent vasoconstriction agent, and signals
in platelets through G, and GIJ, causing dense granule release and (XllhP.1 activation.
Patients and mice deficient in TxA2 formation have a mild bleeding phenotype
(Thomas et al, 1998). The efficacy of aspirin as an anti-thrombotic agent is mediated
by inhibition of TxA2 formation. Aspirin acts by irreversibly inhibiting prostaglandin
G/H synthase, and can be used at a low dose to selectively target platelets because
they are unable to synthesise new protein.
22
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1.3.6 Thrombin and the PAR receptors
Thrombin is a powerful platelet agonist produced by the cleavage of prothrombin to
thrombin through the activity of Factor Xa and Va. Thrombin acts through PARI and
PAR4 receptors in humans, and PAR3 and PAR4 in mouse. Thrombin does not bind
directly to PARI and PAR4, but causes cleavage of their N-termini. This reveals a
tethered ligand leading to intramolecular binding and intracellular signalling
downstream of the two PAR receptors. In contrast, the role of PAR3 is to present
thrombin to the PAR4 receptor, thereby increasing the net affinity of the interaction.
In platelets, PAR I and PAR4 signal through G, and G 13. In human platelets,
PARI and PAR4 activation leads to aggregation and secretion. If PARI is blocked
with antibodies, PAR4 will signal in response to high concentrations of thrombin
(Kahn et al, 1999) demonstrating PAR I and PAR4 respond to low and high
concentrations of thrombin, respectively. PAR4-1- mice fail to undergo platelet shape
change, mobilise Ca2+, secrete ATP, or aggregate to thrombin, clearly demonstrating
the requirement for PAR4 to mediate thrombin signalling (Sambrano et ai, 200 I).
The action of PAR receptors is turned off due to internalization and degradation.
Thrombin plays a vital role in supporting thrombus formation and in mediating
stabilisation as it cleaves fibrinogen to fibrin, a requirement for clot retraction. The
prevention of thrombin activation through treatment of heparin is a major mechanism
of prevention of deep vein thrombosis.
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1.4 PLATELET ACTIN CYTOSKELETON
The actin cytoskeleton is important in maintaining platelet shape and integrity within
the high shear environment of the vasculature. The platelet's discoid shape is
maintained by a spectrin-based membrane skeleton, a tightly coiled region of
microtubules, and a rigid network of cross-linked actin filaments. Following platelet
adhesion to ECM proteins such as fibrinogen and collagen, the actin cytoskeleton
undergoes a massive rearrangement leading to filopodia and lamellipodia formation
and an overall 'fried-egg' appearance. This shape change is driven by the breakdown
of the microtubular ring which maintains the initial discoid shape of the platelet and
by actin polymerisation (Nachiamas et al, 1980).
1.4.1 The regulation of actin assembly
Actin is the most abundant platelet protein, with a cytoplasmic concentration of
0.55mM which corresponds to approximately two million copies of actin per cell
(Nachmias et aI, 1988). Of this, approximately 40% of actin is present in 2,000-5,000
filaments that make up a rigid network of cytoplasmic actin filaments (Hartwig et al,
1991). The filaments represent polymerised fibres of actin monomers. The remaining
actin is present as monomers in the cytoplasm, most likely complexed with actin
monomer binding proteins.
Actin filaments are polarised, with a fast growing (barbed) and a slow growing
(pointed) end. The terms pointed and barbed originate from the arrow-like structure
of actin filaments dotted with myosin in electron micrographs. The barbed end is
oriented to the periphery of the cell toward the plasma membrane. Actin filaments are
polymerised by the addition of ATP-actin to the barbed end (Fig.1.6). Upon
polyrnerisation, ATP is quickly hydrolysed to ADP, but the phosphate group is not
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readily released. The half life for phosphate release is 6min. During this period the
filament is stable. However, upon phosphate release, cofilin an actin severing and
depolymerising protein, binds the filament causing depolymerisation at the pointed
end. Depolymerised ADP-actin binds either to the actin nucleotide exchange factor
profilin or to thyrnosin-Bd, which prevents nucleotide exchange. Profilin has a greater
affinity for ADP-actin than thymosin-Bd. However, there is significantly less profilin
than ADP-actin within cells. Therefore the excess ADP-actin binds to thyrnosin-Be.
The binding of actin to thymosin-Bd acts as an important buffering mechanism,
preventing the cell from incorporating all of the available actin monomers into
filaments (reviews Pollard et al , 2003, Millard et al, 2005). Within a resting cell, an
actin filament undergoes continuous polymerisation at the barbed end and
depolymerisation at the pointed end (Fig.1.6). Therefore there is a very slow
treadmilling of actin monomers from barbed to pointed end (Fujiwara et al, 2002).
The rate of actin polymerisation is increased upon stimulation via an increase
In barbed end formation, which can be brought about in three ways: uncapping
existing filaments, severing existing filaments and de 110\'0 nucleation. At the present
time it is unclear which of these mechanisms is the most important although, there is
evidence to suggest that de 110m nucleation and actin filament severing are thought to
be the predominant mechanisms in a large number of cell types (Condeelis ct al, 1993,
Zigmund et ai, 1996, and Kiuchi et al. 2007). De 110\'0 nucleation is mediated via the
Arp2/3 complex, a complex comprising of seven proteins. The binding of an activator
to the complex leads to a conformational change and drives actin polymerisation.
Arp2/3 complex activators include the Wiskott-Aldrich Syndrome (WASP) family of
proteins, WASP, N-WASP and WASP-family verprolin-homologous protein
(W AVE)-1-3 (also known as suppressor of cyclic AMP repressor (Scar», and other
26
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proteins such as cortactin, and Spin-90 (Kim et al, 2007, Bryce et al, 2005). The
Arp2/3 complex mediates new barbed end formation by generating new actin
filaments at 70° to the original filament, leading to formation of the 3D meshwork of
actin filaments that is characteristic of lamellipodia. The role of actin severing in
lamellipodia formation is also gaining recognition as this has been shown to be
dependent on the production of new barbed ends by the action of cofilin, at least in
MLTn3 mammary adenocarcinoma cells (Chan et al, 2000). However, in addition
there is also strong evidence that cofilin regulates the actin cytoskeleton dynamics
through regulation of actin monomer availability (Kiuchi et al, 2007).
Uncapping of filaments also plays an important role in increasing the number
of barbed ends, and the correct localisation of actin polymerisation within a cell, i.e
the periphery of the cell. In addition, capping also allows for the formation of short
actin filaments that are of maximum strength to ensure maximum movement. There
are multiple proteins that have been demonstrated to cap actin filaments including
gelsolin, adducin, and capping protein (CP), a homologue of chicken CapZ (Cooper et
al, 2000; Sun et al, 1999; Kuhlman et al, 1996). Within platelets gelsolin, CapZ, and
a-adducin have all been identified (Falet et al. 2000; Gilligan et al, 1999; Barkalow et
al, 1995). Barkalow et al (1995) identified the release of CP released barbed ends
ready for polymerisation in permeabilised platelets stimulated by thrombin. This
release was dependent on gelsolin. Falet et al (2000) reported the uncapping of
gelsolin-capped filaments during actin polymerisation in platelets was required to
mediate Arp2/3 complex mediated actin nucleation induced by CRP. Uncapping of
barbed ends is mediated by membrane phosphoinositides downstream of Rae
(Hartwig et al, 1995). In addition platelets also contain adducin, which in red blood
cells has been identified as a capping protein (Kuhlman et al, 1996). Adducin is
27
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associated with the resting platelet cytoskeleton, in conjunction with spectrin. Upon
platelet activation PKC phosphorylates adducin leading to its disassociation from the
cytoskeleton, and the movement of spectrin to the central region of the platelet. PKC
is fundamental to the formation of lamellipodia within platelets. Due to the
disassociation of adducin new barbed ends are formed ready for actin polymerisation
(Barkalow et ai, 2003).
28
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1.4.2 The regulation of actin polymerisation by Rho family GTPases
The Rho G'TPases, act as molecular switches and are involved in multiple signalling
pathways leading to cell adhesion, migration, cytokinesis, proliferation and
transformation (Nobes et al, 1995, Ridley et al. 1992a&b, reviewed Jaffe et al, 2005).
Rho GTPases cycle between an active, GTP-bound and inactive, GOP-bound state.
This cycling is tightly controlled by GDP exchange factors (GEFs), which stimulate
replacement of GDP by GTP; GTPase-activating proteins (GAPs), which stimulate
the innate GTPase activity of the small GTPases; and by guanine nucleotide
dissociation inhibitors (GDIs), which act as negative regulators by blocking GDP-
dissociation. The GEFs, GAPs and GDIs which regulate Rho family GTPases in
platelets are unknown.
The most well known Rho GTPases are Cdc42, Rae, and RhoA. Their roles
within cells have been demonstrated through microinjection of active forms (reviewed
by Hall et al, 1998). This has led to the identification that these proteins play a
fundamental role in filopodia, larnellipodia, and stress fibre formation respectively in
a wide variety of cell types (Nobes et al, 1995).
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1.4.3 The regulation of the actin cytoskeleton by WASP family proteins
In association with the RhoGTPases, the WASP family playa fundamental role within
the regulation of the actin cytoskeleton. There are five members of the WASP family,
WASP, N-WASP, WAVE-I, -2, and -3. WASP was first identified as a mutated gene
in Wiskott-Aldrich syndrome, a rare X-linked chromosome disorder, associated with
immmunological dysfunction and thrombocytopenia (Derry et al, 1994). WASP is
only present in haematopoeitic cells, WAVE-l and WAVE-3 are mainly neuronal in
origin, but are also found in platelets, and N-WASP and WAVE-2 are ubiquitous
(Miki et al, 1996, Suetsugu et al, 1999).
WASP and N-WASP are effectors of Cdc42. They have highly similar
structures (Fig.l.7), with a C-terminal actin and Arp2/3 complex binding domain, and
aN-terminal WASP homology domain. They are present within the cytoplasm in an
autoinhibited state, but become activated by Cdc42 binding to the CRIB domain.
Both WASP and N-WASP have been identified as potent activators of the Arp2/3
complex. However, their precise cellular role is not yet fully understood. Initial data
indicated a role within filopodia formation (Miki et al, 1998) which is now disputed
(Biyasheva et al, 2004). More recent data has identified a role for both WASP and N-
WASP in vesicle trafficking (review Ridley et al, 2006, Benesch et al, 2002, and
Snapper et ai, 2001).
A lack of N-WASP is embryonically lethal at day II (Snapper et al, 200 I).
Defects were observed within the neural and cardiac tissue, which is similar to defects
associated with WAVE-T- mice. WASp·· mice however are viable, although a lack
of WASP is associated with abnormalities of the immune system, including a
reduction in lymphocytes, and thrombocytopenia (Zhang et al, 1999). The difference
between the
30
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two knockouts is consistent with the ubiquitous expression of N-WASP, in
comparison to the haematopoietic-specific expression of WASP (Miki et ai, 1996,
Derry et aI, 1994).
WAVE is a major target for the small GTPase Rae, WAVE is structurally
similar to WASP and N- WASP, with a near identical C-terminal actin and Arp2/3
complex binding domain. However, the N-terminus of WAVE has a WAVE
homology domain of unknown function (Fig. I. 7). WAVE is constitutively active, a
crucial difference to the Arp2/3 complex and WASP/N- WASP. To prevent WAVE
activation it is complexed with four other proteins, PIR121, Nap125, Abi-2, and
HSPC300 (Fig.1.8). WAVE is activated by the binding of GTP-Rac and Nck to
PIRl21 and NAPI25 respectively, which leads to dissociation of WAVE and
HSPC300. WAVE and HSPC300 then trans locate to the leading edge of the cell,
where WAVE binds the Arp2/3 complex, driving actin polymerisation. WAVE is
reported to be switched off in cerebellar granular neurons through the activity of a
Rae GEF, WRP (Soderling et ai, 2003). WAVE is phosphorylated by Abl kinase, and
this is also believed to be a method of regulation (Miki et ai, 1999), although not in
platelets which do not express Abl (SAGE data and western blotting unpublished
Mike Tomlinson). The distinct isoforms of WAVE have been proposed to play
different roles in different cell types. It is believed that WAVE-2 plays a fundamental
role in fibroblast lamellipodia formation and migration. However, WAVE-I has been
implicated in transmigration of fibroblasts through the ECM but not lamellipodia
formation (Suetsugu et ai, 2002).
WAVE-I-I- mice have been produced by two different groups (Soderling et ai,
2003; Dahl et aI, 2003). Dahl et ai, made WAvs.r" mice via gene trapping
(Zambrowics et ai, 1998). The Scar/W AvE-l-l- mice exhibited increased post-natal
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mortality, living for only 3-4 weeks. This differs to Soderling et al, (2003) who
produced WAYE-l-!- mice via WAYE-l targeting vectors in ES cells. They identified
a reduction in viability and a reduction in body mass, but by 8 weeks the WAYE-I-!-
mice were comparable to wild-type. There was no increase in post-natal mortality.
Although there are clear differences in the two studies, probably due to the differing
targeting strategies there are a number of similarities. The mice are smaller, have
reduced brain size but otherwise normal physiology. WAYE-l-'- mice show reduced
anxiety, learning and memory, have sensorimotor retardation and a resting leg tremor.
This illustrates the role of WAYE-I within the central nervous system, correlating
with its expression. The lack of a major phenotype outside of the brain indicates that
other WAYE isoforms can compensate for WAYE-I. WAYE-T- mice are
embryonically lethal at day 9-12 (Yan et al, 2003; Yamazaki et al, 2003) due to a
number of developmental problems, most notably in the formation of the vasculature.
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1.4.4 The regulation of filopodia formation
After stimulation, the actin cytoskeleton is initially reorganised into filopodia.
Filopodia are highly dynamic rod-like extensions from the cell surface. They are
made up of bundles of parallel actin filaments, which grow at the tip end (Oldenbourg
et ai, 2000), and are crosslinked with a-actinin, fascin and filamin. Their formation is
independent of the Arp2/3 complex (Svitkina et ai, 2003) and so they do not undergo
branching, retaining their rod-like structure.
Filopodia were initially thought to be regulated downstream of Cdc42 through
association of N-WASP or WASP with the Arp2/3 complex (Nobes et al, 1995;
Stradal et ai, 2004) (Fig 1.9). However, deletion of WASP (Biyasheva et al, 2004) or
N-WASP (Lommel et al, 2001, Snapper et ai, 2001) does not abolish Cdc42-induced
filopodia formation. This is consistent with the presence of filopodia in both human
and mouse WASP-!- platelets (Gross et ai, 1999). Moreover, a recent study reported
filopodia formation in Cdc42-!- fibroblastoid cells (Czuchra et ai, 2005). However, it
must be noted that another paper disputes this and demonstrates an important role for
Cdc42 in filopodia formation in mouse embryo fibroblasts (Yang et al, 2006).
There is increasing evidence from several cell types that filopodia formation is
dependent on the fonnin, mDia2 (Pellegrin et al, 2005; Schirenbeck et al, 2005).
mDia2 has been identified at the tips of Cdc42 induced filopodia (review Faix et al,
2006). In addition, it can induce filopodia independently of Cdc42, but dependent on
another RhoGTPase, Rif (Pellegrin et ai, 2005; Ellis et al, 2000). Formins are prime
candidates to drive filopodia extension as they drive linear actin polymerisation
independent of the Arp2/3 complex (review Pollard et aI, 2003). Allied to this,
formins can uncap filaments, causing the presentation of barbed ends ready for
polymerisation (Schirenbeck et al, 2005).
35
Chapter 1: General Introduction
tn
:l- u:l .... ca •E £x:.-...
tn
36
Chapter 1: General Introduction
1.4.5 The regulation of lamellipodia formation
After filopodia formation, the gaps between the filopodia are filled in by a sheet-like
structure, known as lamellipodia. Lamellipodia consist of highly branched short actin
filaments that form a 3D layer of cross-linked actin and are instrumental in cell
motility and cell spreading (Ridley et ai, 1995, Nobes et ai, 1995). The Arp2/3
complex is essential for lamellipodia formation as it causes branching of actin
filaments leading to formation of a 3D meshwork of actin.
Rae is believed to drive lamellipodia formation through association with
WAVE, leading to the activation of the Arp2/3 complex (Fig 1.9). Rae was first
identified as playing a role in lamellipodia formation within Swiss 3T3 fibroblasts
(Ridley et ai, 1992). The role of Rae has been firmly established through the use of
Rae dominant-negative mutants (review Ridley et ai, 2001, and Hartwig et ai, 1995),
and the generation of murine knock outs of Rac-I and Rac-2 (Walmsley et ai, 2003,
and Gu et ai, 2003). Three isoforms of Rae have now been identified, with expression
dependent on tissue type. Rae activation is believed to take place beneath the plasma
membrane.
Effectors of Rae have been implicated in lamellipodia formation, including
PAK, and WAVE. PAK is a serine/threonine kinase, of which there are multiple
isoforms, all of which interact with both Cdc42 and Rae through a CRIB domain. It is
involved in multiple cell signalling pathways including the JNK and p38 kinase
pathways that control gene expression (reviewed Bokoch 2003). PAK is implicated in
disassembly of stress fibres, cell motility, and in lamellipodia formation through
interaction with cortactin (Sells et al, 1997, Vidal et ai, 2002), which is involved in
lamellipodia stabilisation (reviewed Olazabal et ai, 2001), and through activation of
cofilin. PAKI controls the formation of the complex between P-Pix and Rac-l , which
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is vital for Rae-I activation in HEK293 and MDCKII cells (Ten Klooster et ai, 2006).
Both PAK and ~-Pix interact with the adaptor protein Nck, which is important in
multiple tyrosine kinase signalling pathways, affecting adhesion and cytoskeletal
reorganisation (Bokoch et al, 1996; Lim et ai, 2003).
WAVE is vital for the activation of the Arp2/3 complex, as exemplified by the
removal of WAVE-2 in both fibroblasts and endothelial cells leading to the abolition
of lamellipodia. If WAVE-2 is returned to the cell, lamellipodia can be restored
(Yamazaki et ai, 2003).
In addition Spin-90, a Nck binding protein, with a SH3 domain, 3 proline rich
regions, and a serine/threonine region (Lim et ai, 2001 & 2003) is implicated within
lamellipodia formation in HeLa cells. Spin-90 forms a complex with ~-Pix, WASP
and Nck upon adhesion within HeLa cells, and moves to lamellipodia upon cell
spreading (Lim et ai, 2003; Kim et ai, 2006). In addition Spin-90 RNAi prevented
lamellipodia formation (Kim et ai, 2006). Furthermore, Spin-90 is able to bind actin
and the Arp2/3 complex through its C-terminal region, and thereby drive actin
polymerisation independent of the WASP family proteins (Kim et ai, 2006 & 2007).
1.4.6 The regulation of stress fibre formation
After, or possibly during lamellipodia formation, the actin cytoskeleton undergoes
further reorganisation as stress fibres are formed. Stress fibres are similar in
arrangement to muscle cell sarcomeres, but the polarity is less regular. They contain
the non-muscle counterparts to many of the muscle proteins, such as actin, myosin-II,
tropomyosin and troponins. They are crosslinked with a-actinin, and can form dorsal
or ventral stress fibres, and transverse arcs (Hotulainen et ai, 2006). Ventral stress
fibres are contractile assemblies that cross the cell, and are connected at either end to
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focal adhesions. They are important in cell adhesion and contraction. Transverse arcs
are curved actomyosin bundles not connected to focal adhesions. Dorsal stress fibres
are connected to focal adhesion but rise vertically (Small et ai, 1998). Stress fibres
are important in cell adhesion and the maintenance of cell structure and integrity.
Stress fibre formation is mediated via RhoA activation of its effectors ROCK
(Ridley et al, 1992) and the formin, mOlA 1 (review Jaffe and Hall, 2005) (Fig.1.9).
ROCK is a serine/threonine protein kinase. There are two different forms, ROCK I
and II, both ubiquitously expressed within mouse, rat and human tissues (Yoneda et
al, 2005). ROCK induces myosin light chain (MLC) phosphorylation, through
inhibition of MLC phosphatase, leading to myosin-Il activation. Non-muscle myosin-
lis are involved in multiple cellular responses, platelet shape change and stress fibre
formation (Canobbio et al, 2005). They are made up of two heavy chains and four
light chains, (two regulatory and two essential). Myosin-Il interacts with the actin
cytoskeleton, leading to contraction and thereby giving the cell structural integrity. At
the same time as activating ROCK, RhoA also activates mDIA I (review Jaffe and
Hall, 2005). mDIA 1 mediates stress fibre formation by driving actin polymerisation
at focal adhesions (Hotulainen et ai, 2006). ROCK also indirectly facilitates stress
fibre formation via phosphorylation of LIMkinase. LIM Kinase in turn phosphorylates
cofilin, inhibiting its actin severing activity, thereby increasing actin filament stability.
1.4.7 Specialised actin structures associated with cell spreading
Within a spreading cell a number of additional actin structures have been both
identified and characterized. These include podosornes, focal adhesions, dorsal
ruffles and peripheral ruffles, yeast actin patches, and invadopodia. Each of these is
discussed in detail below.
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Podosomes were first identified within monocyte-derived cells such as
osteocJasts (Marchisio et al, 1984). Podosomes consist of a dot-shaped F-actin
enriched structure, which acts as a matrix contact point (Fig. I. I 0). Podosomes are
usually found in large numbers and make up a rosette structure. They are 1-21lm in
diameter, and between 200-400nm in height. Within the central core of a podosorne,
the actin filaments are surrounded by a ring consisting of vinculin, tal in, a-actin in,
Src, WASP, the Arp2/3 complex, gelsolin and tyrosine-phosphorylated proteins
(Marchisio et ai, 1988). The presence of actin polymerisation proteins such as the
Arp2/3 complex and WASP differentiate podosomes from focal adhesions (Marchisio
et ai, 1984, 1988). Podosome formation in monocytes is PKC-dependent (Marchisio
et al, 1988, and Giadano et al, 1990). The role of podosomes is little understood. A
role in adhesion is proposed due to the similarity with focal adhesions, or due to the
dynamic nature of podosomes; they might transfer membrane tension along the
substrate, as the lamellipodia extends (review Buccione et al, 2004).
Focal adhesions connect stress fibres to the ECM. Focal adhesions are similar
111 shape to podosomes. Their structure is maintained by proteins such as FAK,
vinculin, cortactin, and integrins. Neither the Arp2/3 complex nor WASP are present
within focal adhesions, a defining difference to podosomes, although there is a report
which indicates that the Arp2/3 complex can interact with focal adhesions through
interactions with vinculin (DeMali et al, 2002). The production of a focal adhesion
requires continual protein synthesis, and is thought to be a long process taking over
60min to complete (review Buccione et aI, 2004).
Dorsal and peripheral ruffles are associated with lamellipodia formation.
Peripheral ruffles occur at the leading edge of larnellipodia, and are thick areas of
actin which are highly motile moving in a wave-like manner and arc thought to playa
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role in cell motility (Abercrombie et al, 1970). Dorsal ruffles are dynamic F-actin
enriched waves, that occur behind the leading edge of the lamellipodia and extend in
an upward direction (Legg et al, 2007). They are shortlived structures, which have a
time course of 2-30min, and often form circular waves associated with
macropinocytosis (Araki et al, 2000, Legg et ai, 2007).
Yeast actin patches are enriched areas of F-actin within budding yeast cells
(Adams et ai, 1984). They are associated with endocytosis and exocytosis (review
Moseley et ai, 2006). They have a lifespan of between 10-20 seconds, are highly
motile with a range of speed from 0.1-0.5pmls (Carlsson et al. 2002). Motility
requires actin polyrnerisation, as demonstrated through inhibition by Latrunculin A
(Pelham et ai, 2001).
Invadopodia are cellular protrusions usually associated with transformed or
cancerous cells. Invadopodia are large structures in vitro, being on average Sum wide
and 2pm deep (Polishchuk et al. 2000), which approximates to the size of a fully
spread platelet. Invadopodia secrete matrix metalloproteases which degrade the
underlying matrix, allowing cellular invasion of the underlying matrix. Invadopodia
formation is dependent on the activity of a N- WASP-Arp2/3-dynamin-cortactin
complex (review Buccione et ai, 2004).
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1.4.8 Platelet filopodia formation
Within platelets it is not known whether Cdc42 drives filopodia formation. Cdc42 is
present within platelets at an estimated cytosolic concentration of 0.21 JlM and moves
to the cytoskeletal fraction upon platelet activation (Azim et ai, 2000). It was
previously believed that Cdc42 was responsible for filopodia formation through
activation of WASP. However, filopodia formation has been reported on immobilised
CRP in WASp·'- mouse platelets and human WASP patient platelets demonstrating a
distinct pathway of regulation (Gross et al, 1999; Falet et aI, 2002).
This is particularly interesting in the context of the recent discovery that the
Cdc42 analagous Rho GTPase, Rif, is able to drive filopodia formation independent
of Cdc42 (Pelligrin et ai, 2005; Ellis et ai, 2000) and that there is a high copy number
of Rif in a SAGE library made from a highly purified preparation of megakaryocytes
(Tomlinson unpublished data). However, at the present time there is no evidence for
the role of Rif, or a Cdc42-independent mechanism of filopodia formation within
platelets.
1.4.9 Platelet lamellipodia formation
The control of platelet lamellipodia formation is multifactorial. It has been identified
that Rae plays a major role within lamellipodia formation, but that signalling
molecules such as Src kinases, PLCy2 and PI 3-kinase are also required for
lamellipodia formation, most likely as they play a role within regulation of Rae,
Src kinase inhibition leads to removal of lamellipodia but maintenance of
adhesion and filopodia on fibrinogen (Obergfell et al, 2002). This is due to the
fundamental role of Src kinases within outside-in signalling of the integrin UllbP.1.
PLCy2-1- platelets do not form lamellipodia when spread on fibrinogen (Wonerow et
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al, 2003). PLCy2 plays an important role in the regulation of both Ca2+ and PKC.
Human platelets on fibrinogen treated with the PKC inhibitor R03l-8220, or the Ca2+
inhibitor BAPTA-AM, do not form lamellipodia (Wonerow et aI, 2003) although will
form filopodia. In addition PKC induced phosphorylation of c-adducin is
fundamental in the dissociation of adducin from the cytoskeleton, and the formation
of new barbed ends ready for actin polyrnerisation, and lamellipodia formation
(Barkalow et al, 2003). PI 3-kinase also plays an important role in lamellipodia
formation. PI 3-kinase is involved in both UllhP_, and GPYI signalling. PI 3-kinase
inhibition with either Ly294002, or wortmanin leads to inhibition of lamellipodia in
human platelets spread on CRP and fibrinogen (Falet et aI, 2000; Senis et aI, 2005).
The requirement for PI 3-kinase is likely to be due to the requirement for PIP_, to
recruit PLCy2 to the membrane, and induce PKC activation and Ca2+ mobilization.
Rae activation is important for platelet lamellipodia formation. Platelets
express only Rac-I, possibly -2, and do not express Rac-3. The presence of Rac-2 is
controversial, but studies on Rac-Z" platelets indicate that, even if it is present it does
not play a functional role within platelet function. Rae is activated by multiple
platelet agonists including TRAP (Azim et al, 2000), thrombin (Hartwig et aI, 1995,
Sou let et aI, 2001), collagen (Soulet et aI, 2001), ADP (Soulet et al, 2005), U466l9
(Gratacap et aI, 200 I) and fibrinogen (Pearce et aI, 2007). Rac-I is responsible for
lamellipodia formation upon platelet spreading on fibrinogen, laminin and collagen,
with Rac-2 having little role or no role within platelets as demonstrated using mutant
mouse platelets (McCarty et aI, 2005). Rae is thought to play an important role
alongside that of gelsolin in driving lamellipodia formation, Gelsolin drives the
generation of new barbed ends through severing, whilst Rae activates the Arp2/3
complex driving actin polymerisation (Falet et al, 2002).
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Rae targets play a role within platelet lamellipodia formation. PAK is required
for lamellipodia formation induced by thrombin and to activate cortactin, a protein
implicated in lamellipodia stabilisation (Vidal et al. 2002). Cofilin has been shown to
play a role in actin reorganisation downstream of UllbP3 (Falet et al, 2005). Platelets
express WAVE-l and -2, and possibly WAVE-3 (Kashiwagi et al, 2005, Oda et al.
2005, Chapter 5).
1.4.10 Platelet Stress fibre formation
Platelet stress fibre formation IS driven vra the RhoA/ROCK pathway
(Fig. I. I I ), and myosin-Il activation, through MLC phosphorylation. RhoA is
activated by multiple adhesive surfaces and by GPCR coupled receptors downstream
of the GI2'I3 pathway. Stress fibre formation on fibrinogen and collagen is inhibited
by treatment with the ROCK inhibitors, C3 exoenzyme or Y27632 (Leng et al, 1998,
Suzuki-Inoue et al, 2001). In addition to stress fibre inhibition, focal adhesion
formation is also inhibited through the use ofC3 exoenzyme (Leng et al, 1998).
Myosin-Ila is thought to be the major isoform present in platelets (Maupin et
aI, 1994). The role of myosin- Ila is demonstrated by the MYH9 group of disorders,
which include May-Hegglin, Fecthner, Epstein, and Sebastian syndromes. These
syndromes are associated with thrombocytopenia and formation of large platelets
(Seri et al, 2003). Upon platelet activation, the platelets show defective shape change,
and spreading, though normal aggregation (Cannobio et al, 2005). Myosin-Il also
plays an important role within clot retraction (Suzuki-Inoue et aI, 2007).
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1.4.11 Other actin structures within platelets
Within platelets only a few other cytoskeletal structures other than filopodia,
larnellipodia, and stress fibres have been clearly identified. Focal adhesions were
identified by Leng et al, (1998) in 48% of spread platelets on fibrinogen, although
interestingly only 2 or more focal adhesions were identified per platelet, and whether
they are focal adhesions remains in doubt. However, there have been no other reports
of focal adhesion formation on other matricies. Peripheral have been identified on
multiple surfaces including collagen, CRP, and VWF (unpublished oberservations;
Platelets, Elservier Inc., 2007). However, dorsal ruffles are yet to be reported.
Podosomes have been identified within megakaryocytes spread on collagen (Sabri et
ai, 2006). However, to date there have been no reports of podosomes within platelets.
In addition, the presence of invadopodia, and endocytic or granule associated actin
structures within platelets have yet to be reported.
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1.5 THE ROLE OF THE ACTIN CYTOSKELETON IN THROMBUS
GROWTH
At the present time the role of the actin cytoskeleton within thrombus formation is
unclear. This is because it has multiple roles within platelet activation, including
shape change, clot retraction and GPYI signalling (Wilde et al, 2000; Wonerow et al,
2002; Suzuki-Inoue et al, 2007). However, it is possible to investigate the role of
individual actin structures such as lamellipodia, with the use of mutant mice and
specific inhibitors.
The role of actin polymerisation can be investigated usmg the inhibitors
cytochalasin A-E or Latrunculin A. Cytochalasins prevent actin polymerisation by
capping barbed ends inhibiting actin association and dissociation (Godette et al,
1986). Latrunculin A binds G-actin causing alterations within its structure preventing
its incorporation into the actin cytoskeleton (Morton et al. 2000). These reagents
partially inhibit signalling by glycoprotein receptors, including GPYI and integrin
allb~3, leading to a partial decrease in platelet aggregation to all agonists. The role of
the cytoskeleton in secretion is unclear. There are conflicting reports with thrombin,
calcium ionophore, ADP, and collagen, of having no effect, inhibiting, or augmenting
secretion (Haslam et al, 1977; Cox et al. 1988; Hashimoto et al, 1986; Yatomi et al.
1986). However, recently Flaumenhaft et aI, (2005), identified that dense and alpha
granule secretion to the thrombin peptide (SFLLRN) was affected depending on the
concentration of actin inhibitor used. Low concentrations of either Cytochalasin E or
Latrunculin A accelerated alpha granule release, but did not affect dense granule
release. However at higher concentrations alpha granule secretion was inhibited, but
dense granule release was accelerated.
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Inhibition of actin polymerisation does prevent platelet spreading but not
platelet adhesion. At high shear both adhesion and initial thrombus formation is
maintained, but the thrombi formed are highly unstable, and undergo embolisation,
decreasing the overall height of the thrombi. This implicates the actin cytoskeleton in
maintenance of thrombus stability.
The role of filopodia in thrombus assembly is unclear. A recent study has
reported that inhibition of Cdc42, by secramine A leads to an inhibition of filopodia
formation and aggregation to collagen (Pula et ai, 2006). It is unclear however why
secramine A, blocks both shape change and actin polymerisation, as similar effects
are not seen with cytochalasin D. This indicates that secramine A maybe having
additional effects. Studies on Cdc4T- mice are required to address this.
The role of lamellipodia can be selectively investigated in Rac-l-I- mice. Rae-
1-1- platelets exhibit normal aggregation and secretion to G protein receptor agonists,
but have a mild impairment in signalling by the collagen receptor GPVI (McCarty et
al,2005). They fail to form lamellipodia on matrix proteins leading to the generation
of thickened and elongated filopodia. The process of platelet adhesion and
aggregation can still be observed on collagen at high shear, but is associated with
increased embolisation and a decrease in overall thrombus growth (McCarty et al,
2005). Although, it is difficult to determine whether the mechanism behind the
thrombus defect is due to impairment ofGPVI signalling or lamellipodia formation, it
is striking that a similar defect in aggregate assembly is not seen in mutant mice that
cause a similar level of inhibition of GPVI signalling, and that aggregate formation is
also impaired under flow conditions on a surface of thrombin and VWF (McCarty et
al, 2005). Therefore, lamellipodia formation appears to be important for aggregate
stability under flow conditions, rather than initial platelet adhesion and this
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presumably contributes to the marked defect in thrombus formation observed in Rae-
1-1- mice in vivo. In comparison, PLCyr- platelets show a marked reduction in
adhesion at high shear, and do not form thrombi, a clear difference to that seen with
the Rac-I-I-, with the difference being explained by loss of inside-out regulation of
Ullb133 by GPYI (Suzuki-Inoue et ai, 2003).
Several studies have investigated the role of stress fibre formation in adhesion
and aggregate formation. Stress fibre formation mediated via the RhoA/ROCK
pathway is activated by multiple adhesive surfaces and GPCR agonists in platelets
(Leng et ai, 1998; Suzuki-Inoue et ai, 200 I; Schoenwaelder et ai, 2002; Jirouskova et
al,2007). RhoA or ROCK inhibition, using C3 exoenzyme and Y27632 respectively,
has no effect on platelet aggregation to thrombin, collagen and ADP (Leng et al, 1998,
Schoenwaelder et al, 2002) although a reduction in secondary aggregation to
adrenaline has been reported (Leng et aI, 1998). Similarly, RhoA or ROCK inhibition
has a negligible or minor inhibitory effect on static adhesion to fibrinogen, YWF and
collagen, or platelet capture by VWF under flow conditions (Leng et al, 1998; Suzuki-
Inoue et ai, 2001; Schoenwaelder et ai, 2002; McCarty et ai, 2006; Jirouskova et ai,
2007). RhoA and ROCK have, however, been shown to be important in platelet
tethering to VWF (Schoenwaelder et al. 2002). ROCK inhibition reduced shear
dependent platelet adhesion on VWF and shear induced aggregation in suspension.
However the role of RhoA/ROCK in high shear conditions on collagen has yet to be
reported.
Inhibition of stress fibres with Y27632 or the myosin-II inhibitor, blebbistatin,
inhibits clot retraction (Suzuki-Inoue et ai, 2007). Clot retraction is important in
consolidation of thrombus formation, restriction of thrombus size, and the production
of an insoluble mesh to aid infiltration of other cell types into the damaged area.
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1.6 Aims.
My goal was to investigate glycoprotein receptors regulation of morphological
rearrangments associated with spreading and thrombus formation. This is important
as this work could lead to the formation of new therapies to combat thrombosis and
increase our understanding of bleeding disorders. This work can be broken down into
the following aims:
1. Identi fication of key actin cytoskeletal rearrangements that occur when
platelets spread and form thrombi.
2. Determination of the role of WAVE-J m platelet adhesion and aggregate
formation under static and flow conditions.
3. Determination of the role of RhoA and its target ROCK in stress fibre
formation during platelet adhesion and aggregate formation under static and flow
conditions.
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2.1 MATERIALS
2.1.1 General materials: All general laboratory chemicals were obtained from
Sigma-Aldrich (Dorset, UK). Glass capillary tubes were obtained from Camlab
(Cambridge,UK). Chronolum reagent was obtained from Chronolog Corporation
(Haverton, USA). Ketamine was obtained from Amersham Biosciences (Little
Chalfont, UK) and Xylazine from Millpledge Pharmaceuticals (Scarborough, UK).
2.1.2 Blood anticoagulants: Sodium citrate (4%) was obtained from Sigma-Aldrich
(Dorset, UK), P-PACK was purchased from Merck Biosciences (Nottingham, UK),
and Heparin was obtained from CP Pharmaceuticals (Wrexham, UK).
2.1.3 Inhibitors: Y27632, blebbistatin, Latrunculin A, Ly294002 and AEBSF were
obtained from Merck Biosciences (Nottingham, UK). Integrillin was obtained from
GlaxoSmithKline (Durham, UK). Cytochalasin 0, apyrase, indomethacin, leupeptin,
aprotinin, pepstatin A, and BAPTA-AM were obtained from Sigma-Aldrich (Dorset,
UK). Prostacyclin (PGI2) was obtained from Alexis Biochemicals (Nottingham, UK).
PD0173952 was a gift from Pfizer Global Research and Development (Ann Arbor,
MI, USA and Sandwich, UK).
2.1.4 Platelet agonists: Thrombin, larninin, thrombin related activated peptide
(TRAP) and ristocetin were obtained from Sigma-Aldrich (Dorset, UK). Fibrinogen
and fibronectin were obtained from Enzyme Research (Swansea, UK). Fibrillar type
1 Horm collagen from equine tendon was obtained from Nycomed (Oxford, UK).
VWF purified from human plasma was a gift from Dr MC Berndt (Monash
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University, Melbourne, Australia. eRP was synthesised by Tana Laboratories
(Houston, USA), and by Dr R Farndale (Cambridge, UK).
2.1.5 Fluorescent probes: FITC-phalloidin and rhodamine-phalloidin were
obtained from Sigma-Aldrich (Dorset, UK). DiOC6 and Alexa fluor 488 goat anti-rat
IgG were obtained from Invitrogen (Paisley, UK). Purified anti-mouse CD41 was
obtained from BD Pharminogen (Oxford, UK).
2.1.6 Fixative agents: Paraformaldehyde and glutaraldehyde were obtained from
Sigma-Aldrich (Dorset, UK). Polyetheleneglycol (MW 40,OOOkDa) was obtained
from Universal Biologicals (Cambridge, UK).
2.1.7 Mice: WAYE-l-I- mice were a kind gift of Seung Kwak at Wyeth Research,
Princeton, NJ, USA. Mice were bred as heterozygotes and all experiments were
performed on mice aged 14-20 days of age using litter-matched controls. The mice
used at this age, as the absence of WAYE-l leads to death at an early stage.
Knockout mice were provisionally identified by the small size of the mice, and
subsequently genotyped.
GFP-actin mice were a kind gift from Professor Andrew Matus at Friedrich
Miescher Institute, Basel, Switzerland. Mice were bred as heterozygotes and all
experiments were performed using mice at least 6 weeks old, using B57BI6 wild-type
controls (Charles River, Germany). Mice were genotyped at 1-3 days using uv light
goggles by animal technicians within the BMSU.
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2.1.8 Antibodies:
Antibody Details Source Experimental
target Concentrations*
a-allbP3 Rabbit Santa Cruz 1M: 11200
a-Arp2/3 Rabbit Upstate Technology IM:111000
a-p-Pix Rabbit Chemicon WB:IIIOOO IM:lIl000
IP: 1/500
a-PI integrin Mouse Chemicon IM:1I200
a-CD63 Human Pharminogen 1M: 11100
u-Cortactin Mouse Upstate Technology IM:1/600
a-Csk Rabbit Santa Cruz 1M: III00
a-Fyn Rabbit Mike Tomlinson IM:1/200
JonA Rat Emfret FC:11100
a-Myosin Ha Rabbit Covance 1M: III000
a-Nck Rabbit Chemicon WB:111000 lM:1I5000
IP: 111000
c-Pvselectin Rat Pharrninogen IM:1I100 FC:lIl00
a-tyrosine Mouse Upstate Technology WB: 111000 1M: 111000
_l)_hosphotyrosine (4G 10)
a-mouse IgG Rabbit, PE Dako IM:1/200
linked
a-mouse IgG Mouse Sigma 1M: III00
a-mouse IgG Sheep, HRP- Amersham WB: 1110000
conjugated
a-MLC Rabbit New England Biolabs WB: 111000
a-MLC Rabbit New England Biolabs WB:111000
phosphorylation
a-rabbit IgG Alexa 660 Molecular Probes 1M: 1/100
conjugated
a-rabbit IgG Donkey, HRP Amersham WB: 1110000
conjugated Pharmacia Biotech
u-Rac Mouse Upstate Technology 1M: 11200
a-WAVE-I Mouse Upstate Technology WB:1I50
a-WAVE-2 Mouse Upstate Technology WB: 1150
a-Spin90 Mouse Woo Keun Song 1M: lIlOOO WB: 111000
IP:1/1000
o-Src Mouse Upstate Technology IM:11100
a-Talin Mouse Sigma 1M: 1150
n-Vinculin Mouse Sigma IM:I/IOO
a-Wasp Rabbit Upstate Technology 1M: 11100
*Key: IM:lmmunofluoresence, WB: western blotting, IP: immunoprccipitation,
Fe: flow cytometry
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2.2 METHODS
2.2.1 Genotyping: WAVE mouse genotyping was performed as described by Legg
et ai, (2007), and was performed by Hannah Morris, within Professor Laura
Macheskys lab.
2.2.2 Platelet preparation: Human venous blood was drawn by venipuncture into
4% sodium citrate. If plasma rich plasma (PRP) was to be used whole blood was
centrifuged twice at 200g for 10min, and PRP removed. Platelet poor plasma was
then prepared by centrifugation of whole blood at 1000g for IOmin and the
supernatant was removed.
experimentation.
If washed platelets were to be prepared Acid/citrate/dextrose (ACO: 85mM
Platelets were left for 30min to rest before
sodium citrate, 67mM glucose, 42mM citric acid) was added to the blood to 10% of
the blood volume. PRP was then prepared by centrifugation of whole blood at 200g
for 20min. The platelets were isolated from PRP by centrifugation at 1000g for lOmin
in the presence of O.lllg/ml prostacyclin (PGI2) (Vargas et al, 1982). The pellet was
gently resuspended in 25mls of modified HEPES- Tyrodes buffer (134mM NaCl,
0.34mM Na2HP04, 2.9mM KCI, 12mM NaHCO), 20mM HEPES, 5mM glucose,
lmM MgCI2; pH 7.3) and 3mls of ACD and Oi lug/ml PGI2 added. The platelets were
then centrifuged at lOOOg for IOmin, before being resuspended in HEPES- Tyrodes
buffer. Sul platelets added to l Ornl of isotonic fluid and the platelet number analysed
using a Beckman Coulter counter. Platelet counts were taken twice, and averaged to
obtain the platelet number.
experimentation.
Platelets were left for 30min to rest before
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2.2.3 Mouse platelet preparation: Blood was withdrawn from anaesthetised, and
terminally COrnarcosed mice via cardiac puncture into 10% ACD or 10unit heparin.
PRP was prepared by centrifugation at 200g for 6min. PRP was removed and a
further 200~1 of HEPES-tyrodes was added to the remaining mixture to facilitate the
maximisation of platelet recovery. Blood was recentrifuged at 200g for 6min and the
PRP combined with that from the first centrifugation. For washed platelets, 0.1 ug/rnl
PGh was added to the PRP, and the PRP centrifuged at lOOOg for 6min. Platelets
were resuspended in 1OO~1modified HEPES- Tyrodes buffer. Platelet number was
then counted as per human platelet samples. Platelets were resuspended to Sxl08/ml
before being left to rest for 30min prior to experimentation (McCarty et al, 2005,
Pearce et ai, 2002, 2004, 2007).
2.2.4 Determination of haematological parameters of murine whole blood: A
volume of SO~1of whole blood was taken up the ABX micros 60 (ABX Diagnostics,
Montpelier, France). Levels of red blood cells, leucocytes, platelets, and platelet
mean volume were measured.
2.2.5 Platelet aggregation and secretion: All experiments were performed in a
Born-lumiaggregorneter (Chronolog, Haverton, USA). A quantity of 300~1 platelets
(2x 108/ml) was incubated at 3rC with the appropriate inhibitor for 60s. Chronolum
reagent (20~1) was then added and platelets stirred for 60s at 1200rpm before addition
of the appropriate agonist. Aggregations were allowed to proceed for 3min. The
addition of an ATP standard (2nM) was used to measure ATP secretion. If shape was
to be monitored, aggregation was blocked by the addition of the Ullb133 inhibitor,
integrillin (9~M), which was added 2min prior to stimulation.
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2.2.6 Monitoring of aggregation via single platelet counting: Prior to platelet
aggregation a platelet count was taken as per section 2.2.2. A volume of 50111of
(1.2x 108Iml) washed platelets were incubated at 37°C for 60s, and then for a further
60s whilst stirring, prior to aggregation to either lug/ml or lOug/rnl CRP, 0.02unit/ml
or 0.1 unit/ml thrombin, and Iug/rnl or IOug/ml collagen. 2min post stimulation a
platelet count was taken as per section 2.2.2. Analysis of pre/post counts identifies
the percentage of platelet aggregation.
2.2.7 Immunoblotting: A volume of 300111 platelets (IxlO9/ml) were incubated
with integrillin (9IlM), and either OM SO (0.1 %), Y27632 (3-50IlM) or blebbistatin
(I001lM) for 2min at 37°C before stimulation with collagen (l-30llg/ml) for 1-15min.
Platelets were lysed with a volume of 751115xLaemmli sample buffer (2% SOS, 5%
~-mercaptoethanol, 10% glycerol, 5% stacking buffer, and brilliant blue R) and boiled
for IOmin before centrifugation. Proteins were separated by SOS-PAGE (Bis- Tris 4-
12%) at 180V for 50min. Samples were transferred to a PVOF membrane, II0mA
for 35min, blocked with 5% BSA + 0.1% Sodium Azide for 60min at room
temperature, and western blotted for MLC (I: 1000) or phosphorylated MLC (I: 1000),
diluted in 5% BSA+O.l % Sodium Azide, at 4°C overnight. Membranes were washed
in high salt (363mM NaCI) in TBS- Tween (0.1 %) three times for 20min, before
incubation with anti-rabbit secondary antibody (I: 10000) in TBS- Tween (I Oml, 0.1 %)
for 60min at room temperature. Blots were analysed using ECL western blotting kit
and densitometry via Quantity One software (Bio-Rad, Hemel Hempstead, UK).
For immunoprecipitation samples, samples were run and transferred as above,
but were blotted for SPIN-90, 4GIO, P-Pix, or Nck overnight at 4°C, before washing,
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and incubation with the appropriate secondary antibody. Blots were analysed using
the ECL western blotting kit as above.
2.2.8 Immunoprecipitation: A volume of SOOIlI of platelets (Sxl08/ml) was
incubated with integrillin (9IlM) at 37°C for 2min, before stimulation with 30llg/ml
collagen, 1unit/ml thrombin, and 0.3-10Ilg/ml CRP for l-Smin. I-Smin after
stimulation SOOIlI of ice-cold 2x lysis buffer (300mM NaCI, 20mM Trizma base,
2mM EGTA, 2mM EDTA, ImM AEBSF, luug/ml aprotinin, l Oug/ml Leupeptin,
0.71lg/ml pepstatin A, 2mM sodium orthovanadate, 2% NP-40, pH 7.3), ISIlI of both
PGS and PAS (SO% w/v), and 1III of mouse JgG was added to preclear samples.
Samples were rotated for 60min at 4°C. Samples were pelleted by
microcentrifugation, and the supernatent was removed. 100111of the supernatent was
added to 2SIlI of SxLaemlli loading buffer and each sample was run as a whole cell
lysate to verify stimulation. 1-3111of the appropriate antibody was added to the
remaining supernatent and rotated for ISmin, before addition of 30111of PGS or PAS
depending on the antibody used (PAS for rabbit, PGS for mouse) and samples were
rotated overnight at 4°C. Protein samples were pelleted by microcentrifugation and
washed with 1ml Ixlysis buffer three times, before addition of 40111of 2xLaemlli
buffer. Protein samples were boiled for lOmin, before microcentrifugation for Smin
at 13,000rpm. Protein samples were run and transferred as per section 2.2.7.
2.2.9 Platelet morphology studies: Coverslips were coated with lOuug/rnl
fibrinogen, 1001lg/ml collagen, lOug/rnl VWF+2Ilg/ml botrocetin, l Oug/rnl
VWF+21lg/ml ristocetin, SOIlg/ml laminin, or lOuug/rnl fibronectin overnight at 4°C.
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BSA (5mg/ml) was boiled for 10min before being placed on ice, and filtered with a
0,45).lm filter (Anachem, Luton, UK). Coverslips were washed twice with PBS, and
were incubated with 300).l1BSA (Smg/ml) for 60min at room temperature. Coverslips
were washed twice with PBS prior to addition of platelets. All experiments were
completed in the presence of apyrase (Zunit/ml), and indomethacin (1O).lM). A
volume of 200).l1 platelets (2x 107/ml) were incubated for 2min with either DMSO
(0.1 %), Y27632 (SO~lM), blebbistatin (I OO).lM), PDOl739S2 (20).lM), Ly294022
(2S).lM), BAPTA-AM (40).lM), or Latrunculin A (3).lM) depending on the experiment
(Wonerow et ai, 2003, Senis et ai, 200S, unpublished observations). After incubation
platelets were then allowed to spread on the specific matrix for 4Smin at 37°e. For a
separate set of experiments a volume of 200)..!1platelets (2xl07/ml) were spread for
22.5min before addition of either DMSO (0.1%), PDOl73952 (20).lM), Ly294022
(2S).lM), BAPTA-AM (40).lM), or Latrunculin A (3)..!M)depending on the experiment.
Platelets were then allowed to spread for a further 22.Smin. For both sets of
experiments after 45min spreading, platelets were washed twice with PBS, and then
fixed with a volume of 200)..!1 paraformaldehyde (3.7%) for lOmin at room
temperature. Differential interference contrast (DIC) experiments required mounting
with Hydromount (Fischer, Dublin, Ireland) and platelets were imaged using Kohler
illuminated Nomarski DIC optics.
For immunohistochemistry samples, platelets were fixed as above, and then
lysed with a volume of 200).l1 Triton X-IOO (0.2%) for 5min at room temperature.
Platelets were then washed twice with PBS. Platelets were incubated with FITC-
phalloidin (2).lM) or rhodamine phalloidin (2).lM) and the appropriate antibody for
60min in the dark at room temperature. Platelets were washed twice with PBS, before
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addition of 200J.ll of the appropriate secondary antibody and platelets incubated for
60min in the dark. Platelets were then mounted with Hydrornount, and imaged using
both fluorescent imaging with a Zeiss 63x oil immersion lAO NA plan-apochromat
lens on a Zeiss Axiovert 200M microscope or DM lRE2 confocal microscope (Leica,
Milton Keynes, UK), and DIe microscopy as above.
2.2.10 Realtime platelet morphological studies: All experiments were done in the
presence of apyrase (Zunit/ml) and indomethacin (1OIlM). A volume of 500111
platelets (2xl07/ml) was incubated with the appropriate inhibitors for 2min before
platelets were allowed to spread on the appropriate matrix at 37°C for 30min. For the
appropriate experiments, platelets were allowed to spread for l5min before addition
of either PBS or 0.03unit/ml thrombin. Platelets were allowed to spread for a further
15min. Platelet spreading was monitored using either Kohler illuminated Nomarski
DIC optics, or with Zeiss 63x oil immersion lAO NA plan-apochromat lens on a Zeiss
Axiovert 200M microscope, with an image taken every 5s.
2.2.11 Platelet spreading analysis: Surface area analysis was completed with a java
plugin for Image] (NIH, USA). Platelets were individually outlined, and surface area
quantified by determining the number of pixels within the outlined area. Imaging a
graticule under the same conditions allowed the conversion of pixels to microns. For
platelet adhesion analysis, the number of platelets per image were counted, and at
least three images per slide were analysed. The adhesion results are presented as a
percentage of the control.
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2.2.12 F-actin assay: Filamentous actin was measured using a modified method
from Machesky et ai, (1997). A volume of 500).l1 platelets (5x 108/ml) was incubated
with apyrase (2unitlml), indomethacin (lO).lM), and either DMSO (O.l%), Y27632
(50).lM), or blebbistatin (1OO~lM) for 2min, before being allowed to spread on
collagen coated coverslips for 45min at 37°C. Collagen coated coverslips were
prepared as per Section 2.2.9. A volume of 200).l1was removed from the top platelet
solution for each sample as a basal, and was fixed with 200).l1 of fixation buffer
(20IlM KH2P04, 10llM pipes, 51lM EGTA, 2~lM MgCh, 2% Triton X-lOO, 2~lM
FITC-phalloidin, 3.7% formaldehyde). Coverslips were washed twice with PBS
before addition of 500).l1 of fixation buffer. Coverslips were placed on ice, and
scraped three times to ensure removal of all platelets, and the sample was then rotated
for 60min in the dark. Both basal and adhered platelet samples were pelleted by
microcentrifugation for 2min, washed with 200).l1 saponin washing buffer (20IlM
KH2P04, lOIlM Pipes, 51lM EGTA, 211M MgCh, 2% Triton X-lOO, 0.1% Saponin
v/v), and were re-pelleted by microcentrifugation for 2min. Pl'I'Cvphalloidin was
extracted with 200).l1 methanol for at least 60min at room temperature under rotation,
and measured at 520nm (emission wavelength), using 488nm (excitation wavelength)
on a QuantaMaster spectrofluorimeter (Photon Technology International, West
Sussex, UK). Alongside the F-actin assay, a second set of collagen coverslips was
prepared, and platelets were allowed to spread as above. A basal sample was
removed as above, and the spread platelets were lysed with ice cold 2xlysis buffer
(300mM NaCl, 20mM Trizma base, 2mM EGTA, 2mM EDTA, ImM AEBSF,
l Oug/rnl aprotinin, lOug/rnl Leupeptin, O.7).lg/ml pepstatin A, 2mM sodium
orthovanadate, 2% NP-40, pH7.3). Protein levels of these samples were measured
with Biorad Bradford assay kit to enable normalisation of F-actin results.
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2.2.13 Flow Cytometry: Washed platelets (2x 107/ml) in the presence of 2mM Ca2+,
were treated with 0.001-0.1 unit/ml thrombin, 0.3-30j..lg/ml collagen, or 0.3-30j..lg/ml
CRP in the presence of a FITC-conjugated anti-CD62P mAb (1Oug/rnl) and
rhodamine-conjugated JonA for 15min at 3rc. In selected experiments,
fluorescently labelled isotype-matched IgG mAbs were included for background
fluorescence determination. Samples were diluted with PBS, and were analysed by
flow cytometry on a Beckman Dickinson FACScalibur using Cell Quest software
(Becton Dickinson, San Jose, CA). Platelets were identified by logarithmic signal
amplification for forward and side scatter, and the geometric mean fluorescence of
each specimen was recorded.
2.2.14 Flow adhesion studies: Glass capillary tubes were coated with 100j..lg/ml
collagen and rotated for 60min at room temperature. BSA 5mglml was prepared as
per Section 2.2.9. Capillary tubes were washed, blocked with BSA 5mg/ml, and
rotated for 60min at room temperature. Washed platelets were prepared as per
Section 2.2.1. Red blood cells were isolated by washing with HEPES-buffered saline
(5mM Glucose, 140mM NaCl, 10mM HEPES) and three centrifugations at 2000g for
10min to remove plasma proteins. A volume of 150j..ll or 450j..ll washed platelets
(l x lOvrnl) was incubated for lOmin at 37°C with OMSO (0.1%), Y27632 (50j..lM) or
blebbistatin (1OOj..lM). For real time analysis, both platelets and red blood cells were
incubated with the fluorescent dye, OiOC6 (2j..lM). Washed platelets and red blood
cells were then reconstituted to a haematocrit of 50% and were flowed over collagen
for 3min at 1000s-1 or at 3000s-l• Real-time image sequences were recorded using a
CoolSnap Camera (Photometries, Huntington Beach, CA, USA) on a OM lRB
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microscope (Leica, Milton Keynes, UK) (McCarty et ai, 2005; Auger et ai, 2005).
Platelet thrombi were washed with buffer for 5min, and fixed for 30min at room
temperature with paraformaldehyde (3.7%). Platelets were then stained overnight
with DiOC6 (2J..lM) at room temperature. For determination of thrombus height,
0.5J..lm confocal slices of platelet thrombi were analysed. For flow analysis with
murine whole blood, mouse blood was drawn into heparin (lOIU/ml) and PPACK
(40J..lM). Capillaries prepared as per Section 2.2.9. Anticoagulated whole blood was
perfused for 4min at a wall shear rate of 1OOOS-I,followed by washing with modified
Tyrode's for 3min, before imaging with phase-contrast microscopy. Image analysis
was performed off-line using ImageJ. Platelet adhesion results are expressed as the
percentage of surface area covered by platelets.
2.2.15 Intravital microscopy: This work was completed by Dr Jocelyn Auger, but
analysed by Simon Calaminus. All procedures were undertaken with approval from
the United Kingdom Home Office in accordance with the Animals (Scientific
Procedures) Act of 1986. Male mice were anaesthetised via intraperitoneal injection
with ketamine (lOOmg/kg Vetalar) and 2% xylazine (20mg/kg) before completion of
tracheotomy and carotid artery cannulation. The cremaster muscle, a transparent
muscle surrounding the testicle, was exteriorised and prepared through removal of
connective tissue. The cremaster was superfused with bicarbonate-buffered saline
(36°C) gassed with 5% CO2, 95% N2. Intravital experiments were perfomled as
described by Falati et ai, (2004). The endothelium of arterioles of 15-25 urn in
diameter was injured using a Coumann 440nM nitrogen laser at an appropriate level
for the size of the vessel. To flourescently label platelets in vivo. a volume of 20lll of
the secondary antibody Alexa Fluor 488 goat anti-rat IgG (2mg/ml) and a volume of
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Sill of purified anti-mouse CD41 (O.Smg/ml) was added to a volume of 70111of saline
and infused via the carotid cannula. Thrombus formation was monitored with
Olympus BX-61 WI using both FITC and open channels. Images were captured with
a high rate Senicam CCD camera (Cooke Corporation, Michigan, USA) coupled to a
Gen III image intensifier (Videoscope Int Ltd, Virginia, USA). Several thrombi were
induced and recorded for each mouse before intraperitoneal injection with Y27632 to
give an estimated plasma concentration of 10011M, as described in the results. A
further S thombi were induced in the presence of Y27632 between S-30min following
injection. All images were analysed using Slidebook 4.0 (Intelligent Imaging
Innovations, Inc., Denver, USA). The background intensity of the free platelets was
calculated and removed from the total intensity of the thrombus. The resulting
intensity was identified for each time point, allowing for a kinetic analysis of
thrombus formation and emboli sat ion.
2.2.16 Electron microscopy: Washed platelets (2x 107/ml) were allowed to spread
on fibrinogen coated coverslips, in the presence of apyrase (Zunit/ml}, indomethacin
(lOJlM), and either DMSO (0.1 %), Y27632 (50IlM), or blebbistatin (lOOJlM) for
45min at 37°C. Platelets were then rinsed twice with PBS before addition of an
extraction solution (SOI1M imidazole, pH 6.8, SOI1M KC1, O.SI1M MgCI, O.II1M
EDT A, 111MEGT A, 1% Triton X-lOO, 4% PEG (MW 40,000» for 3-Smin at room
temperature. Platelets were rinsed with cytoskeleton buffer (SOI1M imidazole, pH 6.8,
50l1M KC1, O.SI1M MgCI, O.II1M EDTA, 111M EGTA) 2-3 times, before fixation
overnight at 4°C, in a volume of 400111 of 2% glutaraldehyde (EM grade) in O.IM
sodium cacodylate, pH 7.3. Before processing specimens were brought back to room
temperature. Glutaraldehyde solution was removed, and a volume of 300111 0.1%
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aqueous tannic acid (Mallinckrodt, Inc, Kentucky, USA) was added for 20min at
room temperature. Platelets were then rinsed in distilled water twice, before
incubation in distilled water for 5min. 0.1-0.2% uranyl acetate solution was then
added for 20min at room temperature before, rinsing with distilled water. To undergo
critical point drying, samples were dehydrated by transferring the platelets through
graded ethanols (10%, 30%, 50%, 70%, and 100% (twice», with a 5min incubation at
each grade. Platelets were then placed in 0.1-0.2% uranyl acetate in 100% ethanol for
20min. Platelets were incubated twice for 5min in 100% ethanol, followed by two
incubations for 5min in 100% ethanol dried over molecular sieves. Samples were
placed within the critical point dryer and were submerged within 100% ethanol dried
with molecular sieves. The critical point dryer was cooled to 5-1 ODC and CO2 added.
CO2 changed every 5 min with a maximum of 10 changes. After critical point drying
the coverslips were coated with carbon to achieve a 3D definition of the cytoskeleton.
Images were processed using a Philips XL-30 FEG Environmental scanning electron
microscope (Oxford, UK).
2.2.17 Analysis of results: Where applicable, results are shown as mean ± SEM.
Statistical significance of differences between means was determined by student's t-
test or one-tailed ANOV A. If means were shown to be significantly different with an
ANOV A, multiple comparisons were performed using a Tukey test. Probability
values of P < 0.05 were selected to be statistically significant. In addition where
appropriate, a frequency distribution of the data was obtained, from a combination of
three separate experiments. In addition where the data obtained was not normally
distributed, geometric means were obtained, before statistical analysis as above.
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Chapter 3
Platelet spreading on matrix proteins: identification of a
novel, actin-rich structure
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3 GENERAL INTRODUCTION
3.0 Summary
During platelet spreading, the actin cytoskeleton undergoes a massive reorganisation,
which leads to formation of multiple actin rich structures, including filopodia,
lamellipodia, and stress fibres. The aim of this Chapter was to provide insight into the
mechanisms of the actin dynamics and structures formed when platelets adhere and
spread on various matricies. This work has led to the unexpected identification of a
novel actin structure in platelets, which we have termed an actin nodule. In this
Chapter I provide a detailed analysis of its kinetics, composition and dependence on
adhesion.
3.1 Introduction
Filopodia, lamellipodia, and stress fibres are among the most well known actin
structures formed during cell spreading, whose regulation is mediated by the Rho
GTPases, Cdc42, Rae I, and RhoA, respectively (Nobes et ai, 1995). In addition,
several additional types of actin structures have been described in other cell types,
although very little is known as to whether they contribute to platelet spreading.
These include focal adhesions (Abercrombie et al, 1971), focal complexes (reviewed
by Zamir et al 2001), invadopodia (review Buccione et ai, 2004), podosomes (review
Linder et al 2005), yeast actin patches (review Moseley et ai, 2006), and dorsal and
peripheral ruffles (Abercrombie et ai, 1970 & 1971). However, at the present time
only focal adhesions (Leng et ai, 1998) and peripheral ruffles (unpublished
observations; Platelets, Elservier Inc, 2007) have been identified within platelets.
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have used staining of fixed platelets with the actin-binding protein FITC-
phalloidin and platelets from mice expressing a transgene encoding GFP-actin to
monitor actin polymerisation during platelet spreading on various matrix proteins.
This work has led to identification of punctate areas of actin staining that are formed
early on during platelet spreading which I have termed actin nodules. The actin
nodule is most readily seen when stress fibre formation is inhibited or under certain
conditions of weak platelet activation. The actin nodule can also be labelled with
antibodies to several actin-binding proteins, including the Arp2/3 complex, talin and
cortactin. I propose that the actin nodules are formed during the early stages in actin
polymerisation and that they could represent an important contact site between
platelet and matrix.
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3.2 RESULTS
3.2.1 Monitoring actin polymerisation during platelet spreading.
Human platelets were spread on fibrinogen coated coverslips in the presence of
inhibitors of the major secondary agonists, apyrase (2unit/ml) and indomethacin
(lO)lM), which remove ADP and inhibit TxA2 formation, respectively. Spreading
was monitored in real-time using DIC microscopy and at specific time points by
fixation and staining with FITC-phalloidin (2)lM). After initial adhesion to
fibrinogen, actin-rich fingerlike protrusions termed filopodia extend from the platelet
body (Fig.3.1 i). This is followed by the formation of the sheet like extension,
lamellipodia (Fig.3.1 ii) leading to the characteristic fried egg shape of a fully spread
platelet. Within the fully spread platelet, stress fibres can be identified by staining the
actin cytoskeleton with FITC-phalloidin (Fig.3.1 iii). The timescale for formation of
these actin structures is demonstrated by Fig.3.2. Strikingly, even after full platelet
spreading, the outer membrane of the platelet undergoes continuous movement
(supplementary video 1), most likely reflecting peripheral ruffle formation.
3.2.2 Identification of a new actin structure termed actin nodules
The above analysis identified the presence of prominent, highly-stained actin
structures which could also be detected via DIC microscopy (Fig.3.3). These
structures have been termed actin nodules. Using real-time DIC microscopy, the
nodules can be shown to move continuously throughout the various stages of platelet
spreading, continuing after lamellipodia formation is complete (Fig.3.2 and
supplementary video I). The presence of nodules in resting platelets is difficult to
identify. However, this reflects either their absence or that the platelets have not yet
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settled onto the surface and so actin nodules cannot be resolved. However, actin
nodules are rapidly detected upon contact with the matrix protein (FigJ.3). Within a
population of human spread platelets that had been allowed to spread on fibrinogen
for 45min, 35.4±3.7% of immobilised platelets contain nodules (data not shown).
Within the platelets containing actin nodules, there is great variation within the
number of actin nodules, with a mode of 5, and a median of 14 (Fig.3.4). Strikingly,
the nodules were absent in platelets that had formed stress fibres.
The above studies with human platelets were extended to mouse platelets. In
contrast to human platelets, mouse platelets do not form extensive lamellipodia on
fibrinogen unless stimulated by an agonist such as thrombin (Thornber et ai, 2006).
Nevertheless, as is the case for human platelets, prominent actin-rich structures or
nodules can he seen in mouse platelets that have been allowed to spread on fibrinogen
for 45min (Fig.3.5i). Murine platelets which contain actin nodules, have a similar
variation of actin nodule number in comparison to human platelets, despite the smaller
size of the mouse platelets (data not shown). However, there was a significant
increase in the number of platelets containing actin nodules within mouse platelets
that had spread on fibrinogen, with 80.3±2.7% of platelets containing actin nodules in
comparison to 39.5±2.7% of human platelets containing actin nodules. Addition of
thrombin (0.1 unit/ml), caused full platelet spreading and stress fibre formation
(Fig.3.5ii), with only 6.3±1.7% of platelets containing nodules and 93.7% containing
stress fibres when measured at 45min (Fig.3.5iii). Therefore in agreement with
human platelets, actin nodules form before stress fibres.
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Figure 3.5: Identification of actin nodules in murine platelets on
fibrinogen. Murine platelets (2x107/ml) were allowed to spread on fibrinogen
coated coverslips in the presence of apyrase (2unitlml) and indomethacin
(10r..tM)and either PBS, or 0.1unitlml thrombin for 4Smin. Platelets were then
fixed with paraformaldehyde (3.7%), lysed with Triton X-100 (0.2%), and
stained with FITC-phalloidin (2r..tM).(i) White arrows indicate punctate stains.
(ii) Addition of thrombin removes actin nodules and drives stress fibre
formation. Images are representative of three experiments. (iii) Platelets
were counted and platelets with stress fibres, or actin nodules were identified.
100 platelets were counted per experiment. Analysis is an average±SEM of
three experiments. Statistical analysis completed using a paired student's t-
test. * p<0.05 relative to fibrinogen
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Confirmation that the nodules are actin structures was achieved using mouse
platelets expressing a transgene for GFP-actin (Ludin et ai, 1996). As shown in
Fig.3.6, the actin cytoskeleton undergoes a rapid rearrangement upon adhesion to
fibrinogen leading to actin nodule formation and filopodia. Moreover, the nodules are
highly dynamic structures and undergo rapid movement throughout the spread platelet
(supplementary video 2). As discussed above, mouse platelets do not form full
lamellipodia on fibrinogen and therefore lamellipodia were induced after 15min by
addition of a very low concentration of thrombin (O.03unit/ml). A low concentration
of thrombin was chosen to facilitate monitoring of subsequent changes in actin
polymerisation. As shown in Fig.3.6, the addition of thrombin leads to full
lamellipodia formation, and stress fibre formation and therefore subsequent
breakdown of actin nodules. This is consistent with the concept that the actin nodule
is an early actin structure, preceding stress fibre formation. These data confirm that
actin nodules are a dynamic structure, associated with early platelet actin dynamics.
3.2.3 Actin nodules are correlated with low RhoA and ROCK activity
The above observations demonstrate the inverse relationship between actin nodules
and stress fibre formation. To confirm this finding, the effect of two structurally and
mechanistically distinct inhibitors of stress fibre formation on actin nodule formation
was investigated in platelet spreading of human platelets on fibrinogen. These studies
were completed in the presence of inhibitors of the secondary mediators apyrase and
indomethacin, the ROCK inhibitor Y27632 and the myosin-Il inhibitor, blebbistatin.
Platelets were fixed, and stained with FITC-phalloidin (2f..lM) before imaging using
fluorescent microscopy as described above. As expected, treatment with Y27632 and
blebbistatin inhibited stress fibre formation (Fig.3.7), although neither platelet
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adhesion nor platelet surface area was affected (Fig.3.8). Strikingly, inhibition of
ROCK or myosin-II caused a significant increase in the number of platelets
containing actin nodules from 39.5±2.4% to n.O±I.1 %, and 80.0±2.0% respectively
(Fig.3.9i). As the numbers of platelets containing actin nodules is increased the
number containing stress fibres decreased. Interestingly, the range of actin nodules
present within spread platelets is not affected by treatment with either Y27632, or
blebbistatin (Fig.3.9ii). These data demonstrate that actin nodule formation is
inversely related with ROCK and myosin-II activity and stress fibre formation, and
suggest that they represent a novel, early actin-rich structure.
3.2.4 Actin nodule formation requires actin polymerisation and Src kinase
activity.
A variety of pharmacological inhibitors were used to investigate whether resting
platelets contain actin nodules. These include latrunculin A, which prevents actin
polymerisation by binding G-actin causing alterations within its structure preventing
its incorporation into the actin cytoskeleton (Morton et aI, 2000), PDO173952, which
blocks Src kinases, Ly294002, which inhibits PI 3-kinases and BAPTA-(AM), which
blocks Ca2+ elevation. These inhibitors were chosen as they have all been shown to
disrupt spreading on fibrinogen. Inhibition of Src kinases, PI 3-kinase and Ca2+
elevation blocks lamellipodia formation, although filopodia are retained (Wonerow et
ai, 2003, Senis et al, 2005). In comparison, latrunculin A completely blocks platelet
spreading.
Platelets were pre-incubated with apyrase, indomethacin and the above
inhibitors before being allowed to spread on fibrinogen for 45min. They were then
fixed, lysed and stained with FITC-phalloidin (2J.lM). In agreement with previous
79
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Figure 3.8: ROCK and myosin-II inhibition does not inhibit human
platelet spreading or adhesion on fibrinogen. Platelets were allowed to
spread as per Fig.3.7. (i) Average surface area was analysed using ImageJ.
100 platelets were analysed per experiment, and results are representative of
one experiment. (ii) The number of platelets adhered were counted per
experiment. Results are an average of three experiments±SEM. Statistical
analysis was completed using ANOVA, with no significant result identified.
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• % of platelets with stress fibres
0% of platelets with actin nodules
* *
*
Y27632 Blebbistatin
-+-DMSO
---Y27632
--6- Blebbistatin
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No actin nodules I platelet
Figure 3.9: Actin nodule formation is negatively correlated with ROCK
and Myosin-II activity, but does not affect actin nodule number within
platelets. Platelets were allowed to spread as per Fig 3.7. (i) Platelet's
containing actin nodules were identified and counted. Platelets were counted
from three separate experiments. Results analysed with an ANOVA,
followed by a Tukey test. *p<0.05 is relative to OMSO control (ii) Platelets
that contained actin nodules were identified, and the number of actin nodules
per platelet was counted. At least 50 platelets were counted per experiment.
Three experiments were analysed and a frequency distribution obtained.
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observations, POO173952, Ly294002 and BAPT A-(AM) blocked lamellipodia
formation, but filopodia formation was retained (Fig.3.10). However, latrunculin A
completely inhibited platelet spreading but not adhesion. Interestingly, nodules could
not be seen in platelets pre-treated with the P00173952, latrunculin A or BAPTA-
AM, whereas they were abundant in platelets pre-treated with the PI 3-kinase
inhibitor, Ly294002. Thus, the latter result demonstrates that nodule formation is
independent of lamellipodia formation.
The absence of nodules in the presence of the other three inhibitors could
reflect either their absence in resting platelets or their disruption in the presence of the
inhibitors. To investigate the stability of the nodules in the presence of the inhibitors,
platelets were allowed to spread for 22.5min, in order to generate nodules, before
addition of the inhibitor and continuation of spreading for a further 22.5min. Using
this protocol, nodules were clearly seen in the presence of both Ly294022 and
BAPT A-(AM) at 45min, whereas they largely absent from platelets treated with
POOl7952 and latrunculin A (Fig.3.11 & 3.12). This is consistent with actin nodules
being a dynamic structure requiring actin polymerisation to form and function.
Ly294002, PDOl7952 and latruncalin A also blocked stress fibres formation and this
observation for Ly294002 therefore further dissociates nodule formation from
lamellipodia formation.
3.2.5 Actin nodules are large structures, extending through the platelet height.
Confocal and scanning electron microscopy was used to identify the structure of the
actin nodules. Confocal microscopy was used to measure the height of the actin
nodules by taking 0.251lm slices through the platelet. The average height of the
nodules was 1.20±0.12pm after spreading for 45min and this was unaltered in the
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presence of Y27632, or blebbistatin. The actin nodules were further investigated
using scanning electron microscopy, after spreading for 45min. Analysis clearly
identified filopodia (white arrows), stress fibres (red arrows), and actin nodules
(yellow arrows) (Fig.3.l3). Filopodia are thin bundles of actin filaments extending
from the platelet body. In comparison stress fibres are thick bundles of actin, linear in
nature, and define the edge of the spread platelet. Actin nodules could also clearly be
identified and were substantially greater in height than the rest of the actin
cytoskeleton. They represent dense areas of actin from which actin cables extend, as
if the nodule is the central point upon which actin polymerisation is being driven. The
actin nodules are also frequently found at the base of filopodia, though whether they
have a role in filopodia formation is unknown. Consistent with the above
observations, inhibition of ROCK or myosin-Il inhibited stress fibres, whereas
filopodia and actin nodules were present (Fig.3.13).
This data demonstrate that the actin nodule is a substantial actin structure,
which extends throughout the height of the platelet. The actin nodule has actin
filaments radiating from it in all directions. Overall these results indicate the actin
nodule could play an important role within platelet actin dynamics.
3.2.6 Actin nodules co-localise with significant actin regulatory proteins.
The association of actin-binding proteins with actin nodules was investigated using
immunohistochemistry. The results reveal that Rae, Fyn, the Arp2/3 complex,
cortactin, tal in, Csk, 131and 133integrin all colocalise with the actin nodules (Fig.3.l4
and data not shown). These actin nodules also contain heavily tyrosine
phosphorylated proteins, although the identity of these is unknown. Proteins that are
not associated with actin nodules include WASP, and Src, both of which play
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DMSO
Blebbistatin
Y27632
Figure 3.13: Actin nodules are distinct circular actin structures. Platelets
(2x107/ml) were allowed to spread on fibrinogen coated coverslips in the
presence of apyrase (2unitlml), indomethacin (10f..lM) and either DMSO
(0.1%), Y27632 (50f..lM), or blebbistatin (100f..lM) for 45min. Platelets were
fixed with phalloidin and 4% PEG for 10min, and overnight using 2%
glutaraldehyde (EM grade). Samples were dried with graded alcohols, critical
point dried, and coated with carbon. Samples were analysed using scanning
elecronmicroscopy. Red arrows indicate stress fibre formation, and yellow
arrows identified the formation of actin nodules. Images are representative of
two experiments.
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Figure 3.14: Proteins associated with actin nodules present on
fibrinogen. Platelets (2x107/ml) were allowed to spread on fibrinogen coated
coverslips in the presence of apyrase (2unitlml), and indomethacin (10I-lM) for
45min. Platelets were then fixed with paraformaldehyde (3.7%), lysed with
Triton X-100 (0.2%), and stained with (i-iii) FITC-phalloidin (2I-lM) or (iv)
rhodamine-phalloidin (2I-lM) and the appropriate antibody. Platelets washed
with PBS, before the addition of the appropriate secondary antibody.
Platelets were analysed by confocal microscopy. Images are representative
of three experiments.
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important roles in the formation and control of a number of other actin structures such
as podosomes. P-selectin and CD63 did not colocalise with the actin nodules,
demonstrating that the nodules are not a- or dense granules.
3.2.7 Actin nodules are present on multiple matrices.
Studies were undertaken to investigate whether actin nodules are also present in
spread platelets on other matrix proteins including collagen, fibronectin, laminin,
VWF+botrocetin, and VWF+ristocetin. Therefore platelets (2xl07/ml) were spread
on each matrix for 45min at 37°C, in the presence of apyrase (2unit/ml) and
indomethacin (1OIlM). Platelets were then fixed, lysed, and stained with FITC-
phalloidin (2JlM), before imaging with fluorescence microscopy. All of the matricies
support filopodia and stress fibre formation (Fig.3.15). Again, actin nodules were
absent from platelets with stress fibres consistent with the concept that they precede
stress fibre formation. The number of nodules per platelet and the proportion of
platelets with nodules was the highest on fibrinogen and VWF+botrocetin, while both
numbers were reduced on collagen, fibronectin, laminin and VWF+ristocetin. This
was consistent with the latter surfaces having an increased proportion of platelets with
stress fibres (Fig.3.16).
These results demonstrate that actin nodules are present on all surfaces and
again emphasise that they are absent in platelets with stress fibres suggesting they
may precede their formation.
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3.3 DISCUSSION
The results presented in this chapter identify the formation of a novel actin structure
within spread platelets on a variety of matrix proteins. This actin structure has been
termed an actin nodule. The nodules are identified at an early stage of spreading and
are a dynamic structure, undergoing continuous movement throughout the cell. Their
formation is inversely related to ROCK and myosin-Il activity, and independent of PI
3-kinase, but is dependent on continuous actin polymerisation and Src kinase activity.
Actin nodules are absent in platelets with stress fibres. Actin nodules are therefore an
early actin structure that could be involved within stress fibre formation.
It is important to consider whether the actin nodules are related to actin
structures identified in other cells. Podosomes are F-actin enriched, circular structures
associated with spreading cells that are typically present as a rosette structure.
Podosomes contain the Arp2/3 complex, WASP, Src, PI and p3 integrins, and are
heavily tyrosine phosphorylated (Linder et ai, 2005). Their formation is dependent on
WASP and PKC. The actin nodules however do not form a rosette structure, and are
not produced in large enough numbers. Furthermore, although actin nodules
colocalise with the Arp2/3 complex, Rae, and integrins PI and p3, they do not
colocalise with WASP or c-Src, and can be formed in the presence of PKC inhibition
(data not shown). Electron microscopy images also indicate that the structure is not
an enriched core of actin with a ring round the outside of the centre, such as the
structure of podosomes.
Focal adhesions are actin structures that are associated with phosphorylated
proteins and integrins (review Buccione et ai, 2004). However, the time course for
formation of focal adhesions is typically 60min or more (Buccione et ai, 2004) and
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our actin nodules are rapidly formed short-lived structures. Additionally, focal
adhesions formation is promoted by stress fibre formation.
The actin nodules are also unlikely to be invadopodia, peripheral ruffles or
dorsal ruffles. Invadopodia are large structures of up to 8 urn in size and are present
in protrusions from the cell to facilitate degradation of the ECM. Peripheral ruffles
are composed of branched networks of actin found at the periphery of the platelet and
are associated with the continual wave like motion of the periphery upon full
spreading. Dorsal ruffles are short-lived, dynamic F-actin enriched waves, which
occur at the top of the cell. They have a time course of 2-30min and they often form
circular waves accompanied by macropinocytosis (Araki et al, 2000). However, each
of these structures is not reminiscent of the structure of actin nodules.
The above discussion strongly suggests that the actin structures identified in
other cell types do not correspond to the actin nodules observed within spreading
platelets. Furthermore, the actin nodules do not appear to correspond to known
platelet structures, including a- and dense granules. However, it seems very likely
that the actin nodules have been observed in previous studies in platelets, although
there was no specific comment on their presence (e.g. Chang et al 2005, Falet et al
2002, McCarty et al 2006, Wonerow et al 2003, Atkinson et al 2003, Jirouskova et al
2007).
The critical question is the function of the nodules. At present, this is subject
to speculation, but their early presence and absence in platelets with stress fibres gives
rise to the possibility that they may represent novel sites of actin nucleation, possibly
related to stress fibre formation. In this context, it is noteworthy that the actin nodule
is enriched in many platelet regulatory proteins, including Src kinases, interestingly
not Src but Fyn, Rae, Talin, Csk, 131and 133integrins, and the Arp 2/3 complex, and
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that there is a high proportion of tyrosine phosphorylated proteins within the nodules.
The presence of such important actin and signalling proteins indicates an important
role for the nodules within platelet spreading. Further investigation of the nodules
necessitates identification of the interplay between different actin structures within
platelet spreading. It is necessary to disrupt actin nodule formation dynamically,
through the use of inhibitors, to monitor how their disruption affects platelet spreading
and function. Therefore platelets should be pre-incubated, and incubated with
inhibitors after 15min of spreading to monitor if actin nodules can initially form, and
if they are affected by the addition of the inhibitor once formed.
However, in addition further work must be completed to ensure that the actin
nodule is an actin structure, and is not associated with vesicle movement, or secretion
of granules. The inhibition of dynamin, should prevent endo and exo-cytosis and so if
used within the GFP-actin mice, will demonstrate if the nodules are vesicles. In
addition the use of Hermansky-Pudlack, patients who do not have dense granules, and
staining with antibodies to fibrinogen, should help to eliminate the possibility of the
actin nodules being alpha and dense granules.
In conclusion this Chapter demonstrates the formation of a novel actin
structure, which is illustrated to form prior to stress fibre formation. It requires both
actin polymerisation and Src kinase activity, whilst being negatively correlated to
ROCK and myosin-II activity. It is present on multiple matricies and has all the
proteins required for a major role within actin dynamics.
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Chapter 4
Myosin-II contractility is required for maintenance of
platelet structure during spreading on collagen and
contributes to thrombus stability
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4 GENERAL INTRODUCTION
4.0 Summary
During platelet spreading the actin cytoskeleton undergoes multiple rearrangements
the last being stress fibre formation. Stress fibre formation is mediated by ROCK and
myosin-II activation. The aim of the Chapter was to investigate the functional
significance of myosin-II in platelet spreading and thrombus formation on collagen
using inhibitors of ROCK (Y27632) and myosin-II (blebbistatin). This work led to
the identification of fenestrations within spread platelets, and thrombus instability
both in vivo and in vitro on collagen at high shear in the presence of both inhibitors.
4.1 Introduction
In response to an appropriate stimulus, the platelet actin cytoskeleton generates
finger-like protrusions (filopodia), actin-rich sheet-like protrusions (Iamellipodia) and
bundles of actin and myosin filaments (stress fibres). This actin polymerisation is
regulated by Rho GTPases, with specific family members regulating distinct
structures. For example, Cdc42, Rae and RhoA generate filopodia, lamellipodia and
stress fibres, respectively, in a wide variety of cell types (Ridley et aI, 1992a; Ridley
et aI, 1992b).
Platelets sequentially generate filopodia, lamellipodia and stress fibres as they
spread on a variety of adhesive surfaces, including collagen and fibrinogen (Leng et
aI, 1998; Suzuki-Inoue et ai, 2001). Cdc42 is activated during platelet spreading on
immobilised collagen (Suzuki-Inoue et ai, 200 I) and laminin (Chang et aI, 2005), but
at present there are no reports of a direct link between Cdc42 activation and filopodia
formation in platelets. Rae is activated by a wide range of receptor agonists in
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platelets, including those for ADP, collagen, thrombin and TxA2 (Azim et al, 2000;
Pearce et ai, 2002; Soulet et ai, 2001; Soulet et al, 2005; Gratacap et al, 2001; Hartwig
et al, 1995). In addition, constitutively active Rae drives actin polymerisation in
permeabilised platelets (Hartwig et al, 1995) and studies using mutant murine
platelets have shown that Rac-l is essential for lamellipodia formation on fibrinogen,
collagen, laminin and von Willebrand factor (VWF) both in the absence or presence
of GPCR agonists (McCarty et ai, 2005).
The small GTPase RhoA is activated by a wide variety of adhesive surfaces
and GPCR agonists in platelets, with activation being mediated downstream of the
G12!13 family ofheterotrimeric G proteins (Gratacap et ai, 2001). Activation of ROCK
by RhoA in platelets is associated with myosin light chains (MLC) phosphorylation
and subsequent stress fibre formation and 'shape change' as measured in an
aggregometer (Suzuki-Inoue et ai, 200 I; Bauer et al, 1999; Wilde et ai, 2000). In
addition, stress fibre formation and shape change are regulated through elevation of
Ca2+ which activates MLCkinase leading to MLC phosphorylation (Bauer et ai, 1999).
On the other hand, RhoA or ROCK inhibition, using C3 exoenzyme and Y27632,
respectively, has no effect on platelet aggregation to thrombin, collagen and ADP
(Leng et ai, 1998), although a reduction in secondary aggregation to adrenaline is
reported (Leng et ai, 1998). Similarly, RhoA or ROCK inhibition has a negligible or
minor inhibitory effect on static adhesion to fibrinogen, VWF and collagen, or platelet
capture by VWF under flow conditions (Leng et ai, 1998; Suzuki-Inoue et al. 2001;
Schoenwaelder et ai, 2002). RhoA and ROCK, however, do contribute to stable
platelet adhesion on VWF under arterial rates of shear (Schoenwaelder et ai, 2002).
Myosin-lIs are involved in a wide variety of cellular responses, including
cytokinesis, phagocytosis and cell motility (Canobbio et ai, 2005). Myosin-Ils consist
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of two heavy chains and four light chains. Myosin-Il activation is mediated via MLC
phosphorylation, either through an increase in MLCkinase activity through Ca2!
elevation or by inactivation of myosin phosphatase downstream of ROCK. The
importance of these two pathways in the regulation of MLC phosphorylation can be
identified using the pharmacological inhibitors Y27632 for ROCK and BAPT A-AM
for Ca2+. In addition, it is possible to block the activity of myosin-Il using
blebbistatin. This inhibitor locks myosin-Il in a low affinity state, even after its
phosphorylation by MLCkinase, thereby preventing its interaction with actin
(Allingham et al, 2005; Kovacs et ai, 2004).
The major isoform of myosin-Il in platelets is myosin-Ila (Maupin et ai,
1994), although the presence of a low level of myosin-Ilb is reported (Bodie et ai,
200 I). Mutations of myosin-lla lead to the group of MHY9 disorders, which include
May-Hegglin anomaly, Sebastian, Fechtner and Epstein syndromes (Seri et ai, 2003).
This group of disorders are caused by an autosomal dominant mutation in the gene
encoding non-muscle myosin heavy chain Ha (NMMHC-IIA) and are associated with
thrombocytopenia, giant platelets and a mild bleeding disorder, as well as different
combinations of additional clinical features. Platelets from MHY9 patients exhibit a
defect in cytoskeletal reorganisation in response to activation, leading to impairment
in shape change and spreading. However, platelet aggregation is maintained
(Canobbio et al, 2005).
In the present Chapter I have demonstrated that ROCK and myosin-II are
required for stress fibre formation, and that stress fibre inhibition causes the formation
of fenestrations in spread platelets on collagen. In addition, myosin-II activation is
required for thrombus formation at high shear both in vitro and in vivo. Although this
is not mediated by inhibition of platelet aggregation, or dense granule secretion.
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Therefore I speculate that stress fibre formation contributes to maintenance of platelet
morphology and thrombus stability.
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4.2 RESULTS
4.2.1 Collagen regulates myosin light chain phosphorylation through ROCK
Collagen (30J.lg/ml) stimulates marked MLC phosphorylation in a suspension of
human platelets which peaks at 1min and is reduced at 5min and 15min (Fig.4.1 (i)
and data not shown). Phosphorylation is inhibited in a concentration dependent
manner by the ROCK inhibitor Y27632, with maximal inhibition observed at 30-
50J.lM (Fig.d.If iij), Y27632 induced a much greater inhibition of MLC
phosphorylation following stimulation by collagen for 5min (86±6% inhibition) than
after Imin (44±8%), consistent with previous reports that Ca2+ elevation induces rapid
phosphorylation of MLC and that ROCK mediates sustained MLC phosphorylation
(Bauer et al, 1999, Paul et aI, 1999). Similar observations were made with 1 and
l Oug/ml collagen (data not shown). In contrast in the presence ofblebbistatin, used at
a concentration that completely inhibits platelet stress fibre formation, MLC
phosphorylation induced by collagen (l-30J.lg/ml) over a time course of 1-15min, was
unaffected (Fig.4.I(i) and data not shown). This observation is consistent with
previous reports that blebbistatin traps myosin-II in a low affinity state for actin but
does not inhibit MLC phosphorylation (Allingham et aI, 2005; Kovacs et aI, 2004).
4.2.2 Myosin-II is required for full aggregation and secretion to collagen
A series of experiments were designed to investigate the effect of Y27632,
blebbistatin, and the actin polymerisation inhibitor, cytochalasin 0, on aggregation
and secretion induced by collagen (I and Ioug/rn I). Collagen (Iug/rnl) stimulated
partial aggregation and weak ATP secretion with a characteristic delay (Fig.4.2). At a
ten fold higher concentration, collagen stimulated full aggregation and a more marked
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Figure 4.1: Collagen stimulates phosphorylation of MLC through a
ROCK-dependent pathway. Platelets were treated with either OMSO
(0.1 %), Y27632 (50IlM) or blebbistatin (100IlM) for 2min prior to stimulation
with 30llg/ml collagen for 1min, or 5min at 37°C, and then lysed. Samples
were run on SOS-PAGE gels, transferred to PVOF and western blotted for
MLC using anti-pan MLC and anti-phospho MLC (MLCp) antibodies. (i)
The intensity of MLCp western blots were quantified by densitometry, and
the results are shown as the mean±s.e.m of three experiments. * p<0.05
relative to OMSO control. Statistical analysis completed with a ANOVA. (ii)
Example western blot of MLCp and MLC in the presence of Y27632 (3-
50IlM) at 5min. Images are representative of three experiments.
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ATP secretion (Fig.4.2). In both cases, aggregation was preceded by shape change.
Strikingly, treatment with Y27632 (50J..lM), caused a more pronounced shape change
response to both concentrations of collagen, although the rate and final extent of
aggregation was unaffected when the increase in shape change is taken into account
(Fig.4.2). Y27632 had no effect on secretion induced by either concentration of
collagen (Fig.4.2). In comparison, blebbistatin (I OOJ.lM) caused a significant
inhibition of aggregation and ATP secretion induced by both concentrations of
collagen, while cytochalasin D (IOJ..lM)had a slightly greater inhibitory effect on both
responses (FigA.2 & 4.3). The results with cytochalasin D provide evidence for a
contributory but non-essential role of actin assembly in platelet aggregation and
secretion by collagen, whereas ROCK activity is not required for either response. It is
unclear whether the inhibitory effect of blebbistatin is a consequence of its ability to
produce a greater degree of inhibition of MLCkinase at early times of stimulation
relative to Y27632 or through an additional action.
4.2.3 ROCK is required for stress fibre formation and structural integrity
during spreading on collagen
Human platelets undergo sequential formation of filopodia, lamellipodia and stress
fibres on collagen in the presence of inhibitors of the secondary feedback agonists,
ADP and TxA2• After 45min, the majority of platelets have formed extensive
lamellipodia and stress fibres, and there is extensive colocalisation of actin with
myosin-Ita with the exception of a distinct outer ring of actin (FigAA). The ROCK
inhibitor Y27632 inhibited stress fibre formation on collagen and markedly reduced
the co-localisation of actin and myosin-lla (Fig.4.4). However, there was no
significant change in platelet surface area, at either 22.5 or 45min, in the presence of
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Figure 4.3: The effect of inhibitors of actin remodelling on
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mean±s.e.m of three experiments. *p<O.05 relative to the control.
Statistical analysis completedwith an ANOVA, followed by a Tukey test.
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Y27632 and blebbistatin in comparison to the DMSO control (FigA.5 and data not
shown), demonstrating that lamellipodia formation was unaltered. In addition platelet
adhesion in the presence of either Y27632 or blebbistatin is unaffected (data not
shown). Strikingly, the presence of internal holes and splits could be seen in 10-15%
of the platelets that had spread on collagen in the presence of Y27632 and
blebbistatin, whereas similar structures were present in <0.5% of control cells (FigAA
& 4.5). These structures have been termed fenestrations (i.e. windows). To
investigate whether the fenestrations are due to an increase in permeability of the
plasma membrane, platelets were fixed and incubated with FITC-phalloidin (2~M) in
the absence or presence of Triton X-WO (to induce permeabilisation). Staining of the
actin cytoskeleton by FITC-phalloidin was only observed in the presence of Triton X-
100 demonstrating that membrane integrity is maintained in the presence of Y27632
or blebbistatin (FigA.6). Consistent with this, the fenestrations were observed to
undergo continuous movement throughout the recording (FigA.7 & supplementary
video 3). Together, these studies demonstrate a critical role for ROCK and myosin-II
in stress fibre formation in spread platelets. Furthermore, following inhibition of
ROCK or myosin-II, a significant number of platelets exhibit fenestrations, which
indicates a structural weakening of the actin cytoskeleton.
4.2.4 Actin polymerisation induced by collagen is not altered in the presence of
Y27632 and blebbistatin.
The level of F-actin was measured in platelets that had been allowed to spread on
collagen coated coverslips to investigate whether the loss of stress fibre formation and
appearance of fenestrations was associated with a change in the level of actin
polymerisation. There was no significant difference in the level of F-actin in spread
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DIC
(i) FITC-phalloidin
(ii)
lTC-phalloidin
+ Triton X-100
(iii
Figure 4.6: Demonstration of dynamic fenestration formation and
maintenance of platelet integrity. Platelets were stained with (i) FITC-
phalloidin (2~M) (ii) FITC-phalloidin (2~M) after treatment with Triton X-100
(0.2%) (iii) DiOC6 (2~M). for 60min. Images were taken using DIC and
fluorescent optics. The results are representative of three experiments.
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platelets treated with either Y27632 or blebbistatin in comparison to the DMSO
control (Table 1).
Treatment Fold increase in F-actin in comparison
to basal
DMSO 1.81+0.03
Y27632 (50~M) 2.04+0.14
Blebbistatin (1OO~M) 2.04+0.36
Table 1: Actin polymerisation induced by collagen is not altered in the presence
of Y27632 and blebbistatin. Platelets (2x I08/ml) were incubated with either DMSO
(0.1 %), Y27632 (50).lM) or blebbistatin (lOO).lM) for 2min before spreading on
collagen-coated plates for 45min. F-actin levels were measured and compared to that
of a protein matched basal platelet sample as described in the methods.
4.2.5 Stress fibre formation is required for aggregate integrity under flow
The significance of stress fibre inhibition on platelet aggregate formation on collagen
under shear conditions was examined. These studies were performed at intermediate
and high shear rates of 1000S-1 and 3000s-1 that are typically found in the arteriolar
system, using washed platelets labelled with the fluorescent dye DiOC6 (2~M).
Washed platelets were used because of extensive protein binding of blebbistatin
rendering it ineffective in plasma (unpublished observations). The experiments were
performed in the presence of red blood cells to ensure flow of platelets at the edge of
the chamber.
Inhibition of ROCK and myosin-II caused a significant reduction in mean
aggregate height at both shear rates, although the effect was more pronounced at
3000s-1 (Fig.4.8i&ii). The relative small nature of the inhibition at 1000s-1 indicates
III
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Figure 4.8: Y27632 and blebbistatin inhibit platelet aggregate
formation on collagen. Washed platelets were reconstituted with red
blood cells and incubated with either DMSO (0.1%), Y27632 (50~M), or
blebbistatin (100JlM) for 10min at 37°C. Platelets were then flowed over
collagen for 3min at either 1000s-1 or 3000s-1, before washing with Tyrode' s
buffer for 5min. Thrombi were fixed using paraformaldehyde (3.7%) for
30m in and incubated with DiOC6 (2JlM) overnight at room temperature.
Thrombus height at (i) 1000s-1 (ii) 3000s-1 was calculated using confocal
microscopy. Statistical analysis completed with an ANOVA, followed by a
Tukeytest.
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that aggregate formation is largely independent of ROCK and myosin-Il at
intermediate shear but that this becomes more dependent on the actin cytoskeleton as
shear is increased. The reduction in thrombus height is mirrored by an increase in the
frequency of embolisation relative to OM SO-treated controls (FigA.9i). In contrast,
neither inhibitor had a significant effect on surface area coverage (data not shown).
Examination of real-time video recordings demonstrates that platelet capture and
aggregate formation is similar in the presence of Y27632 and blebbistatin suggesting
that the increase in emboli sat ion underlies the decrease in aggregate formation
(FigA.9ii). Together, these results indicate that blockage of stress fibre formation
leads to aggregate instability on collagen, although platelet capture is maintained.
4.2.6 Inhibition of ROCK with Y27632 inhibits thrombus formation in vivo
Intravital microscopy was undertaken, in conjunction with Or Jocelyn Auger, to
investigate the functional significance of inhibition of ROCK activation using
Y27632. Similar studies could not be performed using blebbistatin because of
extensive protein binding in plasma (unpublished observations). Initially, a series of
experiments were performed to establish the degree of protein binding of Y27632 in
plasma using platelet shape change as a readout (FigA.lO). These studies were
performed in BAPT A-AM loaded platelets to prevent MLCkinase activation by Ca2+
elevation. Y27632 (1OJ..lM&100J..lM) caused partial and complete block of shape
change to the PAR-4 specific peptide, TRAP, respectively (FigA.I0i). Similar results
were obtained in washed platelets (FigA.IOii), demonstrating that Y27632 is
minimally protein bound in plasma. This observation was used to estimate the dose of
Y27632 to induce inhibition of ROCK following intraperitoneal injection in mice, on
the assumption that Y27632 distributes freely in the aqueous compartments in the
113
Chapter 4: Myosin-Il activity is required for thrombus formation
(i)
30 *
fIJ 25 *..,c:
G>
>
G> 20e
0
:;::;
tU
fIJ 15
'0
.Q
E 10G>....
0
?I- 5
0
D~'ISO Y27632 Blebbistatin
(ii)
Direction of Flow
Dl\ISO
.• •
.• t-o •
.. " a-"'" '..,"..... • y.,.. .
Y27632
Osee 10 sec 30 sec
Figure 4.9: Y27632and blebbistatin inhibit platelet aggregate formation
on collagen. Thrombiwere formed and imagedas per Fig.4.B.(i) The rate
of embolisation was measured by analysis of realtime time courses.
Embolisation was defined as movement of platelets from original point of
contact. Results are shown as mean±s.e.mof three experiments. Statistical
analysis completed with an ANOVA. followed by a Tukey test. * p<O.05
relative to the control. (ii) An example recording illustrating thrombus
embolisation in the presence of Y27632 (50~M). The arrow at Osec
illustrates the build up of a small thrombus, which then embolises in the
direction of flow. Imagesare representativeof three experiments.
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Figure 4.10: Inhibition of platelet shape change after administration of
Y27632 to washed platelets and platelet-rich plasma. (i) Washed
platelets were treated with BAPTA-AM (40IlM) for 30min to block the
regulationof shape change downstreamof Ca2+, and Y27632 (10-50IlM) for
2min, before stimulation by TRAP (250IlM) (indicated by the arrow).
Aggregationwas inhibitedwith allbj33 blocker, integrillin (9IlM). (ii) Platelets
were stimulated in platelet-rich-plasma by TRAP (250f.lM) (indicated by
black arrowhead) under the same conditions as for (i). (iii) Mice injected
with saline, 2.37, or 23.74mgs/kgsY27632 for 30min before exsanguination.
Platelet rich plasma was prepared and loaded with BAPTA-AM for 30min
before stimulationwith 30f.lg/mlcollagen (indicatedby arrow). All traces are
representativeof three experiments.
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cell. Ex vivo analysis of platelet shape change in BAPT A-AM loaded platelets
revealed that 2.37mg/kg, and 23.7mg/kg induce partial and full blockade of shape
change to 30llg/ml collagen (FigA.l Oiii).
Thrombus formation in vivo was analysed by inducing damage to the
endothelial layer using a nitrogen dye laser and monitoring realtime thrombus
formation using a non-blocking FITC-conjugated antibody that recognises the major
platelet integrin UllbPJ (Falati et ai, 2004). Thrombus formation induced by laser
injury was measured before and after injection of Y27632 (23.7mg/kg). All
experimentation was carried out between 5-30min following treatment with Y27632.
FigA.ll illustrates the steady build up of platelets into a large, stable thrombus under
control conditions with minimal embolisation. In comparison, following laser injury
in the presence of Y27632, platelets were unable to form large stable thrombi and
exhibited rapid embolisation. Thrombus formation was significantly reduced
following treatment with Y27632 (FigA.II). These results demonstrate ROCK is
required for stable thrombus formation at arterial rates of shear in vivo.
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Figure 4.11: Decreased thrombus formation in Y27632 treated mice
after laser induced injury. The effect of Y27632 (23.74mgs/kg) on
thrombus formation was monitored within the same animal, with an average
of five thrombi produced both before and after administration of Y27632
(with recordings between 5-30min following Y27632 injection). (A) An
example recording illustrating thrombus embolisation in control and Y27632
treated animals (100~M). (8) Mean integrated fluoresence of five thrombi
pre and post Y27632 injection. The data is representative of experiments on
three animals.
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4.3 DISCUSSION
The present study demonstrates ROCK and myosin-II play critical roles in
maintaining platelet morphology and thrombus stability under in vitro and in vivo
conditions. Inhibition of ROCK and myosin-II significantly affects platelet
morphology during platelet spreading on collagen, as demonstrated by formation of
internal holes and splits (fenestrations) and blockade of stress fibre formation. These
changes may therefore underlie the increase in embolisation observed under in vitro
and in vivo conditions, possibly as a consequence of loss of structural integrity,
although there is no direct evidence that this is the case. The increase in embolisation
is, however, very likely to contribute to the bleeding diathesis that is seen in patients
with the MHY9 group of disorders caused by mutation of non-muscle myosin heavy
chain IIa, along with the associated thrombocytopenia.
The present results agree with earlier studies that platelet spreading on
fibrinogen and collagen is unaltered by inhibition of ROCK (Leng et al, 1998; Suzuki-
Inoue et al. 2001). However, this is the first study to report fenestration formation in
platelets in the presence of Y27632, thereby revealing a critical role for ROCK in
maintaining platelet morphology. Significantly, a similar set of observations was
obtained with blebbistatin. Real-time video microscopy demonstrated that
fenestration formation in the presence of Y27632 and blebbistatin was not simply due
to a loss of platelet integrity, as the change in morphology was continuous, and
moreover actin fibres could not be stained with the membrane-impermeable toxin,
FITC-phalloidin, without prior permeabilisation. Fenestration formation was not due
to a reduction in F-actin production. The present results are similar to the effect of
Rho A inhibition by C3 toxin in Swiss 3T3 cells (Rottner et al, 1999). In this study,
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the presence of fenestrations is readily apparent in C3 toxin-treated but not in control
fibroblasts that have been allowed to undergo spreading.
The possibility that the reduction in thrombus stability is due to the loss of
structural integrity is consistent with the proposal by Canobbio et al (2005) that
GTPase incorporation into the cytoskeleton is vital for late events of thrombus
formation. On the other hand, thrombus formation is regulated by multiple factors
and it is possible that additional actions of ROCK and myosin-II, rather than
fenestration formation or stress fibre inhibition, contribute to this instability. For
example, ROCK inhibition by Y27632 is reported to reduce aggregate formation in a
cone-and-plate visocometer and adhesion of platelets to VWF within a high shear
environment (Schoenwaelder et aI, 2002). In addition, it is possible that the inhibitors
have other inhibitory actions that have contributed to the reduction in thrombus
stability. For example, blebbistatin causes a partial reduction in secretion and
aggregation but this cannot explain the reduction in thrombus stability as Y27632 had
a negligible effect on these two responses. On the other, ROCK has been implicated
in a number of other pathways that could have potentially contributed to the thrombus
stability that was seen in vivo, including expression of tissue factor and pro-coagulant
activity (Kunedia et al, 2003; Rolfe et ai, 2005). Pro-coagulant activity is known to
play an important role in the laser-induced injury model alongside that of the
thrombin receptor, PAR4, and the collagen receptor, GPVI (Mangin et ai, 2006;
Dubois et ai, 2006). Therefore the contribution of coagulation to thrombus formation
after laser induced injury may be reduced in the presence of Y27632. It is also
possible that the contribution of ROCK to contraction of vascular smooth muscle,
reduction in blood pressure, nitric oxide synthesis (eNOS), and maintenance of
vascular tone effects thrombus formation in vivo (Budzyn et ai, 2006) has contributed
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to the decrease in thrombus formation. Importantly, however, inhibition of these
responses is unable to account for the increase in embolisation that is seen under in
vitro flow conditions that are seen in the presence of Y27632.
The effect of Y27632 in vivo, is further complicated by Y27632 affecting
other cells in the bloodstream, including endothelial cells. ROCK inhibition is
associated with an increase in nitric oxide synthesis from endothelial cells, which
could drive vasodilation and reduce platelet activation (Wolfrum et aI, 2004). ROCK
inhibition also leads to a reduction in migration, cell adhesion, and cell permeability.
The present results can be compared with the recent observations of McCarty
et al (2005) who demonstrated increased platelet embolisation on immobilised
collagen or immobilised VWF/thrombin in Rac-l-I- platelets. Rac-l-I- platelets cannot
form lamellipodia and therefore also have altered stress fibre formation which could
have contributed to the thrombus instability observed in the absence of the small
GTPase. Therefore, our results are consistent with stable thrombus formation
requiring both lamellipodia formation and stress fibre generation and that Rae and
Rho co-ordinate with each other to mediate stable thrombus formation ill vivo under
flow.
In conclusion I have demonstrated a requirement for ROCK and rnyosin-Il in
maintaining the platelet cytoskeleton and thrombus stability on collagen at arterial
rates of flow. These studies further underscore the role of the cytoskeleton in
contributing to thrombus formation ill vivo. Additionally, this study emphasises the
potential of a ROCK inhibitor in the treatment of hypertension and its associated
thrombotic complications, as the inhibitor would have both an antihypertensive and
antihrombotic action.
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5 GENERAL INTRODUCTION
5.0 Summary
WASP family proteins are implicated within platelet lamellipodia formation. The aim
of this chapter was to identify the role of WAYE-l within platelet activation and
thrombus formation at high shear. This work led to identification that WAYE-l plays
a major role in lamellipodia, and platelet activation downstream of GPYI. GPCR
signalling pathways were unaffected in WAYE-l-I- platelets, indicating either WAYE-
I was not required or that WAYE-2 could compensate for the lack of WAYE-I.
5.1 Introduction
Actin reorganisation is a consequence of platelet activation. F-actin levels almost
double after platelet activation as the platelet changes from a discoid shape to a
sphere, and then forms filopodia and lamellipodia. These distinct actin
reorganisations are mediated via multiple different signalling pathways.
The Rho GTPase family plays a fundamental role, with Cdc42, Rae, and RhoA
implicated in the formation of filopodia, lamellipodia, and stress fibres respectively
(Nobes et aI, 1995). Rac-l was recently identified as fundamental for lamellipodia
formation and F-actin production in platelets. In addition Rac-I-I- cannot form stable
thrombi, implicating lamellipodia formation in thrombus formation (McCarty et aI,
2005).
WAYE is an important Rae target. WAYE is important in lamellipodia
formation, as it is activated by Rae, leading to WAYE binding the Arp2/3 complex.
Removal of WA YE leads to the removal of lamellipodia (Yamazaki et al, 2003).
There are three isoforms of WAYE, of which WAVE-I and -3 are mainly neural, and
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WAYE-2 is ubiquitous. Due the redundancy in the WA YE structures, it is possible
that the isoforms could compensate for each other in vivo. This is demonstrated by
the viability of the WAYE- r/-mouse.
Platelets express WAYE-I, -2, and possibly -3 (Kashiwagi et aI, 2005; Oda et
aI, 2005). WAYE-l may playa role in megakaryocytes, as WAYE-l is upregulated
by five fold during megakaryocyte differentiation. WAYE-2 expression is maintained
at a constant level (Kashiwagi et aI, 2005). WAYE-l IS also implicated within
migration through the ECM (Suetsugu et al, 2002) a process that requires
metalloprotease activity. This process is required by megakaryocytes to allow platelet
budding into the vasculature.
The aim of this Chapter was to identify the role of WAYE-I within platelet
activation, spreading and aggregate formation. I demonstrate that WAYE-l is
important within the GPYI signaling cascade, but plays a much smaller role within
GPCR signaling. In addition WAYE-l does not play a role within aggregate
formation in vitro.
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5.2 RESULTS
5.2.1 Confirmation of expression of WAVE isoforms present within human and
murine platelets.
In order to identify the role of WAVE within platelets, it was necessary to identify the
WAVE isoforrns present within platelets. Therefore wild-type and WAVE-l-1-
platelet lysates were Western blotted with WAVE specific antibodies, alongside
human lysates. It is clear that human and murine platelets contain both WAVE-l and
-2 (Fig.S.I). WAVE-3 could not be identified in human or murine samples using
available antibodies. WAVE-l-1- platelets however, contain just WAVE-2
(Fig.5.l C&O). Importantly, the expression of WAVE-2 is not increased within
WAVE-I-1- platelets, indicating WAVE-2 is not upregulated to compensate for the
lack of WAVE-I.
5.2.2 Platelet production is maintained within WAVE-I-I- mice
The mean platelet volume and platelet number of the WAVE-l-1- mice was
investigated in view of the defect in platelet production that has been described in the
absence of WASP (Ochs et al, 1980). Table.l demonstrates that both platelet number
and volume is not significantly different within the WA VE- r". to a wild-type control.
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Parameter Wild- T~l!_e WAVE-l
Leucocytes 100/mi 3.39±0.67 1.09±0.21 *
Erythrocytes 106/ml 3.54±0.14 3.39±0.57
Platelets, 10°/011 329.2±IS.9 260.4±47.S
mean Platelet volume, fL 5.24±0.07 5.28±0.16
Table 1: Haematological parameters of wild-type and WAVE-I-1- mice. Samples
of whole blood (50lll) were analysed using an ABX Micros 60. Data are presented as
mean ± SO from five mice. * p<O.Ol with respect to wild-type.
There is also no difference in red blood cell production. However, leucocyte
production is significantly reduced in the absence of WAVE-I-1-. This suggests that
platelet production and platelet volume is maintained as normal in WAVE-l-1- mice,
but that WAVE-l is implicated in leucocyte production.
5.2.3 WA VE-l is implicated in lamellipodia formation on CRP and laminin
Due to the role of WAVE-I downstream of Rae, WAVE-I and wild-type platelets
were spread on a number of matricies both in the presence and absence of G-protein
coupled agonists. On fibrinogen both wild-type and WAVE-I-1- platelets formed
filopodia, and partial lamellipodia. Full lamellipodia could be induced both in wild-
type and WAVE-I-1- platelets by the addition of thrombin or ADP (Fig.5.2 and Table
2).
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Surface Treatment Wild-type WAVE-rl-
Fibrinogen - 14.7±0.12 14.2±0.28
Fibrinogen ADP lS.4±O.lS lS.1±0.16
Fibrinogen Thrombin 24.9±0.13 24.6±0.22
Collagen - lS.6±0.22 IS.0±0.08
Collagen ADP IS.5±0.2 lS.7±0.11
Collagen Thrombin lS.S±0.17 IS.2±0.15
Laminin - 24.S±0.21 15.5±0.lS*
Laminin ADP 25.2±0.11 23.S±0.1
Laminin Thrombin 25.7±0.19 24.0±0.12
CRP - 21.9±0.lS 15.S±0.21 *
CRP ADP 23.S±O.21 24.3±0.09
CRP Thrombin 24.6±0.19 25.1±0.18
Table 2: Average platelet surface area in wild-type and WAVE_r/-. Purified
human and wild-type and WAVE- rl- murine platelets (2x 107/ml) were placed on
coverslips coated with fibrinogen, collagen, laminin, and CRP for 45min at 37°C. In
selected experiments, platelets were treated with thrombin (Iunit/ml) or ADP (lOJ.lM).
Values are reported as follows: platelet surface area (um") = mean±SEM of at least
200 platelets. * p<0.05 with respect to wild-type.
Surface area analysis indicated no difference between wild-type and WAVE-l-
f- mice. Interestingly, 26.2±0.3% WAVE-I-I- platelets induced elongated filopodia in
the absence of thrombin and ADP, which are at least as twice as long as seen within
wild-type platelets. This is a similar result to that seen within Rae 1-1- (McCarty et ai,
2005), and is presumably due to increased F-actin monomer incorporation into
filopodia.
Wild-type platelets form filopodia and full lamellipodia on collagen, laminin
or CRP (Fig.5.3). Strikingly, although WAVE- rf- platelets spread fully on collagen,
they do not form lamellipodia on laminin (which signals via a6(3 I, and GPVI) (Inoue
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et al. 2005) and CRP (which signals via GPVI). Interestingly, lamellipodia formation
can be induced in the presence of thrombin or ADP. However, WAVE-l-I- filopodia
formation is unchanged on all surfaces. Therefore, these results suggest a role for
WAVE-l in mediating lamellipodia formation downstream of GPVI but not GPCRs.
5.2.4 GPVI mediated platelet activation is impaired in the WAVE-I-I-mice
The role of WAVE-J within aggregation to both G protein and tyrosine kinase based
receptors was measured either through single platelet counting, or by measuring the
change in optical density with a Born aggregometer. The latter demonstrated that
WAVE-I-I' platelets showed a marked delay of shape change and impaired
aggregation to I ug/rnl CRP (Fig.5.5). The inhibition of aggregation to 1ug/rn) CRP,
was confirmed by single platelet counts 2min after agonist stimulation (75.1 %±5.8%
wild-type platelets within aggregates v. 42.3±5.2% WA VE- r/-platelets). However, a
high concentration of CRP (I Oug/ml) stimulated shape change and full aggregation of
WAVE-l platelets, a result that was confirmed by single platelet counting (91.9±3.0%
wild-type platelets within aggregates v. 92.5±4.2% WAVE-l'l- platelets within
aggregates). In contrast stimulation of WAVE- ri- platelets with either low or high
concentrations of collagen did not induce a significant difference between wildtype
and WAVE-I-I' mice responses (Fig.5.S).
The role of WAVE-I in alpha granule secretion was investigated by
monitoring of P-selectin exposure. Surprisingly analysis indicated that P-selectin
exposure was decreased by between 30-50% for CRP, thrombin and collagen,
although the reduction in P-selectin exposure to CRP was greater than that to
thrombin (Fig.S.6). Therefore, this raises the possibility that the WAVE-l'I' mice had
reduced P-selectin expression, or there could be a secretion defect associated with the
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Figure 5.5:. Role of WAVE-1 in platelet P-Selectin exposure. Washed
platelets (2x107/ml) from wild-type (black bars) and WAVE-1-1- (white bars)
stimulated with 10J..l.g/ml GRP I 0.1unit/ml thrombin or 30J..l.g/ml collagen for
15min at 37°G. The degree of FITG-conjugated anti P-Selectin mAb was
recorded via FAGS analysis in arbitary units (au). Values are mean±SEM
from three experiments. *p<O.01with respect to wild-type.
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WAVE-I-!-mice. Unfortunately the low yield of platelets from the WAVE-I-!- mice
did not allow for the further investigation of this effect.
5.2.5 The role of WAVE-l in aggregate formation under high shear.
The functional role of WAVE-I platelets within thrombus formation was investigated
using an ill vitro flow based assay. Aggregate formation on collagen could be
monitored using fluorescent microscopy at high shear. Whole blood was flowed over
collagen at 1000S-1 for 4min. WAVE-I-1- blood generated stable aggregate formation
with densely packed platelets, which were similar in appearance to those observed in
wild-type blood. The similarity was confirmed by analysis of surface area coverage
and quantification of protein lysates (Fig.5.7 A&B) indicating that WAVE- r'platelets
formed large thrombi, that were similar in size to wild-type platelets (51.7±5.7% v.
60.0±5.7%, control and WAVE-I-1- surface area coverage respectively). This
indicates that WAVE-l is not required for aggregate formation on collagen at high
shear.
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(A) Wild-type WAVE-1-1-
FLOW.. 10 urn
(8)
Wild-type WAVE-1-1-
Figure 5.6: Role of WAVE-1 in platelet adhesion and aggregate
stability on collagen under flow. Mouse blood anticoagulated with P-
Pack and heparin was perfused through collagen coated microslide at a
shear rate of 1000s-1 for 4min follwed by modified Tyrode's buffer for 3min
to remove non-adherent platelets. Slides were then visualised using
phase-contrast microscopy. (A) Representative images of platelet adhesion
from wild-type (left panel) and WAVE-1-1-(right panel) mice are shown.
Images are representative of three experiments. (B) Platelet adhesion
results are expressed as mean±SEM of surface area covered by platelets.
Work completed by Dr.J.Auger.
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5.3 DISCUSSION
WASP family proteins have been implicated as downstream effectors of Rae, and thus
have an important role in the activation of the Arp2/3 complex leading to lamellipodia
formation. However, WASP, is reported to play little role within platelet actin
dynamics and activation of the Arp2/3 complex (Falet et ai, 2002, Gross et ai, 1999)
while the levels of N-WASP in platelets are extremely low. Within this chapter I
have demonstrated that both human and mouse platelets contain WAVE-l and -2.
WAVE-l was required for lamellipodia formation on CRP and laminin, and for shape
change and aggregation to low concentrations of CRP. CRP is highly specific for
GPVI, and laminin is shown to mediate lamellipodia formation downstream of GPVI
(Inoue et ai, 2005). In contrast the stimulation of platelet shape change and
aggregation by thrombin is not altered in the absence of WAVE-l, while spreading on
fibrinogen is similar in the WAVE-I-I- and control platelets. These results therefore
imply a selective role for WAVE-l downstream of GPVI, which maybe similar to that
seen in the absence of Rae. An important caveat to the conclusion is that mouse
platelets do not form extensive lamellipodia on fibrinogen (in the absence of a
secondary agonist) and so a more minor role for WAVE-l in signalling via allb(33 may
have been missed.
The inability of WAVE-I"/- platelets to form lamellipodia on CRP, or laminin,
and the defect identified within shape change and aggregation to low concentrations
of CRP indicates a GPVI signalling defect. However, this is at odds to the normal
spreading identified on collagen. This may be due to collagen signalling via a2PI, or
that binding to collagen causes a net increase in the affinity for GPVI (Watson et ai,
2005), enabling collagen to act as a more powerful agonist thereby masking the role
of WAVE-I. This argument may not apply to laminin, which requires binding to
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a6PI, in order to enable its interaction with GPYI, as laminin has a tenfold lower
affinity for GPYI, or a6PI may induce a smaller signal than a2PI.
These results indicate that GPYI may induce lamellipodia through WAYE-I,
and GPCR agonists via WAYE-2. If this is the case then this suggests that WA YE-l
is involved in tyrosine phosphorylation cascades. Tyrosine phosphorylation of
WAVE has been identified in other cell types (Miki et ai, 1999), but platelets lack the
Abl kinases involved within tyrosine phosphorylation of WAYE and I was not able to
demonstrate tyrosine phosphorylation of WAYE downstream of CRP (unpublished
data). This indicates that the regulation of WAYE may differ depending on the cell
type. Interestingly the observation that platelets undergo full spreading on collagen
indicates in the absence of WAYE-I, collagen can also regulate WAYE-2.
The removal of WAYE did not prevent either filopodia or lamellipodia
formation on fibrinogen. Indeed a proportion of platelets had abnormally long
filopodia, as was also seen with Rac-r/- platelets on fibrinogen (McCarty et ai, 2005).
This could indicate a shift in the incorporation of actin filaments into filopodia from
lamellipodia, as previously reported in gelsolin" platelets (Falet et ai, 2000). Gelsolin
is thought to be important in the generation of the new barbed ends that are required
for Arp2/3 complex induced lamellipodia formation (Falet et ai, 2005).
It has been recently reported Rac-I is critical for lamellipodia formation in
platelets. In addition Rac-l-I- platelets do not form stable thrombi on collagen at high
shear (McCarty et al, 2005). However, this chapter identifies that WAYE-I-I- have
normal aggregate formation on collagen, in agreement with the normal WAYE-I-/-
spreading on collagen. In addition this difference could be due to the secondary
mediators, ADP and TxA2, driving lamellipodia formation through WAYE-2 (Yan et
ai, 2003, Yamazaki et ai, 2003). The production of either a WA YE-2-1- or a WAYE-
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lIT-, would investigate this hypothesis. However, in order to identify the role of
WAVE-2 within platelets a conditional knock out must be made as a traditional knock
out is embryonically lethal (Yan et al 2003; Yamazaki et aI, 2003; Dahl et aI, 2003,
Soderling et aI, 2003). However, the recent description of a PF4-Cre mouse that
confers megakaryocyte/platelet specific knockdowns is a welcome contribution to the
field (Tiedt et al. 2007). Interestingly there is already some precedent for a difference
in role between WAVE-I and WAVE-2 with mouse embryonic fibroblasts, where
WAvs.r has little or no effect on lamellipodia formation whereas WAVE-2 has a
major effect on lamellipodia formation (Yan et a12003; Yamazaki et aI, 2003).
At the moment it is unclear whether WAVE-l is critical for cytoskeletal
rearrangements downstream of CRP, or whether WA VE-I plays an additional
important role within the GPVI signalling cascade. The reduction in aggregation and
elongation in shape change to CRP, is very similar to that seen with the Rac-I-I- to low
doses of CRP. In both cases the aggregation can be recovered with the use of high
doses ofCRP. The similarity of phenotype may be to be expected as WAVE is a Rae
target. Interestingly recent data within Rac-I-I- mice, indicates a reduction in PLCy2
and Syk phosphorylation at low doses of CRP (Pearce unpublished data).
Unfortunately it was not possible to extend this experiment to WAVE-I-I- platelets,
due to the limited amount of material.
WAVE-l-I- mice did not have altered red blood cells, platelet number or mean
platelet number. This is in agreement with the Rac-I-I- mouse data (McCarty et ai,
2005). Rac-l deficient fibroblasts have been identified as having normal chemotaxis
and migration (Vidali et al, 2006). This suggests that the Rac/WAVE pathway is not
required for movement of megakaryocytes from the osteoblastic to the vascular niche
(Avercilla et al. 2004). This is markedly different to the WASP-I- mouse that has
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defective platelet production (Sabri et al, 2006). Interestingly leucocyte production is
significantly affected within the WAYE-l-I- mice, clearly indicating a role for WAYE-
I within leucocyte production. Further experiments are required to establish the basis
of this defect.
This chapter indicates that WAYE-l plays an important role within GPYI
signalling, relative to GPCR signalling, raising the possibility that WAYE-l is
specifically regulated by tyrosine kinase linked receptors.
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6 GENERAL INTRODUCTION
6.0 Summary
Cell activation is associated with cytoskeletal rearrangements that are regulated
downstream of multiple signalling pathways. The role of many cytoskeletal-
associated proteins in the regulation of actin assembly is unclear. The aim of this
Chapter is to characterise two actin-binding proteins that have been recently identified
in platelets using a proteomics-based approach (Garcia et ai, 2006), namely the
Arp2!3 complex-binding protein Spin-90 and the Rae GTP exchange factor ~-Pix.
This work has confirmed that each of these proteins is tyrosine phosphorylated in
platelets downstream of GPCR and tyrosine kinase-linked receptors, but has
demonstrated that in contrast to observations in other cells, these proteins do not form
a complex with each other or the adapter Nck upon platelet activation either in
suspension or following adhesion to a surface.
6.1 Introduction
In the majority of cells, cytoskeletal dynamics is controlled by the Rho GTPases
Cdc42, Rae, and RhoA leading to filopodia, lamellipodia, and stress fibre formation,
respectively. The mechanism of regulation of these RhoGTPases within platelets and
many other cell types, however, is not well understood. Recently, two novel actin-
regulatory proteins, Spin-90 and ~-Pix, were reported to be tyrosine phosphorylated
downstream of the collagen receptor GPVI in platelets using a novel proteomics-
based approach (Garcia et al, 2006). Although this was the first report of their
expression in platelets, they had been previously been implicated in the regulation of
the cytoskeleton in several other cell types (Lim et al, 2003, Ten Klooster et al, 2006).
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Interestingly, in cardiac myocytes, Spin-90, ~-Pix, and WASP form a complex in
suspension, which upon adhesion to a surface recruits Nck (Lim et aI, 2003).
Tyrosine phosphorylation of Spin-90 was responsible for recruitment of Nck, and the
complex of all four proteins was implicated in the stabilisation of adhesion.
Furthermore. Spin-90 has been shown to localise to lamellipodia where it binds to the
Arp2/3 complex through its C-terminus, stimulating actin polymerisation (Kim et al,
2006 & 2007). These observations clearly implicate Spin-90 as an important
regulator of actin dynamics and lamellipodia formation in cardiac myocytes (Kim et
al, 2006, Lim et al, 2003). Importantly, ~-Pix has been shown to lie upstream of
activation of the Rho GTPase Rae in HEK293 and MDCKIII cells (Ten Klooster et al,
2006), thereby suggesting that it is also involved in lamellipodia formation. In
addition ~-Pix and GITl, an adaptor protein, can bind PLCyl, leading to the
activation of both Cdc42 and Rae, within multiple cell types and so is a requirement
for cell motility and spreading (Jones et al, 2007).
In the present Chapter, I have set out to confirm expression and to investigate
the regulation and function of Spin-90, ~-Pix, and Nck following activation of
platelets in suspension and upon adhesion by GPCR and tyrosine kinase-linked
receptors.
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6.2 RESULTS
6.2.1 Characterisation of Spin-90, f3-Pix, and Nck antibodies
The minimum amount of the Spin-90 antibody that could be used in
imrnunoprccipitation studies was determined prior to experimentation in view of a
limited supply, since the antibody was kindly donated by Professor Woo Keun Song.
The ~-Pix and Nck antibodies were also characterised simultaneously. Platelets
(5x 108/011) were lysed with 2xlysis buffer and proteins immunoprecipitated with
either I, 2 or 3pl of each antibody, or the relevant IgG control. Immunoprecipitation
and western blotting were performed as described in the methods. Fig.6. IA&B
identifies that 3pl each of the ~-Pix, and Nck antibodies generated a robust band and
so were used in further immunoprecipitations. Fig.6.1 C identifies that 2,.t1 of Spin-90
generated the strongest band, but due to limited supply of the antibody, IpI of
antibody was chosen for experimentation. IgG controls identified that there were no
overlapping bands associated with the relevant bands for each antibody.
6.2.2 Spin-90 is tyrosine phosphorylated downstream of GPVI
A series of experiments were designed to confirm that Spin-90 undergoes tyrosine
phosphorylation upon platelet activation. Platelets (5x IOs/ml) were stimulated with a
range of concentrations of CRP and for differing times as shown in Fig.6.2. The
synthetic collagen stimulates marked tyrosine phosphorylation of Spin-90 at 60s
which increases slightly by 300s (Fig.6.2A). However, there was no significant
increase in phosphorylation at 20s. even though CRP induces a marked increase in
tyrosine phosphorylation of several proteins in the whole cell lysate (Fig.6.2B).
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Figure 6.1: Characterisation of Spin-SO, J3-Pix and Nck for
immunoprecipitation. Platelets (5x108/ml) were lysed without stimulation
with 2xlysis buffer and immunoprecipitated with (A) 1 or 3,..tI of P-Pix (B) 1J..l1
and 3J..l1of Nck (C) 1, or 2~1 of Spin-SO.. In addition the relevant IgG control
was immunoprecipitated. Images are representative of two experiments.
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Figure 6.2: Spin-90 is tyrosine phosphorylated downstream of GPVI.
Platelets (5x108/ml) were stimulated with 0.3-10J..Lg/ml CRP, for 0-300s, before
lysis with 2xlysis buffer. (A) A timecourse of immunoprecipitated Spin-90 (8)
Whole cell Iysates of timecourse samples (C) Dose response curve of
immunoprecipitated Spin-90 to CRP were western blotted for tyrosine
phosphorylation. For both A&C Spin-90 was reprobed for Spin-90 to ensure
equal loading. Image are representative of two experiments.
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Fig.6.2C demonstrates the concentration-dependent nature of the increase in tyrosine
phosphorylation that is induced by CRP, peaking at a concentration of Jug/rnl.
Therefore all remaining immunoprecipitations were performed using 60s stimulation
and 3llg/ml CRP.
6.2.3 Measurement of tyrosine phosphorylation of ~-Pix, Nck, and Spin-90
Experiments were performed to investigate whether Spin-90 undergoes tyrosine
phosphorylation in response to activation by collagen, GPVI and the GPCR agonist,
thrombin, alongside studies on the Spin-90-binding proteins Nck and ~-Pix. Collagen
induced a slightly greater increase in tyrosine phosphorylation of Spin-90 relative to
that induced by thrombin and CRP (Fig.6.3A). Similarly, collagen also stimulated a
greater increase in tyrosine phosphorylation of Nck, with the response to thrombin
being particularly weak (Fig.6.3B). Strikingly, however, collagen stimulates a
marked increase in tyrosine phosphorylation of ~-Pix relative to CRP and thrombin,
with the response to the latter two agonists only being detectable on long exposures
(Fig.6.3C). This result implies that ~-Pix phosphorylation by collagen is mediated
downstream of the integrin a2~1 and not GPVI, whereas phosphorylation of Spin-90
and Nck is likely to be mediated downstream of GPVl. I was unable to find evidence
for co-association of ~-Pix, Nck and Spin-90 by western blotting of the corresponding
immunoprecipitations (data not shown) suggesting that they are not present as a
complex in platelets, which is consistent with distinct modes of regulation.
A further series of studies were performed to investigate whether ~-Pix, Nck
and Spin-90 undergo tyrosine phosphorylation and form a complex following
adhesion to fibrinogen. For these studies, platelets (5x108/ml) were allowed to spread
on a fibrinogen-coated petri dish for 45min. Prior to lysis, a 500lli aliquot of platelets
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Figure 6.3: P-Pix, Nck, and Spin-90 are tyrosine phosphorylated by both
GPCR and tyrosine kinase signalling pathways, Platelets (5x10B/ml) were
stimulated with 3f.Lg/mleRP, 30f.Lg/ml collagen, or 1unit/ml thrombin for 60s
before lysis with 2xlysis buffer. Basal platelets were also lysed, before
immunoprecipitation with (A) Spin-90 (8) P-Pix, (C) Nck. Samples were
western blotted for P-Pix, 4G10 (tyrosine phosphorylation), Spin-90, and Nck
for each immunoprecipitation. Images are representative of two experiments.
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was removed from the suspension and used as a basal sample. A protein assay was
performed in order to match the number of platelets in the suspension and adhered
samples before analysis by immunoprecipitation and western blotting. Strikingly,
neither J3-Pix nor Nck undergo tyrosine phosphorylation following adhesion to
fibrinogen (Fig.6.4). In addition, Spin-90, Nck and J3-Pix did not form a complex
upon adhesion (data not shown). Consistent with the apparent absence of regulation,
there was no apparent movement of J3-Pix and Nck to lamellipodia in platelets that
have been allowed to spread on fibrinogen (Fig.6.S). This is in contrast to Spin-90,
which, although it stains the cytosplasm, does move to the platelet periphery and stain
the lamellipodia. This is in agreement with Kim et al, 2006, who identified the
presence of Spin-90 at lamellipodia, with the same antibody.
Thus, the above results reveal agonist-specific modes of regulation of tyrosine
phosphorylation of Spin-90, J3-Pix and Nck in platelets, but fail to reveal formation of
a complex of the three actin-regulatory proteins.
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Figure 6.4: f3-Pix and Nck are not tyrosine phosphorylated upon
adhesion to fibrinogen. Platelets (5x10B/ml) were allowed to spread on
fibrinogen coated petri dishes before lysis with 2xlysis buffer. Prior to lysis,
500J..l1of platelets were removed from the supernatent, lysed with 2xlysis
buffer and used as a basal sample. Immunoprecipitations were completed
with both f3-Pix and Nck, followed by western blotting for Spin-gO, 4G10, f3-
Pix, and Nck. This experiment was performed once.
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Figure 6.5: Spin-gO moves to the platelet periphery upon adhesion.
Platelets (2x107/ml) were allowed to spread on fibrinogen coated coverslips
for 45min at 37°C. Platelets were fixed with paraformaldehyde (3.7%), lysed
with Triton X-100 (0.2%), and stained with (i) Spin-90, (ii) f3-Pix and (iii) Nck
before addition of the appropriate secondary antibody for a further 60min.
Platelets were imaged using fluorescent microscopy. Images are
representative of two experiments.
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6.3 DISCUSSION
The results in this Chapter demonstrate that Spin-90, 13-Pix, and Nck undergo
tyrosine phosphorylation downstream of both GPCR and tyrosine kinase signalling
cascades in platelets, but that they do not form a complex of Spin-90, 13-Pix and Nck
upon activation. Furthermore, although all three proteins undergo tyrosine
phosphorylation, it was notable that the profile of phosphorylation of 13-Pix was
distinct in that it was heavily phosphorylated in response to collagen, but not to either
CRP or thrombin. This indicates that 13-Pix is primarily regulated downstream of the
a213! integrin and not the GPVI signalling cascade. 13-Pix has been reported to
promote movement of Rae to membrane ruffles and lamellipodia within HEK293 and
MDCKIII cells (Ten Klooster et ai, 2006) raising the possibility that a similar set of
events downstream of a213! promotes lamellipodia formation in platelets. This is in
agreement with Inoue et aI, (2001), who reported that platelets could form
lamellipodia on the a213! specific matrix, GFOGER. On the other hand, staining for
13-Pix failed to reveal movement to platelet periphery upon platelet adhesion. In
addition Jones et ai, (2007) have identified that 13-Pix is required for cell motility and
spreading mediated by 131integrin signalling. Therefore, a possible mechanism for
the activation and role of 13-Pix in platelets is identified within Fig.6.6. a213!activates
PLCyl, leading to the recruitment of 13-Pix and possibly the adaptor protein GITI
(recently identified within platelets (Sato et ai, 2007)). This leads to the recruitment
of Rae, WAVE, and the Arp2/3 complex, causing actin reorganisation. This
potentially explains the missing link between PLCyl and Rae activation within
platelets.
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Figure 6.6: Actin reorganisation downstream of <l2J31is dependent on
PLCy1 and J3-Pix. a,2P 1 activates a signalling pathway dependent on Src
kinase activation of PLCy1. Downstream of PLCy1 GIT1 and J3-Pix, are
activated, leading to Rac activation, and then actin reorganisation
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The lack of formation of a complex between ~-Pix, Spin-90, and Nck in
suspended and adhered platelets indicates a difference in cell signalling in comparison
to cardiac myocytes. However, there are similarities between the two systems. Spin-
90 moves to lamellipodia upon platelet adhesion thereby localising it to the Arp2/3
complex, consistent with observations by Kim et al (2006 & 2007). However, it is
important to note that Spin-90 does not undergo tyrosine phosphorylation upon
adhesion to fibrinogen suggesting that it may not be active. Additional studies are
required to address this apparent contradiction.
Further experimentation is required to understand the function of these three
tyrosine phosphorylated proteins within both GPCR and tyrosine kinase platelet cell
signalling pathways. Due to the possible role of Spin-90 in actin polymerisation and
interaction with the Arp2/3 complex, it would be interesting to test whether Spin-90
does play a role within both platelet and megakaryocyte spreading, migration, and
platelet production. However, without access to mice that are deficient in each
protein, or with the application of RNAi-based technology in primary
megakaryocytes, it will be difficult to establish their functional roles in platelet
function and regulation.
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7.0 Summary
This thesis is concerned with the actin structures associated with platelet spreading
and thrombus formation downstream of glycoprotein receptors. It demonstrates the
importance of WAVE-I, the RhoA/ROCK signalling pathway, and myosin-II within
lamellipodia and stress fibre formation and the formation of a novel actin structure
with unknown function. In addition, the present results further emphasise the role of
the actin cytoskeleton within thrombus formation, both in vitro and in vivo.
7.1 Actin morphological rearrangements associated with platelet activation
downstream of glycoprotein receptors
Chapters 3-5 focus on the actin structures associated with platelet spreading on
multiple matricies. Each Chapter builds on previous knowledge, furthering the
investigation of the roles of actin morphological changes within platelet activation and
function.
One of the initial actin structures that is associated with platelet activation is
filopodia. However, the observations in Chapter 3 also identify an actin structure that
we have termed an actin nodule. Actin nodule formation on collagen and fibrinogen
is dependent on Src kinases. This is not surprising as Src kinases play a fundamental
role in cell signalling downstream of both allb~3 and GPVI. The actin regulatory
proteins Rae and the Arp2/3 complex are present in the actin nodules, further
emphasising their likely importance in actin assembly. However, to date the function
and physiological role of actin nodule formation is unknown.
After the formation of actin nodules and filopodia, lamellipodia are formed.
Rac-l is fundamental for lamellipodia formation in platelets (McCarty et aI, 2005).
Chapter 5 builds on this observation by demonstration of a specific role for WAVE-I
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in lamellipodia formation mediated downstream of GPVI. Furthermore, as is also the
case for Rac-I, WAVE-I is required for aggregation and secretion to low
concentrations of GPVI-specific agonists. Nevertherless, WAVE-I is not required for
thrombus growth and stability, presumably because of the presence of WA VE-2
within platelets. Thus, there appear to be agonist-specific pathways of regulation of
WAVE-I, downstream of GPVI, and WAVE-2, downstream of GPCR agonists.
The final actin rearrangement, stress fibre formation, requires activation of the
RhoNROCK signalling pathway and myosin-II. Inhibition of either ROCK or
myosin-II inhibits formation of stress fibres, causes fenestrations, and thrombus
instability, both in vitro and in vivo. However, interestingly, neither ROCK nor
myosin-II playa significant role in aggregation and secretion. I therefore speculate
that the thrombus instability is due to inhibition of stress fibre inhibition. However, as
yet, there is no direct evidence linking thrombus instability with cytoskeletal defects.
A series of studies were also undertaken to investigate the role of the actin
binding adapter proteins, Spin-90 and Nck, and also the GDP/GTP exchange factor,
~-Pix, downstream of glycoprotein receptors. All three of these proteins have been
reported to form a complex within cardiac myocytes upon adhesion (Lim et al, 200 I
& 2003). Moreover, Spin-90 and ~-Pix were identified as novel tyrosine
phosphorylated proteins in GPVI-activated platelets using a proteomics approach
(Garcia et ai, 2006). However, these three proteins do not form a complex in platelets
either when stimulated in suspension or upon adhesion even though all three undergo
tyrosine phosphorylation in suspension. Interestingly, however, collagen stimulates a
marked increase in tyrosine phosphorylation of ~-Pix relative to that induced by CRP,
thereby indicating that phosphorylation maybe downstream of integrin a2~1. In
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addition the activation of [3-Pix downstream of U2[31could be the missing link leading
to Rae activation, as indicated by Fig.6.6 and Jones et al (2007).
7.2 General Discussion
7.2.1 The role of the cytoskeleton in intracellular signalling cascades
The present thesis, and earlier observations, demonstrate an important role for
the cytoskeleton in intracellular signalling downstream of GPVI. This is illustrated by
treatment of platelets with the actin polymerisation inhibitor, cytochalasin D, which
causes a partial inhibition of GPVI-mediated tyrosine phosphorylation of PLCy2, Syk
and FAK (Obergell et ai, 2002; Wonerow et ai, 2002). Importantly, the reduction in
phosphorylation of Syk argues that inhibition occurs at proximal stage in the GPVI
signalling pathway, possibly being mediated by a defect in GPVI clustering.
Strikingly though, cytochalasin D-treated platelets can still adhere, secrete and
undergo aggregation to a number of agonists even though they cannot form stable
thrombi under high shear (Chapter 5, Auger thesis 2005). However, it is unclear
whether the loss of thrombus stability is due to a defect in signalling or a defect in
thrombus formation.
There is also a reduction in GPVI signalling within the Rac-I-f- platelets,
although this defect is smaller than that seen with cytochalasin 0 treatment
demonstrating that the effect of the latter is not solely due to blockade of lamellipodia.
Furthermore, other mutant platelet lines, for example LArf- platelets, have a similar
reduction in PLCy2 phosphorylation, but show little inhibition of lamellipodia.
Therefore it is likely the lamellipodia defect associated with the Rac-I-I- is
cytoskeletal rather than due to a cell signalling defect, associated with loss of Rae.
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Although cytochalasin D-treated platelets will secrete a- and dense-granules,
their secretion is differentially regulated. For example, a-granule release is inhibited
by blockade of actin polymerisation, whilst dense granule release is unaffected
(Flaumenhaft et ai, 2005). However, it is unclear if cytochalasin D prevented the
signalling events that lead to release or whether it prevents the actin rearrangements
that are needed for release.
ROCK and myosin-II inhibition cause a novel cytoskeletal phenotype that is
associated with inhibition of stress fibres formation, unstable thrombi and the
appearance of fenestrations. On the other hand, ROCK inhibition does not affect
platelet aggregation or dense-granule secretion. Myosin-II inhibited platelets, in
contrast to ROCK inhibited platelets, have a small degree of platelet inhibition that is
similar to that seen with cytochalasin D, although high concentrations of agonists can
overcome the inhibitory effect. In addition it is also possible that this inhibitory effect
is due to an additional action of blebbistatin. Allied to this, and bearing in mind that
platelet activation in the presence of a ROCK inhibitor is normal, the thrombus
instability is likely to be cytoskeletal in origin. This is further reinforced as the higher
the shear stress the greater the reduction in thrombus height, indicating a greater role
for the cytoskeleton with increasing shear stress.
Although the majority of the evidence demonstrates that the cytoskeleton
plays an important but relatively minor role in platelet activation, it should be noted in
other cell types the cytoskeleton is required for processes such as vesicle trafficking,
and correct localisation of signalling proteins. Therefore, in other cell types the
cytoskeleton may playa more major role, especially in motile cells, where movement
and cell signalling have to be intricately linked in order to function appropriately.
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7.2.2 Does platelet spreading playa role in thrombus formation in vivo?
Under in vitro conditions, platelets undergo a characteristic pattern of actin
reorganisation that is associated with filopodia, actin nodules, lamellipodia, and stress
fibres formation as demonstrated in Chapter 3-6. However, although it is possible to
assign a role for each structure in vitro, the role of these specific actin structures in
vivo, including whether they are formed, is unclear.
The major role of the platelet in vivo is prevention of blood loss through
thrombus formation. Within thrombi whilst it is possible to identify the formation of
filopodia (Maxwell et aI, 2006, Remijn et aI, 2001), the formation of lamellipodia, and
therefore stress fibres is less well defined. In vitro it is reported that platelets will
spread and form lamellipodia in aggregates, and that fibrinogen is a requirement for
this spreading, and for formation of densely packed thrombi (Remijn et aI, 2001).
This is in agreement with in vitro flow data, which indicates that lamellipodia and
fully spread platelets (and therefore it is presumed stress fibres) are clearly identified
on the bottom layer of a thrombus (Fig.7.1; McCarty et aI, 2005). However, confocal
analysis of aggregates in vitro (Fig. 7.1) indicates that platelets not in contact with
collagen do not spread, and so the upper levels of thrombi consist of rounded
platelets, not spread platelets. Interestingly however, Maxwell et al (2007) identify
that within thrombi in vivo platelets seem to lose their spherical shape, and become
elongated, possibly indicating platelet spreading.
Although platelet spreading in vivo is not clearly demonstrated it is likely that
in vivo thrombus formation will mimic in vitro in terms of initial platelet adhesion to
the damaged endothelium. Therefore, the first layer of platelets should spread, aiding
the prevention of blood loss, due to the increase in surface area coverage of a spread
platelet. However if the bottom layer of the thrombus spreads, and recruits further
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(i)
Base of thrombus
(ii)
Mid-thrombus
Figure 7.1: Identification of rounded platelets within thrombi. Whole
blood was flowed across collagen at high shear before fixation with
paraformaldehyde (3.7%), and staining with DiOC6 (2IlM). Images taken by
O.5J.lm slices through thrombi using confocal microsocopy (i) Thrombi
imaged at their base and spread platelets are clearly identified. (ii) White
arrows identify rounded platelets within the upper regions of thrombi.
Images are representative of 9 experiments.
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platelets to the thrombus, it is important to consider if these also spread. This is an
important question and illustrates an important limitation of focussing on the events
that take place on the surface i.e. within a 2D environment. However, the platelets
that lie above the monolayer are interacting in a 3D environment. This is likely to
change the actin rearrangements that take place because (i) a change in the agonist
that mediates activation, and (ii) the matrix is no longer uniform, nor fixed in place.
There is precedent in other cell types that a 3D environment is very different to that of
a 2D environment. Fibroblasts alter their morphologies by developing a more starlike
and elongated shape within a 3D matrix. Interestingly, differences in phosphorylation
downstream of integrin signalling have been detected within fibroblasts within a 3D
relative to a 20 matrix (Cukierman et aI, 2001).
In addition to platelets responding differently to a 3D environment, the shear
stress may also affect cytoskeletal rearrangements. Maxwell et al, (2006) identified
that at low shear stress (600s·') platelets extended both tethers and filopodia. At
higher shear (1,800-5,000s·') platelets adopted a spherical morphology with numerous
surface projections. At very high shear (10,000-20,000s·') filopodia were retracted
and the platelets developed a smooth ball like appearance. The reasons for the
changes in shape are unclear but the changes were controlled by both microtubules,
and the cytoskeleton indicating that morphology could play a role in thrombus
formation.
Several lines of evidence suggest that it is important for platelets to reorganise
their actin within a thrombus. For example, Rac-l·/· platelets, or treatment with
cytochalasin D, form thrombi that readily embolise. Moreover, although these
platelets have a defect in GPYI signalling, a similar defect in thrombus stability is
seen on a monolayer of thrombin and YWF (McCarty et ai, 2005). Interestingly,
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however, under these conditions, the monolayer that lies at the base of the thrombus
usually does not embolise, demonstrating that the defect is associated with the upper
regions of the thrombus. This is similar to the situation observed for the ROCK- and
myosin-II-inhibited platelets. Interestingly, analysis of the thrombus using confocal
microscopy, reveals that the upper layers contain circular platelets (Fig.7.1). This
clearly illustrates that the morphological rearrangements identified within a 2D
system, may not be the same as those within a 3D system.
7.2.3 The role of the cytoskeleton as a platelet drug target
This thesis indicates that the cytoskeleton plays a minor role within platelet cell
signalling, but that it plays an important role in platelet spreading and thrombus
stability. Therefore, the question of whether the cytoskeleton a viable drug target for
thrombosis is worthy of consideration.
The actin cytoskeleton is implicated In multiple disease states, including
cancer metastasis, plaque formation, hypertension (Mallat et ai, 2003, review
Shimokawa et al, 2007, Jurasz et al. 2004), through activity of RhoGTPases. This is
clearly demonstrated by the use of the ROCK inhibitor, fasudil as an anti-hypertensive
drug, which reduces blood pressure and plaque formation (Higashi et aI, 2003).
In the context of targeting thrombosis, the observation that the cytoskeleton
plays a minor role in cell signalling is significant, as platelet activation would be
largely unaffected. Therefore, the observation that interference in platelet spreading,
through disruption of lamellipodia, or stress fibres, or actin polyrnerisation, leads to
thrombus instability offers hope as a new means of preventing excessive thrombus
formation (McCarty et ai, 2005, Chapter 5, Auger et al unpublished data). On the
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other hand, ROCK and Rae are both present within all cells and so such targets could
give rise to many side effects.
A further consideration is whether inhibition of actin polymerisation would
cause a bleeding phenotype. The in vivo data indicates that thrombus formation is
heavily affected by interference of the cytoskeleton, but that there is still partial
thrombus formation.
7.4 Future Directions
The work in this thesis has focused on the regulation and role of lamellipodia and
stress fibre formation in thrombus formation. Similar studies are warranted for
filopodia, which are believed to be regulated downstream of Cdc42, but with no
reports to confirm this. Further to this, it would be interesting to investigate whether
inhibition of filopodia also leads to a reduction in thrombus stability.
In addition to the above, further work is needed to completely understand the
function and physiological relevance of the actin nodules. It is surprising that a such
structure does not appear to have been identified in other cell types. However, it may
that the platelet's small size has enabled its identification.
Finally the role of the actin cytoskeleton within megakaryocytes is a growing
field. Much is known about the role of microtubules within megakaryocytopoesis,
and platelet production (Italiano et aI, 1999), but little about the role of the
cytoskeleton. Clearly the cytoskeleton is vital for migration, allowing the
megakaryocytes to move from the osteoblastic niche, to the vascular niche, but its role
within platelet production is unclear. At the present time, both the RhoA/ROCK
signalling pathway and myosin-II is reported to playa negative role in proplatelet
formation (Chang et aI, 2007). However, interestingly, the Rae-I, Rac-2, Rac-ll2-I-,
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and Scar-F" all have normal platelet numbers indicating no role for these important
actin regulatory proteins within proplatelet formation. However, Cdc42/Rac double
knockout has a major defect in platelet production, which may possibly be mediated
at earlier stage in development, clearly indicating that there is a role for the
cytoskeleton within platelet production (Pleines et ai, 2007).
163
Chapter 8: References
REFERENCES
Abercrombie, M., J. E. Heaysman, et al. (1970). "The locomotion of fibroblasts in
culture. II. "RRuffling"." Exp Cell Res 60(3): 437-44.
Abercrombie, M., 1. E. Heaysman, et al. (1971). "The locomotion of fibroblasts in
culture. IV. Electron microscopy of the leading lamella." Exp Cell Res 67(2):
359-67.
Adams, A. E. and J. R. Pringle (1984). "Relationship of actin and tubulin distribution
to bud growth in wild-type and morphogenetic-mutant Saccharomyces
cerevisiae." J Cell Bioi 98(3): 934-45.
Allingham, J. S., R. Smith, et al. (2005). "The structural basis of blebbistatin
inhibition and specificity for myosin II." Nat Struct Mol Bioi 12(4): 378-9.
Araki, N., T. Hatae, et al. (2000). "Actinin-4 is preferentially involved in circular
ruffling and macropinocytosis in mouse macrophages: analysis by
fluorescence ratio imaging." J Cell Sci 113 (Pt 18): 3329-40.
Arias-Salgado, E. G., S. Lizano, et al. (2003). "Src kinase activation by direct
interaction with the integrin beta cytoplasmic domain." Proc Natl Acad Sci U
SA 100(23): 13298-302.
Asazuma, N., Y. Ozaki, et al. (1997). "Glycoprotein Ib-von Willebrand factor
interactions activate tyrosine kinases in human platelets." Blood 90(12): 4789-
98.
Asazuma, N., 1. I. Wilde, et al. (2000). "Interaction of linker for activation of T cells
with multiple adapter proteins in platelets activated by the glycoprotein VI-
selective ligand, convulxin." 1 Bioi Chem 275(43): 33427-34.
Atkinson, B. T., W. Ellmeier, et al. (2003). "Tee regulates platelet activation by GPVI
in the absence ofBtk." Blood 102(10): 3592-9.
Auger, J. M., M. 1. Kuijpers, et al. (2005). "Adhesion of human and mouse platelets to
collagen under shear: a unifying model." Faseb 119(7): 825-7.
Avecilla, S. T., K. Hattori, et al. (2004). "Chemokine-mediated interaction of
hematopoietic progenitors with the bone marrow vascular niche is required for
thrombopoiesis." Nat Med 1O( 1): 64-71.
Azim, A. c., K. Barkalow, et al. (2000). "Activation of the small GTPases, rae and
cdc42, after ligation of the platelet PAR-I receptor." Blood 95(3): 959-64.
Bamburg, J. R., A. McGough, et al. (1999). "Putting a new twist on actin:
ADF/cofilins modulate actin dynamics." Trends Cell Bioi 9(9): 364-70.
Barkalow, K. and J. H. Hartwig (1995). "The role of actin filament barbed-end
exposure in cytoskeletal dynamics and cell motility." Biochem Soc Trans
23(3): 451-6.
Barkalow, K. L., H. Falet, et al. (2003). "Role for phosphoinositide 3-kinase in Fc
gamma RIIA-induced platelet shape change." Am J Physiol Cell Physiol
285(4): C797-805.
Barkalow, K. L., J. E. Italiano, Jr., et al. (2003). "Alpha-adducin dissociates from F-
actin and spectrin during platelet activation." J Cell Bioi 161(3): 557-70.
Bauer, M., M. Retzer, et al. (1999). "Dichotomous regulation of myosin
phosphorylation and shape change by Rho-kinase and calcium in intact human
platelets." Blood 94(5): 1665-72.
Bazzoni, G., E. Dejana, et al. (1991). "Platelet-neutrophil interactions. Possible
relevance in the pathogenesis of thrombosis and inflammation."
Haematologica 76(6): 491-9.
164
Chapter 8: References
Becker, R. P. and P. P. De Bruyn (1976). "The transmural passage of blood cells into
myeloid sinusoids and the entry of platelets into the sinusoidal circulation; a
scanning electron microscopic investigation." Am J Anat 145(2): 183-205.
Benesch, S., S. Lommel, et al. (2002). "Phosphatidylinositol 4,5-biphosphate (PIP2)-
induced vesicle movement depends on N-WASP and involves Nck, WIP, and
Grb2." J Bioi Chern 277(40): 37771-6.
Bennett, J. S. (2001). "Novel platelet inhibitors." Annu Rev Med 52: 161-84.
Biyasheva, A., T. Svitkina, et al. (2004). "Cascade pathway of filopodia formation
downstream of SCAR." J Cell Sci 117(Pt 6): 837-48.
Bodie, S. L., I. Ford, et al. (2001). "Thrombin-induced activation of RhoA in platelet
shape change." Biochem Biophys Res Commun 287( 1): 71-6.
Bokoch, G. M. (2003). "Biology of the p21-activated kinases." Annu Rev Biochem
72: 743-81.
Bokoch, G. M., Y. Wang, et al. (1996). "Interaction of the Nck adapter protein with
p21-activated kinase (PAKl)." J Bioi Chern 271(42): 25746-9.
Bryce, N. S., E. S. Clark, et al. (2005). "Cortactin promotes cell motility by enhancing
lamellipodial persistence." Curr Bioi 15(14): 1276-85.
Buccione, R., J. D. Orth, et al. (2004). "Foot and mouth: podosomes, invadopodia and
circular dorsal ruffles." Nat Rev Mol Cell Bioi 5(8): 647-57.
Budzyn, K., P. D. Marley, et al. (2006). "Targeting Rho and Rho-kinase in the
treatment of cardiovascular disease." Trends Pharmacol Sci 27(2): 97-104.
Buensuceso, C. S., A. Obergfell, et al. (2005). "Regulation of outside-in signaling in
platelets by integrin-associated protein kinase C beta." J BioI Chern 280(1):
644-53.
Canobbio, I., A. Bertoni, et al. (2001). "Platelet activation by von Willebrand factor
requires coordinated signaling through thromboxane A2 and Fe gamma HA
receptor." J Bioi Chern 276(28): 26022-9.
Canobbio, I., P. Noris, et al. (2005). "Altered cytoskeleton organization in platelets
from patients with MYH9-related disease." J Thromb Haemost 3(5): 1026-35.
Carlsson, A. E., A. D. Shah, et al. (2002). "Quantitative analysis of actin patch
movement in yeast." Biophys J 82(5): 2333-43.
Chan, A. Y., M. Bailly, et al. (2000). "Role of cofilin in epidermal growth factor-
stimulated actin polymerization and lamellipod protrusion." J Cell BioI148(3):
531-42.
Chang, J. C., H. H. Chang, et al. (2005). "The integrin alpha6betal modulation of
PI3K and Cdc42 activities induces dynamic filopodium formation in human
platelets." J Biomed Sci 12(6): 881-98.
Chang, Y., F. Aurade, et al. (2007). "Proplatelet formation is regulated by the
Rho/ROCK pathway." Blood 109(10): 4229-36.
Chen, Z., O. Naveiras, et al. (2007). "The May-Hegglin anomaly gene MYH9 is a
negative regulator of platelet biogenesis modulated by the Rho-ROCK
pathway." Blood 110(1): 171-9.
Chiang, T. M., F. Cole, et al. (2002). "Cloning, characterization, and functional
studies of a 47-kDa platelet receptor for type III collagen." J Bioi Chern
277(38): 34896-901.
Chiang, T. M., A. Rinaldy, et al. (1997). "Cloning, characterization, and functional
studies of a nonintegrin platelet receptor for type I collagen." J Clin Invest
100(3): 514-21.
Condeelis, J. (1993). "Life at the leading edge: the formation of cell protrusions."
Annu Rev Cell BioI 9: 411-44.
165
Chapter 8: References
Conti, M. A., S. Even-Ram, et al. (2004). "Defects in cell adhesion and the visceral
endoderm following ablation of nonmuscle myosin heavy chain II-A in mice."
J Bioi Chem 279(40): 41263-6.
Cooper, J. A. and D. A. Schafer (2000). "Control of actin assembly and disassembly
at filament ends." Curr ODin Cell BioI 12(1): 97-103.
Coughlin, S. R. (2005). "Protease-activated receptors in hemostasis, thrombosis and
vascular biology." J Thromb Haemost 3(8): 1800-14.
Cox, A. C. (1988). "Cytochalasin E enhances the protein kinase C-dependent process
of secretion." Biochem Biophys Res Commun 150(2): 745-51.
Cukierman, E., R. Pankov, et al. (2001). "Taking cell-matrix adhesions to the third
dimension." Science 294(5547): 1708-12.
Czuchra, A., X. Wu, et al. (2005). "Cdc42 is not essential for filopodium formation,
directed migration, cell polarization, and mitosis in fibroblastoid cells." Mol
Bioi Cell 16(l0): 4473-84.
Dahl, J. P., J. Wang-Dunlop, et al. (2003). "Characterization of the WAVE 1 knock-
out mouse: implications for CNS development." J Neurosci 23(8): 3343-52.
DeMali, K. A., C. A. Barlow, et al. (2002). "Recruitment of the Arp2/3 complex to
vinculin: coupling membrane protrusion to matrix adhesion." J Cell BioI
159(5): 881-91.
Derry, J. M., H. D. Ochs, et al. (1994). "Isolation of a novel gene mutated in Wiskott-
Aldrich syndrome." Cell 79(5): following 922.
Doolittle, R. F., K. W. Watt, et al. (1979). "The amino acid sequence of the alpha-
chain of human fibrinogen." Nature 280(5722): 464-8.
Dubois, c., L. Panicot-Dubois, et al. (2006). "Glycoprotein VI-dependent and -
independent pathways of thrombus formation in vivo." Blood 107(10): 3902-
6.
Ellis, S. and H. Mellor (2000). "The novel Rho-family GTPase rif regulates
coordinated actin-based membrane rearrangements." Curr BioI 10(21): 1387-
90.
Eto, K., H. Nishikii, et al. (2007). "The WAVE21Abi I complex differentially
regulates megakaryocyte development and spreading: implications for platelet
biogenesis and spreading machinery." Blood.
Ezumi, Y., K. Shindoh, et al. (1998). "Physical and functional association of the Src
family kinases Fyn and Lyn with the collagen receptor glycoprotein VI-Fe
receptor gamma chain complex on human platelets." J Exp Med 188(2): 267-
76.
Fabre, J. E., M. Nguyen, et al. (1999). "Decreased platelet aggregation, increased
bleeding time and resistance to thromboembolism in P2Yl-deficient mice."
Nat Med 5( 10): 1199-202.
Faix, J. and K. Rottner (2006). "The making of filopodia." CUff Opin Cell BioI18(1):
18-25.
Falati, S., C. E. Edmead, et al. (1999). "Glycoprotein Ib-V-IX, a receptor for von
Willebrand factor, couples physically and functionally to the Fe receptor
gamma-chain, Fyn, and Lyn to activate human platelets." Blood 94(5): 1648-
56.
Falati, S., P. Gross, et al. (2002). "Real-time in vivo imaging of platelets, tissue factor
and fibrin during arterial thrombus formation in the mouse." Nat Med 8( 10):
1175-81.
166
Chapter 8: References
Falati, S., P. L. Gross, et al. (2004). "In vivo models of platelet function and
thrombosis: study of real-time thrombus formation." Methods Mol BioI 272:
187-97.
Falet, H., K. L. Barkalow, et al. (2000). "Roles of SLP-76, phosphoinositide 3-kinase,
and gelsolin in the platelet shape changes initiated by the collagen receptor
GPVI/FcR gamma-chain complex." Blood 96(12): 3786-92.
Falet, H., G. Chang, et al. (2005). "Integrin alpha(IIb)beta3 signals lead cofilin to
accelerate platelet actin dynamics." Am J Physiol Cell Physiol 289(4): C819-
25.
Falet, H., K. M. Hoffmeister, et al. (2002). "Normal Arp2/3 complex activation in
platelets lacking WASp." Blood 1OO( 6): 2113-22.
Falet, H., K. M. Hoffmeister, et al. (2002). "Importance of free actin filament barbed
ends for Arp2/3 complex function in platelets and fibroblasts." Proc Natl Acad
Sci USA 99(26): 16782-7.
Fink, L., H. Holschermann, et al. (2003). "Characterization of platelet-specific mRNA
by real-time PCR after laser-assisted microdissection." Thromb Haemost
90(4): 749-56.
Flaumenhaft, R., J. R. Dilks, et al. (2005). "The actin cytoskeleton differentially
regulates platelet alpha-granule and dense-granule secretion." Blood 105(10):
3879-87.
Foster, C. 1., D. M. Prosser, et al. (2001). "Molecular identification and
characterization of the platelet ADP receptor targeted by thienopyridine
antithrombotic drugs." J Clin Invest 107(12): 1591-8.
Fujiwara, I., S. Suetsugu, et al. (2002). "Visualization and force measurement of
branching by Arp2/3 complex and N-WASP in actin filament." Biochem
Biophys Res Commun 293(5): 1550-5.
Furie, B. C. and B. Furie (2006). "Tissue factor pathway vs. collagen pathway for in
vivo platelet activation." Blood Cells Mol Dis 36(2): 135-8.
Gaidano, G., L. Bergui, et al. (1990). "Integrin distribution and cytoskeleton
organization in normal and malignant monocytes." Leukemia 4( 10): 682-7.
Garcia, A., Y. A. Senis, et al. (2006). "A global proteomics approach identifies novel
phosphorylated signaling proteins in GPVI-activated platelets: involvement of
G6f, a novel platelet Grb2-binding membrane adapter." Proteomics 6( 19):
5332-43.
George, J. N., J. P. Caen, et al. (1990). "Glanzmann's thrombasthenia: the spectrum of
clinical disease." Blood 75(7): 1383-95.
Gibbins, J. M., S. Briddon, et al. (1998). "The p85 subunit of phosphatidylinositol 3-
kinase associates with the Fe receptor gamma-chain and linker for activitor of
T cells (LAT) in platelets stimulated by collagen and convulxin." J BioI Chern
273(51): 34437-43.
Gibbins, J. M., M. Okuma, et al. (1997). "Glycoprotein VI is the collagen receptor in
platelets which underlies tyrosine phosphorylation of the Fe receptor gamma-
chain." FEBS Lett 413(2): 255-9.
Gilligan, D. M., L. Lozovatsky, et al. (1999). "Targeted disruption of the beta adducin
gene (Add2) causes red blood cell spherocytosis in mice." Proc Natl Acad Sci
USA 96(19): 10717-22.
Goddette, D. W. and C. Frieden (1986). "Actin polymerization. The mechanism of
action of cytochalasin D." J Bioi Chern 261(34): 15974-80.
167
Chapter 8: References
Gratacap, M. P., B. Payrastre, et al. (2001). "Differential regulation of Rho and Rae
through heterotrimeric G-proteins and cyclic nucleotides." J BioI Chern
276(51): 47906-13.
Gross, B. S., J. I. Wilde, et al. (1999). "Regulation and function of WASp in platelets
by the collagen receptor, glycoprotein VI." Blood 94(12): 4166-76.
Gu, Y., M. D. Filippi, et al. (2003). "Hematopoietic cell regulation by Rae 1 and Rac2
guanosine triphosphatases." Science 302(5644): 445-9.
Hall, A. (1998). "Rho GTPases and the actin cytoskeleton." Science 279(5350): 509-
14.
Hartwig, J. H., G. M. Bokoch, et al. (1995). "Thrombin receptor ligation and activated
Rae uncap actin filament barbed ends through phosphoinositide synthesis in
penneabilized human platelets." Cell 82(4): 643-53.
Hartwig, 1. H. and M. DeSisto (1991). "The cytoskeleton of the resting human blood
platelet: structure of the membrane skeleton and its attachment to actin
filaments." J Cell BioI112(3): 407-25.
Hashimoto, K., K. Kawarabayashi, et al. (1986). "Inhibition of platelet secretion of
ATP by phalloidin." Cell Bioi Int Rep 10(1): 41-7.
Haslam, R. J. and J. A. Lynham (1977). "Relationship between phosphorylation of
blood platelet proteins and secretion of platelet granule constituents. I. Effects
of different aggregating agents." Biochem Biophys Res Commun 77(2): 714-
22.
Hechler, 8., N. Lenain, et al. (2003). "A role of the fast ATP-gated P2Xl cation
channel in thrombosis of small arteries in vivo." J Exp Med 198(4): 661-7.
Higashi, M., H. Shimokawa, et al. (2003). "Long-term inhibition of Rho-kinase
suppresses angiotensin Il-induced cardiovascular hypertrophy in rats in vivo:
effect on endothelial NAD(P)H oxidase system." Circ Res 93(8): 767-75.
Hollopeter, G., H. M. Jantzen, et al. (2001). "Identification of the platelet ADP
receptor targeted by anti thrombotic drugs." Nature 409(6817): 202-7.
Hotulainen, P. and P. Lappalainen (2006). "Stress fibers are generated by two distinct
actin assembly mechanisms in motile cells." J Cell Bioi 173(3): 383-94.
Inoue, 0., K. Suzuki-Inoue, et al. (2003). "Integrin alpha2betal mediates outside-in
regulation of platelet spreading on collagen through activation of Src kinases
and PLCgamma2." J Cell BioI160(5): 769-80.
Inoue, 0., K. Suzuki-Inoue, et al. (2006). "Laminin stimulates spreading of platelets
through integrin alpha6betal-dependent activation of GPVI." Blood 107(4):
1405-12.
Italiano, J. E., Jr., P. Lecine, et al. (1999). "Blood platelets are assembled principally
at the ends of proplatelet processes produced by differentiated
megakaryocytes." J Cell BioI147(6): 1299-312.
Jackson, S. P., S. M. Schoenwaelder, et al. (1994). "Adhesion receptor activation of
phosphatidylinositol 3-kinase. von Willebrand factor stimulates the
cytoskeletal association and activation of phosphatidylinositol 3-kinase and
pp60c-src in human platelets." J Bioi Chern 269(43): 27093-9.
Jaffe, A. B. and A. Hall (2005). "Rho GTPases: biochemistry and biology." Annu Rev
Cell Dev Bioi 21: 247-69.
Jenkins, A. L., L. Nannizzi-Alaimo, et al. (1998). "Tyrosine phosphorylation of the
beta3 cytoplasmic domain mediates integrin-cytoskeletal interactions." J Bioi
Chern 273(22): 13878-85.
168
Chapter 8: References
Jirouskova, M., J. K. Jaiswal, et a!. (2007). "Ligand density dramatically affects
integrin alpha lib beta 3-mediated platelet signaling and spreading." Blood
109( 12): 5260-9.
Jones, N. P. and M. Katan (2007). "Role of Phospholipase C {gamma} I in Cell
Spreading Requires Association with a {beta}-PixlGITl-Containing Complex,
Leading to Activation ofCdc42 and Rac1." Mol Cell BioI 27(l6): 5790-805.
Judd, B. A., P. S. Myung, et a!. (2002). "Differential requirement for LAT and SLP-
76 in GPVI versus T cell receptor signaling." J Exp Med 195(6): 705-17.
Jurasz, P., D. Alonso-Escolano, et a!. (2004). "Platelet--cancer interactions:
mechanisms and pharmacology of tumour cell-induced platelet aggregation."
Br J PharmacoI143(7): 819-26.
Kahn, M. L., M. Nakanishi-Matsui, et al. (1999). "Protease-activated receptors I and
4 mediate activation of human platelets by thrombin." J Clin Invest 103(6):
879-87.
Kashiwagi, H., M. Shiraga, et al. (2005). "Expression and subcellular localization of
WAVE isoforms in the megakaryocyte/platelet lineage." J Thromb Haemost
3(2): 361-8.
Kim, D. 1., S. H. Kim, et a!. (2007). "F-actin binding region of SPIN90 C-terminus is
essential for actin polymerization and lamellipodia formation." Cell Commun
Adhes 14(1): 33-43.
Kim, D. 1., S. H. Kim, et a!. (2006). "Interaction of SPIN90 with the Arp2/3 complex
mediates lamellipodia and actin comet tail formation." J Bioi Chern 281(1):
617-25.
Kiuchi, T., K. Ohashi, et al. (2007). "Cofilin promotes stimulus-induced
lamellipodium formation by generating an abundant supply of actin
monomers." J Cell BioI 177(3): 465-76.
Kovacs, M., 1. Toth, et al. (2004). "Mechanism of blebbistatin inhibition of myosin
IL" J BioI Chern 279(34): 35557-63.
Kuhlman, P. A., C. A. Hughes, et a!. (1996). "A new function for adducin.
Calcium/calmodulin-regulated capping of the barbed ends of actin filaments."
J Bioi Chern 271( 14): 7986-91.
Kunieda, Y., K. Nakagawa, et a!. (2003). "HMG CoA reductase inhibitor suppresses
the expression of tissue factor and plasminogen activator inhibitor-I induced
by angiotensin II in cultured rat aortic endothelial celis." Thromb Res 110(4):
227-34.
Law, D. A., F. R. DeGuzman, et al. (1999). "Integrin cytoplasmic tyrosine motif is
required for outside-in aiphaIIbbeta3 signalling and platelet function." Nature
401(6755): 808-11.
Legg, J. A., G. Bompard, et al. (2007). "N-WASP involvement in dorsal ruffle
formation in mouse embryonic fibroblasts." Mol Bioi Cell 18(2): 678-87.
Leng, L., H. Kashiwagi, et al. (1998). "RhoA and the function of platelet integrin
alphallbbeta3." Blood 91(11): 4206-15.
Leon, C., B. Hechler, et a!. (1999). "Defective platelet aggregation and increased
resistance to thrombosis in purinergic P2Y(l) receptor-null mice." J Clin
Invest 104(12): 1731-7.
Lim, C. S., S. H. Kim, et al. (2003). "Regulation of SPIN90 phosphorylation and
interaction with Nck by ERK and cell adhesion." J BioI Chern 278(52): 52116-
23.
169
Chapter 8: References
Lim, C. S., E. S. Park, et al. (200 I). "SPIN90 (SH3 protein interacting with Nck, 90
kDa), an adaptor protein that is developmentally regulated during cardiac
myocyte differentiation." J Bioi Chern 276(16): 12871-8.
Lindemann, S., N. D. Tolley, et al. (2001). "Activated platelets mediate inflammatory
signaling by regulated interleukin Ibeta synthesis." J Cell Bioi 154(3): 485-90.
Linder, S. and P. Kopp (2005). "Podosomes at a glance." J Cell Sci 118(Pt 10): 2079-
82.
Lo, S. H. (2006). "Focal adhesions: what's new inside." Dev Bioi 294(2): 280-91.
Lommel, S., S. Benesch. et al. (200 I). "Actin pedestal formation by enteropathogenic
Escherichia coli and intracellular motility of Shigella flexneri are abolished in
N-WASP-defective cells." EMBO Rep 2(9}: 850-7.
Lopez, 1. A., R. K. Andrews, et al. (1998). "Bernard-Soulier syndrome." Blood
91(12): 4397-418.
Ludin, B., T. Doll, et al. (1996). "Application of novel vectors for GFP-tagging of
proteins to study microtubule-associated proteins." Gene 173( 1 Spec No): 107-
II.
Machesky, L. M. and A. Hall (1997). "Role of actin polymerization and adhesion to
extracellular matrix in Rae- and Rho-induced cytoskeletal reorganization." J
Cell Bioi 138(4): 913-26.
Mallat, Z., A. Gojova, et al. (2003). "Rho-associated protein kinase contributes to
early atherosclerotic lesion formation in mice." Circ Res 93(9): 884-8.
Mangin, P., C. L. Yap, et al. (2006). "Thrombin overcomes the thrombosis defect
associated with platelet GPVI/FcRgamma deficiency." Blood 107(11): 4346-
53.
Marchisio, P. C, L. Bergui, et al. (1988). "Vinculin, talin, and integrins are localized
at specific adhesion sites of malignant B lymphocytes." Blood 72(2): 830-3.
Marchisio, P. C., D. Cirillo, et al. (1984). "Cell-substratum interaction of cultured
avian osteoclasts is mediated by specific adhesion structures." J Cell Bioi
99(5}: 1696-705.
Marshall, S. L, N. Asazurna, et al. (2002). "Glycoprotein lib-IlIa-dependent
aggregation by glycoprotein Ibalpha is reinforced by a Src family kinase
inhibitor (PPI j-sensitive signalling pathway." Biochem J 361(Pt 2): 297-305.
Maupin, P., C L. Phillips, et al. (1994). "Differential localization of myosin-Il
isozymes in human cultured cells and blood cells." J Cell Sci 107 (Pt 11):
3077-90.
Maxwell, M. J., S. M. Dopheide, et al. (2006). "Shear induces a unique series of
morphological changes in trans locating platelets: effects of morphology on
translocation dynamics." Arterioscler Thromb Vase BioI 26(3): 663-9.
Maxwell, M. J., E. Westein, et al. (2007). "Identification of a 2-stage platelet
aggregation process mediating shear-dependent thrombus formation." Blood
109(2): 566-76.
McCarty, O. L, S. D. Calaminus, et al. (2006). "von Willebrand factor mediates
platelet spreading through glycoprotein Ib and alpha(IIb )beta3 in the presence
ofbotrocetin and ristocetin, respectively." J Thromb Haemost 4(6): 1367-78.
McCarty, O. L, M. K. Larson, et al. (2005). "Rae I is essential for platelet lamellipodia
formation and aggregate stability under flow." 1 BioI Chern 280(47): 39474-
84.
McCarty, O. L, Y. Zhao, et al. (2004). "Evaluation of the role of platelet integrins in
fibronectin-dependent spreading and adhesion." 1 Thromb Haemost 2(10):
1823-33.
170
Chapter 8: References
Michelson, A. (2007). "Platelets (second edition)."
Miki, H., M. Fukuda, et al. (1999). "Phosphorylation of WAYE downstream of
mitogen-activated protein kinase signaling." J BioI Chern 274(39): 27605-9.
Miki, H., K. Miura, et al. (1996). "N-WASP, a novel actin-depolymerizing protein,
regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner
downstream of tyrosine kinases." Embo J 15(19): 5326-35.
Miki, H., T. Sasaki, et al. (1998). "Induction of filopodium formation by a WASP-
related actin-depolymerizing protein N-WASP." Nature 391 (6662): 93-6.
Miki, H., S. Suetsugu, et al. (1998). "WAVE, a novel WASP-family protein involved
in actin reorganization induced by Rae." Embo J 17(23): 6932-41.
Millard, T. H., S. J. Sharp. ct al. (2004). "Signalling to actin assembly via the WASP
(Wiskott-Aldrich syndrome protein)-family proteins and the Arp2/3 complex."
BiochemJ380(Pt I): 1-17.
Moers, A., N. Wettschureck, et a!. (2004). "Unresponsiveness of platelets lacking both
Galpha( q) and Galpha( 13). Implications for collagen-induced platelet
activation." J BioI Chern 279(44): 45354-9.
Moog, S., P. Mangin, et al. (200 I). "Platelet glycoprotein V binds to collagen and
participates in platelet adhesion and aggregation." Blood 98(4): 1038-46.
Morton, W. M., K. R. Ayscough, et a!. (2000). "Latrunculin alters the actin-monomer
subunit interface to prevent polymerization." Nat Cell BioI 2(6): 376-8.
Moseley, J. B. and B. L. Goode (2006). "The yeast actin cytoskeleton: from cellular
function to biochemical mechanism." Microbiol Mol BioI Rev 70(3): 605-45.
Murugappan, S., H. Shankar, et a!. (2004). "Platelet receptors for adenine nucleotides
and thromboxane A2." Semin Thromb Hemost 30(4): 411-8.
Nachmias, V. T. and K.-1. Yoshida (1988). "The cytoskeleton of the blood platelet:A
dynamic structure." Adv Cell Biol2: 181-211.
Nesbitt, W. S., S. Kulkarni, et a!. (2002). "Distinct glycoprotein Ib/Y/IX and integrin
alpha IIbbeta 3-dependent calcium signals cooperatively regulate platelet
adhesion under flow." J BioI Chern 277(4): 2965-72.
Ni, H., C. V. Denis, et al. (2000). "Persistence of platelet thrombus formation in
arterioles of mice lacking both von Willebrand factor and fibrinogen." J Clin
Invest 106(3): 385-92.
Ni, H., P. S. Yuen, et a!. (2003). "Plasma fibronectin promotes thrombus growth and
stability in injured arterioles." Proc Natl Acad Sci USA 100(5): 2415-9.
Nieswandt, B., C. Brakebusch, et al. (2001). "Glycoprotein VI but not alpha2betal
integrin is essential for platelet interaction with collagen." Embo J 20(9):
2120-30.
Nieswandt, B. and S. P. Watson (2003). "Platelet-collagen interaction: is GPVI the
central receptor?" Blood I02( 2): 449-61.
Niiya, K., E. Hodson, et al. (1987). "Increased surface expression of the membrane
glycoprotein lib/ilia complex induced by platelet activation. Relationship to
the binding of fibrinogen and platelet aggregation." Blood 70(2): 475-83.
Nobes, C. D. and A. Hall (1995). "Rho, rac and cdc42 GTPases: regulators of actin
structures, cell adhesion and motility." Biochem Soc Trans 23(3): 456-9.
Obergfell, A., K. Eto, et al. (2002). "Coordinate interactions of Csk, Src, and Syk
kinases with [alpha]lIb[beta]3 initiate integrin signaling to the cytoskeleton." J
Cell BioI 157(2): 265-75.
ObergfeII, A., B. A. Judd, et al. (200 I). "The molecular adapter SLP-76 relays signals
from platelet integrin alphaIlbbcta3 to the actin cytoskeleton." J BioI Chern
276(8): 5916-23.
171
Chapter 8: References
Ochs, H. D., S. J. Slichter, et al. (1980). "The Wiskott-Aldrich syndrome: studies of
lymphocytes. granulocytes. and platelets." Blood 55(2): 243-52.
Oda, A., H. Miki. et al. (2005). "WAYE/Scars in platelets." Blood 105(8): 3141-8.
Olazabal, I.M. and L. M. Machesky (2001). "Abplp and cortactin, new "hand-holds"
for actin." J Cell Bioi 154(4): 679-82.
Oldenbourg, R.. K. Katoh. et al. (2000). "Mechanism of lateral movement of filopodia
and radial actin bundles across neuronal growth cones." Biophys J 78(3):
1176-82.
Oury, C, E. Toth-Zsamboki, et al. (2001). "The ATP-gated P2X1 ion channel acts as
a positive regulator of platelet responses to collagen." Thromb Haemost 86(5):
1264-71.
Oury, C., E. Toth-Zsamboki, et al. (2002). "P2X(I)-mediated activation of
extracellular signal-regulated kinase 2 contributes to platelet secretion and
aggregation induced by collagen." Blood 100(7): 2499-505.
Pasquet, J. M.. R. Bobe, et al. (1999). "A collagen-related peptide regulates
phospholipase Cgamma2 via phosphatidylinositol 3-kinase in human
platelets." Biochem J 342 (Pt I): 171-7.
Paul, B. Z., J. L. Daniel. et al. (1999). "Platelet shape change is mediated by both
calcium-dependent and -independent signaling pathways. Role of pl60 Rho-
associated coiled-coil-containing protein kinase in platelet shape change." J
Bioi Chem 274(40): 28293-300.
Pawson, T., G. D. Gish, et al. (2001). "SH2 domains, interaction modules and cellular
wiring." Trends Cell Bioi 11(12): 504-11.
Pearce, A. c., O. J. McCarty, et al. (2007). "Yav family proteins are required for
optimal regulation of PLCgamma2 by integrin alphaIIbbeta3." Biochem J
401(3): 753-61.
Pearce, A. C, Y. A. Sen is, et al. (2004). "Yavl and vav3 have critical but redundant
roles in mediating platelet activation by collagen." J Bioi Chem 279(52):
53955-62.
Pearce, A. C., J. I. Wilde, et al. (2002). "Yavl, but not Yav2, contributes to platelet
aggregation by CRP and thrombin, but neither is required for regulation of
phospholipase C" Blood 100(10): 3561-9.
Pelham, R. J., Jr. and F. Chang (200 I). "Role of actin polymerization and actin cables
in actin-patch movement in Schizosaccharomyces pombe." Nat Cell BioI3(3):
235-44.
Pellegrin. S. and H. Mellor (2005). "The Rho family GTPase Rif induces filopodia
through mDia2." Curr Bioi 15(2): 129-33.
Phillips, D. R., I. F. Charo, et al. (1988). "The platelet membrane glycoprotein lIb-IlIa
complex." Blood 71(4): 831-43.
Pleines, I., E. M., et al. (2007). "Double deficiency of Rac-I and Cdc42 severely
affects platelet production and function." ISTH.
Polishchuk, R. S.. E. Y. Polishchuk, et al. (2000). "Correlative light-electron
microscopy reveals the tubular-saccular ultrastructure of carriers operating
between Golgi apparatus and plasma membrane." J Cell BioI148(1): 45-58.
Pollard, T. D. and G. G. Borisy (2003). "Cellular motility driven by assembly and
disassembly of actin filaments." Cell 112(4): 453-65.
Poole, A., J. M. Gibbins, et al. (1997). "The Fe receptor gamma-chain and the tyrosine
kinase Syk are essential for activation of mouse platelets by collagen." Embo J
16(9): 2333-41.
172
Chapter 8: References
Pula, G., K. Schuh, et al. (2006). "PKCdelta regulates collagen-induced platelet
aggregation through inhibition of VASP-mediated filopodia formation." Blood
108(13): 4035-44.
Quek, L. S., 1. M. Pasquet, et al. (2000). "Fyn and Lyn phosphorylate the Fe receptor
gamma chain downstream of glycoprotein VI in murine platelets, and Lyn
regulates a novel feedback pathway." Blood 96(13): 4246-53.
Remijn, 1. A., Y. P. Wu, et al. (200 I). "Absence of fibrinogen in afibrinogenemia
results in large but loosely packed thrombi under flow conditions." Thromb
Haemost 85(4): 736-42.
Ridley, A. J. (1995). "Microinjection of Rho and Rae into quiescent Swiss 3T3 celis."
Methods Enzymol 256: 313-20.
Ridley, A. 1. (2001). "Rho family proteins: coordinating cell responses." Trends Cell
Bioll1(l2): 471-7.
Ridley, A. J. (2006). "Rho GTPases and actin dynamics in membrane protrusions and
vesicle trafficking." Trends Cell Bioi 16( 10): 522-9.
Ridley, A. 1. and A. Hall (1992). "The small GTP-binding protein rho regulates the
assembly of focal adhesions and actin stress fibers in response to growth
factors." Cell 70(3): 389-99.
Ridley, A. 1., H. F. Paterson, et al. (1992). "The small GTP-binding protein rae
regulates growth factor-induced membrane ruffling." Cell 70(3): 401-10.
Rolf, M. G., C. A. Brearley, et al. (2001). "Platelet shape change evoked by selective
activation of P2Xl purinoceptors with alpha.beta-methylene ATP." Thromb
Haemost 85(2): 303-8.
Rolfe, B. E., N. F. Worth, et al. (2005). "Rho and vascular disease." Atherosclerosis
183(1): 1-16.
Rottner, K., A. Hall, et al. (1999). "Interplay between Rae and Rho in the control of
substrate contact dynamics." Curr BioI 9( 12): 640-8.
Ruggeri, Z. M. (2007). "Von Willebrand factor: looking back and looking forward."
Thromb Haemost 98( I): 55-62.
Sabri, S., A. Foudi, et al. (2006). "Deficiency in the Wiskott-Aldrich protein induces
premature proplatelet formation and platelet production in the bone marrow
compartment." Blood 108(1): 134-40.
Sambrano, G. R., E. J. Weiss, et al. (200 I). "Role of thrombin signalling in platelets in
haemostasis and thrombosis." Nature 413(6851): 74-8.
Sato, H., K. Suzuki-Inoue, et al. (2007). "G protein-coupled receptor kinase-
interacting protein I (GIT!) is tyrosine-phosphorylated downstream of Integrin
alpha lIb beta3 in platelets." ISTH.
Schirenbeck, A., T. Bretschneider, et al. (2005). "The Diaphanous-related formin
dDia2 is required for the formation and maintenance of filopodia." Nat Cell
BioI 7(6): 619-25.
Schoenwaelder, S. M., S. C. Hughan, et al. (2002). "RhoA sustains integrin alpha
IIbbeta 3 adhesion contacts under high shear." J Bioi Chem 277( 17): 14738-
46.
Sells, M. A., U. G. Knaus, et al. (1997). "Human p21-activated kinase (Pak I)
regulates actin organization in mammalian cells." Curr BioI 7(3): 202-10.
Senis, Y. A., B. T. Atkinson, et al. (2005). "Role of the pllOdelta PI 3-kinase in
integrin and ITAM receptor signalling in platelets." Platelets 16(3-4): 191-202.
Seri, M., A. Pecci, et al. (2003). "MYH9-related disease: May-Hegglin anomaly,
Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not
173
Chapter 8: References
distinct entities but represent a variable expression of a single illness."
Medicine (Baltimore) 82(3): 203-15.
Shimizu, Y., D. Thumkeo, et al. (2005). "ROCK-I regulates closure of the eyelids and
ventral body wall by inducing assembly of actomyosin bundles." J Cell Bioi
168(6): 941-53.
Shimokawa, H. and M. Rashid (2007). "Development of Rho-kinase inhibitors for
cardiovascular medicine." Trends Pharmacol Sci 28(6): 296-302.
Small, J. V., K. Rottner, et al. (1998). "Assembling an actin cytoskeleton for cell
attachment and movement." Biochim Biophys Acta 1404(3): 271-81.
Snapper, S. B., F. Takeshima, et al. (200 I). "N-WASP deficiency reveals distinct
pathways for cell surface projections and microbial actin-based motility." Nat
Cell Bioi 3(10): 897-904.
Soderling, S. H., L. K. Langeberg, et al. (2003). "Loss of WAVE-I causes
sensorimotor retardation and reduced learning and memory in mice." Proc
Nat! Acad Sci USA 100(4): 1723-8.
Soulet, C., S. Gendreau, et al. (2001). "Characterisation of Rae activation in thrombin-
and collagen-stimulated human blood platelets." FEBS Lett 507(3): 253-8.
Soulet, C., B. Hechler, et al. (2005). "A differential role of the platelet ADP receptors
P2Yl and P2YI2 in Rae activation." J Thromb Haemost 3(10): 2296-306.
Stradal, T. E., K. Rottner, et al. (2004). "Regulation of actin dynamics by WASP and
WAVE family proteins." Trends Cell Bioi 14(6): 303-11.
Suetsugu, S., H. Miki, et al. (1999). "Identification of two human WAVE/SCAR
homologues as general actin regulatory molecules which associate with the
Arp2/3 complex." Biochem Biophys Res Commun 260(1): 296-302.
Suetsugu, S., H. Miki, et al. (2002). "Spatial and temporal regulation of actin
polymerization for cytoskeleton formation through Arp2/3 complex and
WASP/WAVE proteins." Cell Motil Cytoskeleton 51(3): 113-22.
Sun, H. Q., M. Yamamoto, et al. (1999). "Gelsolin, a multifunctional actin regulatory
protein." J BioI Chem 274(47): 33179-82.
Suzuki-Inoue, K., C. E. Hughes, et al. (2007). "Involvement of Src kinases and
PLCgamma2 in clot retraction." Thromb Res 120(2): 251-8.
Suzuki-Inoue, K., O. Inoue, et al. (2003). "Murine GPVI stimulates weak integrin
activation in PLCgamma2-1- platelets: involvement of PLCgammal and PI3-
kinase." Blood 102(4): 1367-73.
Suzuki-Inoue, K., D. Tulasne, et al. (2002). "Association of Fyn and Lyn with the
proline-rich domain of glycoprotein VI regulates intracellular signaling." J
Bioi Chem 277(24): 21561-6.
Suzuki-Inoue, K., Y. Yatomi, et al. (2001). "Rae, a small guanosine triphosphate-
binding protein, and p21-activated kinase are activated during platelet
spreading on collagen-coated surfaces: roles of integrin alpha(2)beta( I)."
Blood 98(13): 3708-16.
Svitkina, T. M., E. A. Bulanova, et al. (2003). "Mechanism of filopodia initiation by
reorganization of a dendritic network." J Cell Bioi 160(3): 409-21.
Takano, S., 1. Kimura, et al. (1999). "No requirement of P2X1 purinoceptors for
platelet aggregation." Eur J PharmacoI372(3): 305-9.
Tang, Y. Q., M. R. Yeaman, et al. (2002). "Antimicrobial peptides from human
platelets." Infect Immun 70(12): 6524-33.
ten Klooster, J. P., Z. M. Jaffer, et al. (2006). "Targeting and activation of Racl are
mediated by the exchange factor beta-Pix." J Cell Bioi 172(5): 759-69.
174
Chapter 8: References
Thomas, D. W., R. B. Mannon, et al. (1998). "Coagulation defects and altered
hemodynamic responses in mice lacking receptors for thromboxane A2." J
Clin Invest 102( 11): 1994-2001.
Thornber, K., O. 1. McCarty, et al. (2006). "Distinct but critical roles for integrin
alphaIIbbeta3 in platelet lamellipodia formation on fibrinogen, collagen-
related peptide and thrombin." Febs J 273(22): 5032-43.
Thumkeo, D., J. Keel, et al. (2003). "Targeted disruption of the mouse rho-associated
kinase 2 gene results in intrauterine growth retardation and fetal death." Mol
Cell BioI 23( 14): 5043-55.
Tiedt, R., T. Schomber, et al. (2007). "Pf4-Cre transgenic mice allow the generation
of lineage-restricted gene knockouts for studying megakaryocyte and platelet
function in vivo." Blood 109(4): 1503-6.
Tomer, A., R. E. Scharf, et al. (1994). "Bernard-Soulier syndrome: quantitative
characterization of megakaryocytes and platelets by flow cytometric and
platelet kinetic measurements." Eur J HaematoI52(4): 193-200.
Torti, M., A. Bertoni, et al. (1999). "Rap 1Band Rap2B translocation to the
cytoskeleton by von Willebrand factor involves Fcgammall receptor-mediated
protein tyrosine phosphorylation." J BioI Chern 274(19): 13690-7.
Tsuji, M., Y. Ezumi, et al. (1997). "A novel association of Fe receptor gamma-chain
with glycoprotein VI and their co-expression as a collagen receptor in human
platelets." J BioI Chern 272(38): 23528-31.
Vargas, 1. R., M. Radomski, et al. (1982). "The use of prostacyclin in the separation
from plasma and washing of human platelets." Prostaglandins 23(6): 929-45.
Vidal, C., B. Geny, et al. (2002). "Cdc42/Racl-dependent activation of the p21-
activated kinase (PAK) regulates human platelet lamellipodia spreading:
implication of the cortical-actin binding protein cortactin." Blood 100(13):
4462-9.
Vidal, M., V. Gigoux, et al. (2001). "SH2 and SH3 domains as targets for anti-
proliferative agents." Crit Rev Oncol Hematol 40(2): 175-86.
Vidali, L., F. Chen, et al. (2006). "Rae l-null mouse embryonic fibroblasts are motile
and respond to platelet-derived growth factor." Mol BioI Cell 17(5): 2377-90.
Wagner, C. L., M. A. Mascelli, et al. (1996). "Analysis of GPIIb/IIIa receptor number
by quantification of7E3 binding to human platelets." Blood 88(3): 907-14.
Walinsley, M. J., S. K. Ooi, et al. (2003). "Critical roles for Racl and Rac2 GTPases
in B cell development and signaling." Science 302(5644): 459-62.
Wang, D., J. Feng, et al. (2000). "Phospholipase Cgamma2 is essential in the
functions of B cell and several Fe receptors." Immunity 13(1): 25-35.
Watson, S. P., N. Asazuma, et al. (2001). "The role of ITAM- and ITIM-coupled
receptors in platelet activation by collagen." Thromb Haemost 86(1): 276-88.
Watson, S. P., J. M. Auger, et al. (2005). "GPVI and integrin alphaIIb beta3 signaling
in platelets." J Thromb Haemost 3(8): 1752-62.
Wentworth, J. K., G. Pula, et al. (2006). "Vasodilator-stimulated phosphoprotein
(VASP) is phosphorylated on Serl57 by protein kinase C-dependent and -
independent mechanisms in thrombin-stimulated human platelets." Biochem J
393(Pt 2): 555-64.
White, J. G. (2005). "Platelets are covercytes, not phagocytes: uptake of bacteria
. involves channels of the open canalicular system." Platelets 16(2): 121-31.
Wilde, J. I., M. Retzer, et al. (2000). "ADP-induced platelet shape change: an
investigation of the signalling pathways involved and their dependence on the
method of platelet preparation." Platelets 11(5): 286-95.
175
Chapter 8: References
Wolfrum, S., A. Dendorfer, et al. (2004). "Inhibition of Rho-kinase leads to rapid
activation of phosphat idyl inositol 3-kinase/protein kinase Akt and
cardiovascular protection." Arterioscler Thromb Vasc Bioi 24(10): 1842-7.
Wonerow, P., A. Obergfell, et al. (2002). "Differential role of glycolipid-enriched
membrane domains in glycoprotein VI- and integrin-mediated phospholipase
Cgamma2 regulation in platelets." Biochem J 364(Pt 3): 755-65.
Wonerow, P., A. C. Pearce, et al. (2003). "A critical role for phospholipase Cgamma2
in alphaIIbbeta3-mediated platelet spreading." J BioI Chern 278(39): 37520-9.
Woodside, D. G., A. Obergfell, et al. (2001). "Activation of Syk protein tyrosine
kinase through interaction with integrin beta cytoplasmic domains." Curr Bioi
11(22): 1799-804.
Wu, Y., K. Suzuki-Inoue, et al. (200 I). "Role of Fe receptor gamma-chain in platelet
glycoprotein Ib-mediated signaling." Blood 97(12): 3836-45.
Yamazaki, D., S. Suetsugu, et al. (2003). "WAVE2 is required for directed cell
migration and cardiovascular development." Nature 424(6947): 452-6.
Yan, C., N. Martinez-Quiles, et al. (2003). "WAVE2 deficiency reveals distinct roles
in embryogenesis and Rae-mediated actin-based motility." Embo J 22(14):
3602-12.
Yang, L., L. Wang, et al. (2006). "Gene targeting of Cdc42 and Cdc42GAP affirms
the critical involvement of Cdc42 in filopodia induction, directed migration,
and proliferation in primary mouse embryonic fibroblasts." Mol BioI Cell
17(11): 4675-85.
Yatomi, Y., M. Higashihara, et al. (1986). "Separable function of platelet release
reaction and clot retraction." Biochem Biophys Res Commun 140(1): 329-34.
Yoneda, A., H. A. Multhaupt, et al. (2005). "The Rho kinases I and II regulate
different aspects of myosin II activity." J Cell Bioi 170(3): 443-53.
Zambrowicz, B. P., G. A. Friedrich, et al. (1998). "Disruption and sequence
identification of 2,000 genes in mouse embryonic stem cells." Nature
392(6676): 608-11.
Zamir, E. and B. Geiger (200 I). "Molecular complexity and dynamics of cell-matrix
adhesions." J Cell Sci 114(Pt 20): 3583-90.
Zhang, J., A. Shehabeldin, et al. (1999). "Antigen receptor-induced activation and
cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-
. deficient lymphocytes." J EXDMed 190(9): 1329-42.
Zlgmond, S. H. (1996). "Signal transduction and actin filament organization." Curr
ODin Cell Bioi 8( 1): 66-73.
176
APPENDIX
Supplementary Video I: Human platelet spreading on fibrinogen
Supplementary Video 2: Murine GFP-spreading on fibrinogen
Supplementary Video 3: Human platelet spreading on collagen in the presence ofY27632
These can be found in the CD in the back sleeve.
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